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Chapter 1.
General introduction
- Zou je op de omslag de titel en naam om 
willen draaien, dus je leest het nu als het 
boekje op zijn kop ligt, maar je zou het moeten 
kunnen lezen als het boekje met de bovenkant 
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Youth care is aimed at improving the well-being of children and adolescents and their 
parents. Moreover, youth care aims to prevent society from the burden of misbehavior 
and crime due to behavioral problems. Given these aims and the importance of them 
to society, substantial budgets are available for youth care in the Netherlands. To spend 
these budgets wisely, it would be worthwhile to be able to justify the reimbursement of 
youth care interventions based on cost-effectiveness data. Such information, however, 
is scarce because methods of cost-effectiveness analyses in youth care are not fully 
developed and data needed for such studies are difficult to obtain. As a result, little is 
known about the (cost-) effectiveness of most of the available youth care interventions. 
Therefore, this thesis aims at contributing to the development of research tools to 
determine the effectiveness and cost-effectiveness of interventions in youth care. 
Dutch youth care
The Dutch youth care system comprises a broad range of interventions. To get an 
impression of the available interventions, the ‘database effective youth interventions’ can 
be consulted (DEI; ‘databank effectieve jeugdinterventies’ in Dutch; Netherlands Youth 
Institute, 2016a). The DEI provides insight into the quality, feasibility, and effectiveness 
of interventions and aims to connect academic research and theories with youth care 
practice (Netherlands Youth Institute, 2016b). The underlying thought is that practice-
based evidence can lead to evidence-based practice to improve the services rendered 
to children, adolescents, and their parents (Veerman, van Yperen, Bijl, Ooms, & Roosma, 
2008). According to APA standards, evidence-based practice is “the integration of the 
best available research with clinical expertise in the context of patient characteristics, 
culture and preferences” (APA Presidential Task Force on Evidence-based practice, 
2006, p. 273). This definition underscores the aim of the DEI to be transparent about the 
available evidence for each youth care intervention. The effectiveness of interventions in 
the DEI is ranked according to the so-called ‘effectladder’ that comprises four categories 
of evidence: the intervention has potential (i.e., is well described), is promising (i.e., 
has a good underlying program theory), is effective in daily clinical practice (i.e., shows 
first signs of effectiveness based on, for example, routine outcome monitoring), or the 
intervention is effective based on a research design with an experimental and a control 
condition (Veerman & van Yperen, 2008). The higher the level of evidence, the more 
proof that the outcomes found after finishing an intervention indeed resulted from the 
intervention itself and were not caused by confounding factors (Veerman & van Yperen, 
2008). Various committees consisting of clinicians and scientists with a specific area 
of expertise rank submitted interventions on their level of effectiveness (Netherlands 
Youth Institute, 2016c). Gathering available evidence and structuring it for all youth 
care interventions in the DEI supports clinicians, youths and families, but also policy 
makers in weighing the pros and cons of the interventions offered and, thus, making 
well-informed choices. 
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Not being randomized
A Randomized Controlled Trial (RCT) is considered to be the golden standard for 
comparing the effectiveness of interventions; its results are considered as the highest 
scientific evidence. In an RCT the internal validity is high, because participants are 
randomized over an experimental and control condition and the aim is to obtain 
unbiased treatment effect estimates: the treatment selection bias is assumed to be zero 
(APA, 2006; Imai, Kind, & Stuart, 2008; Stuart, Cole, Bradshaw, & Leaf, 2011). Proven 
effectiveness in an RCT is also the highest level of evidence for interventions to be 
marked as effective in the DEI. 
However, conducting an RCT is not always feasible due to ethical or practical 
constraints (Black, 1996). Therefore, alternative options should be considered to obtain 
evidence for clinical practice. For example, a quasi-experimental study design using 
observational data could be used in evaluating the effectiveness of interventions in 
clinical practice. Using such a study design, regular clinical practice can be followed 
and participants are not randomly allocated to interventions. The external validity of the 
results found in such studies could be higher than in RCT’s, since participants represent 
the actual target population and the sample selection bias is closer to zero (Imai et al., 
2008; Stuart et al., 2011). However, to increase the internal validity of non-randomized 
samples, and decrease the treatment selection bias, one should minimize the effect of 
allocation bias in evaluating the effectiveness of interventions.
Without controlling for possible baseline differences due to allocation bias in non-
randomized studies, the effect of the interventions could be confounded by these initial 
differences. To control for allocation bias in observational data, the propensity score 
(PS) method is a valid and frequently used method. The PS is defined as the conditional 
probability of assignment to an intervention given a set of observed pre-treatment 
differences (Rosenbaum & Rubin, 1983). When applying the PS, the strongly ignorability 
assumption should be considered carefully, meaning that the treatment assignment 
should be independent of the potential outcome, the treatment assignment should 
be independent given a set of measured covariates, and each adolescent should have 
a chance of being in either treatment arm (Shadish, 2013). Given the assumption of 
strongly ignorability, applying the PS to achieve balance in the treatment arms enables 
the achievement of results equivalent to randomized studies (Austin, 2011; Shadish, 
2013; West, Cham, Thoemmes, Renneberg, Schulze, & Weiler, 2014). 
This thesis explores the possibilities of using the PS in youth care evaluation 
studies, because using the PS enables comparative effectiveness studies in youth care 
and increases the external validity of the results. External validity is especially important 
in health policy and, thus, in cost-effectiveness research, since the results should be 
translated to spending public money to reimburse cost-effective interventions. 
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Common practice 
In Dutch youth care, interventions are mostly compared to treatment as usual. As a 
consequence, though treatment as usual can be proven to be effective too, it is not 
known which intervention is more effective when one has to choose between two 
evidence-based interventions. It complicates the choice for the more effective option, 
especially when one should decide on what works best for whom. Furthermore, when 
effective interventions are already available for a certain target population, the question 
is what the standard treatment (i.e., control condition) should be when evaluating a 
new treatment. Therefore, it could be worthwhile to mutually compare evidence-based 
interventions on their effectiveness.
Reimbursement criteria
Establishing the effectiveness is the second criterion when deciding which health care 
interventions should be reimbursed in the Netherlands, according to the ‘Trechter van 
Dunning’ (Busschbach & Delwel, 2010; Roscam Abbin, 1991). The necessity of care, 
based on the burden of disease, is the first criterion, and the cost-effectiveness is the 
third criterion, after which it is decided if the patient can pay the costs of care or whether 
it should be reimbursed by society, which is the fourth criterion (Busschbach & Delwel, 
2010). When we translate these criteria to youth care, the following questions should 
be answered subsequently: 1) Is it necessary to treat children and adolescents with a 
high burden of disease, that prevents them to participate at a societal level? 2) Have 
the treatment options been proven effective  as presented in the DEI? 3) What is the 
cost-effectiveness of the various treatment options?, and 4) Can the youths and their 
families pay the costs of these interventions themselves or should they be reimbursed 
by society? Thus far, research in youth care has mainly focused on the first two questions. 
The third and fourth question have not been given as much attention.
These reimbursement decisions are, however, important in youth care, since the 
responsibility for the budgets available for youth care was transferred from the Dutch 
national government to local authorities in 2015 (Transitiebureau Jeugd, 2015). This 
was done to enable municipalities to develop integrated policies and to tailor youth 
care to local and individual situations and needs. The ultimate goal was to create more 
coherent, more effective, more transparent, and less expensive services for children and 
their families. Because of the shifting budgets, it became even more important to be 
able to show which interventions are available and which of them are proven to be 
effective and cost-effective. 
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Economic evaluation
Given this ‘current state of play’, municipalities have to choose between available 
interventions. However, though there is substantial budget available, the budgets were 
cut in recent years and the budgets are limited, since municipalities have to spend their 
money on various domains (Transitie Autoriteit Jeugd, 2017). As a result, municipalities 
only have a limited budget to help ‘their’ youth and their families by reimbursing these 
interventions. It would thus be useful to have information on both the effectiveness 
and the costs of the interventions offered. Costs and effects are jointly evaluated in 
a cost-effectiveness analysis, which is increasingly being used to inform decisions 
regarding the reimbursement of health care interventions. In these analyses, the costs 
are preferably considered from a societal perspective, in which all relevant costs are 
included, irrespective of the payer perspective (Drummond, Sculpher, Torrance, O’Brien, 
& Stoddart, 2005; Zorginstituut Nederland, 2015). 
A cost-effectiveness analysis can reveal various outcomes. For example, if the new 
intervention is more effective and less costly than the alternative or current treatment, the 
new intervention is preferred over the alternative. Moreover, when the new intervention 
is more effective, and the new and alternative interventions cost the same, or when 
both interventions are equally effective while the new intervention is less costly, the 
new intervention is also preferred. However, the reimbursement decision becomes more 
complicated if the new intervention is more effective and more costly. It should then be 
decided whether the additional effects of the more effective intervention are worth the 
additional costs (Drummond et al., 2005). 
In the situation where the new intervention is more effective and more costly, the 
additional costs of the new intervention can be divided by the additional effects, which 
represents the Incremental Cost-Effectiveness Ratio (ICER). This ICER value can be 
compared to the amount of money the decision-maker, or society, would be willing to 
pay for an additional unit of effect. If the ICER then is lower than the willingness-to-pay 
(WTP) value, the new interventions is cost-effective. However, if the ICER is higher than 
the WTP value, investing in the new intervention is not possible or rather questionable 
and one would stick with the alternative or current intervention (Briggs, Claxton, & 
Sculpher, 2006). 
Although nowadays economic evaluations are often used when evaluating health 
care and especially when evaluating new medicines (Rutten, 2010; Zorginstituut 
Nederland, 2015), cost-effectiveness analyses in youth care are not yet broadly applied. 
In the Netherlands, the guidelines on cost-effectiveness analyses only shortly describe 
their application in mental and forensic health care (Zorginstituut Nederland, 2015). 
Nevertheless, the number of cost-effectiveness analyses in youth care, but also in 
mental health care and in crime prevention, has increased (e.g., Knapp, McDaid, Evers, 
Salvador-Carulla, Halsteinli, & MHEEN Group, 2008; Soeteman & Busschbach, 2008).
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This thesis
This thesis outlines two issues that follow the current state of evidence in youth care. 
The first issue deals with the stringent health care budgets and the municipalities being 
responsible for the reimbursement of interventions in youth care from January 2015 
onwards. In light of these recent developments, it could help municipalities if both costs 
and effects of an intervention are clear and when interventions are compared on both 
outcomes. Therefore, this thesis addresses the issue of whether cost-effectiveness research 
in the field of youth care is feasible. Chapter 2 addresses this issue by illustrating the 
use of a cost-effectiveness model in which Functional Family Therapy (FFT) is compared 
with treatment as usual (TAU). The results of a cost-effectiveness model are, however, 
subject to uncertainty in their cost and effects estimates. This parameter uncertainty 
can be reduced if we would have more information on the costs and effects. Therefore, 
further research could be helpful, but further research is not without costs. In a value of 
information analysis, as presented in Chapter 3, the value of conducting further research 
is estimated and the type of research that would be most useful is identified. As this type 
of analysis has not been applied in the field of youth care before, Chapter 3 presents an 
example of this analysis based on the cost-effectiveness model of Chapter 2. 
The second issue is raised by using available, non-randomized, data in investigating 
the effectiveness of interventions in youth care practice. In such designs, statistical 
methods can help to control for initial, non-random, differences between adolescents 
assigned to different treatment groups. The PS method is such a method, and it is 
increasingly being used in psychological research. In Chapter 4, a Monte Carlo simulation 
study is conducted to find out how the PS can be used in subgroup analysis. In Chapter 
5, everyday practice data is used to compare FFT and Multisystemic Therapy (MST) on 
their effectiveness, using the PS method. Chapter 6, the general discussion, summarizes 
the findings of this thesis and discusses future perspectives and implications for clinical 
practice, policy makers, and researchers in youth care. 
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Chapter 2.
Framework for modelling the cost-effectiveness 
of systemic interventions aimed to reduce youth 
delinquency
Saskia J. Schawo, Hester V. Eeren, Djøra I. Soeteman, Marie-Christine van der Veldt,
Marc J. Noom, Werner Brouwer, Jan J.V. Busschbach, & Leona Hakkaart
Journal of Mental Health Policy and Economics (2012), 15, 187-196
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Abstract
Background: Many interventions initiated within and financed from the health care 
sector are not necessarily primarily aimed at improving health. This poses important 
questions regarding the operationalization of economic evaluations in such contexts. 
Aims of the Study: We investigated whether assessing cost-effectiveness using state-of-
the-art methods commonly applied in health care evaluations is feasible and meaningful 
when evaluating interventions aimed at reducing youth delinquency.
Methods: A probabilistic Markov model was constructed to create a framework for the 
assessment of the cost-effectiveness of systemic interventions in delinquent youth. For 
illustrative purposes, Functional Family Therapy (FFT), a systemic intervention aimed 
at improving family functioning and, primarily, reducing delinquent activity in youths, 
was compared to Treatment as Usual (TAU). “Criminal activity free years” (CAFYs) 
were introduced as central outcome measure. Criminal activity may e.g. be based on 
police contacts or committed crimes. In absence of extensive data and for illustrative 
purposes the current study based criminal activity on available literature on recidivism. 
Furthermore, a literature search was performed to deduce the model’s structure and 
parameters. 
Results: Common cost-effectiveness methodology could be applied to interventions for 
youth delinquency. Model characteristics and parameters were derived from literature 
and ongoing trial data. The model resulted in an estimate of incremental costs/CAFY 
and included long-term effects. Illustrative model results point towards dominance of 
FFT compared to TAU. 
Discussion: Using a probabilistic model and the CAFY outcome measure to assess 
cost-effectiveness of systemic interventions aimed to reduce delinquency is feasible. 
However, the model structure is limited to three states and the CAFY measure was 
defined rather crude. Moreover, as the model parameters are retrieved from literature 
the model results are illustrative in the absence of empirical data.
Implications for Health Care Provision and Use: The current model provides a 
framework to assess the cost-effectiveness of systemic interventions, while taking into 
account parameter uncertainty and long-term effectiveness. 
Implications for Health Policies: The framework of the model could be used to assess the 
cost-effectiveness of systemic interventions alongside (clinical) trial data. Consequently, 
it is suitable to inform reimbursement decisions, since the value for money of systemic 
interventions can be demonstrated using a decision analytic model.  
Implications for Further Research: Future research could be focused on testing the 
current model based on extensive empirical data, improving the outcome measure and 
finding appropriate values for that outcome.
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Introduction 
Child delinquency poses a high economic burden on society (Welsh et al., 2008). 
Therefore, crime prevention and treatment of youth delinquents is of great importance to 
governments, in particular for Justice Departments. Systemic interventions, for instance 
Multisystemic Therapy (MST), Functional Family Therapy (FFT) or Parent Management 
Training Oregon (PTMO), are relatively costly interventions in youth health care aiming 
to reduce delinquent behavior (Aos, Lieb, Mayfield, Miller, & Pennucci, 2004). Cost-
effectiveness studies are still limited in the field of youth health care. However, these 
costly systemic family interventions compete with medical treatments and other 
interventions for health care budgets, increasing the need for knowledge regarding the 
operationalization of economic evaluations in this context. 
In the Netherlands, as part of an ongoing nationwide action plan of the Ministry 
of Justice, recently a selection was made of evidence-based treatments for delinquent 
youth (Ministry of Justice, 2008), among which MST, FFT and PMTO were implemented 
given their apparent effectiveness in reducing criminal activity in youths. The aim of these 
systemic interventions is not primarily to produce health in the sense of physical health 
and absence of disease, as measured in the Quality Adjusted Life Years (QALY) outcome. 
These interventions attempt to improve family functioning and may even intervene with 
the peers and school environment of the youth (i.e. Hendriks, van der Schee, & Blanken, 
2011; Sexton & Alexander, 2000). Still, these treatments are reimbursed by the Dutch 
social health insurance system and, as such, part of the health care sector. Therefore, like 
other health care interventions, each intervention needs to demonstrate value for money 
since it competes for limited funds with other interventions. Efficiency considerations 
are deemed important in guiding decisions on which treatments to reimburse or 
initiate. However, given the atypical aim of these systemic interventions, i.e. reducing 
youth delinquency, an important question is how these types of interventions could 
demonstrate their efficiency or value for money. The conventional health economic 
approach of measuring improvements in terms of QALYs may fall short in this context. 
Indeed, considering the literature on reducing youth delinquency, it becomes clear 
that important differences exist between economic evaluations performed in the health 
care sector and evaluations of crime prevention and treatment programs. It seems 
that both fields commonly perform sophisticated effect studies, including randomized 
controlled trials, meta-analyses and systematic reviews (Glisson et al., 2010; Henderson, 
Rowe, Dakof, Hawes, & Liddle, 2009; King et al., 2006; Teuffel et al., 2011; Ttofi, Farrington, 
Losel, & Loeber, 2011). Considering economic evaluations of crime prevention and 
treatment programs the classical cost-benefit analysis is conventionally used (Loeber & 
Farrington, 2000; Soeteman & Busschbach, 2008). An extensive cost-benefit evaluation 
of crime prevention and intervention programs has been performed by Aos and 
colleagues (2004) in the United States. That evaluation was based on a literature review, 
computation of average effects per treatment program, assignment of a monetary value 
to the effects and subsequently calculation of a net present value in a cost-benefit model 
structure. Furthermore, French and colleagues (2002a; 2002b), for example, conducted 
cost-benefit analyses on addiction treatment for substance abusers. These cost benefit 
analyses were deterministic models (Aos et al., 2004; French, McCollister, Cacciola, et 
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al., 2002; French, McCollister, Sacks, et al., 2002). In addition, Aos and colleagues (2004) 
assessed costs and benefits from a taxpayer perspective. In health economic literature, 
cost-effectiveness analyses are preferably conducted from a societal perspective. 
Another difference between the two fields is, that in health economics sophisticated 
methodological guidelines for economic evaluations have been developed, while in 
the field of criminal justice such guidelines do not (yet) appear to exist. Furthermore, 
in health economic literature, cost-effectiveness or cost-utility analyses dominate 
(Soeteman & Busschbach, 2008). In the field of crime prevention and treatment, these 
analyses are limited. Nevertheless, McCollistar and colleagues (2003a; 2003b; 2004) 
and French and colleagues (2008) conducted various cost-effectiveness analyses related 
to substance abuse treatment, where the effectiveness is for example measured as 
days of re-incarceration (McCollister, French, Inciardi, et al., 2003; McCollister, French, 
Prendergast, et al., 2003; McCollister et al., 2004) or as a delinquency score (French et 
al., 2008). These studies show clearly the use of state of the art methods developed in 
the field of health care, applied in the field of crime prevention and treatment. On the 
other hand, these cost-effectiveness analyses were relatively conventional as parameter 
uncertainty was not captured in the model and long-term estimates were not taken 
into account. A common way to assess the cost-effectiveness in health care is the so-
called decision analytic model (Briggs, Claxton, & Sculpher, 2006; Drummond, Sculpher, 
Torrance, O'Brien, & Stoddart, 2005). This approach provides a mathematical structure, 
synthesizing the evidence on costs and effects in a treated population under a variety 
of treatment options and makes the uncertainty around estimates visible. An additional 
advantage of this decision analytic modelling approach is that long-term effects can 
be modelled, even beyond the duration of the trial. Decision-analytic modelling and 
in particular inclusion of long-term effects may be especially relevant for interventions 
aiming to reduce criminal behavior. Several authors suggested that criminal behavior 
during adulthood tends to be preceded by behavioral disorders during childhood. 
Berger and Boendermaker (2003) stated that serious offenders often have a history 
of problematic behavior in their early years of life. Kim-Cohen and colleagues (2003) 
mentioned that most mental disorders in adults “...should be reframed as extensions of 
juvenile disorders”. This suggests that systemic interventions for juvenile disorders may 
reduce future criminal activity later on in life. Estimates of long-term effects are therefore 
essential to the analysis of these interventions. 
The current study aims to build a probabilistic decision analytic model like common 
models in health care for assessing interventions primarily aimed at crime prevention 
and treatment in youth care. In developing the model the following requirements had 
to be met:
i. The model should be applicable to assess costs and effects of systemic 
interventions primarily aimed in reducing delinquent behavior;
ii. The initial model should be fairly simple however easy to adjust to sophisticated 
details (i.e. severity of delinquency); 
iii. The model should be probabilistic, taking uncertainty into account;
iv. The model should be suitable for long-term analysis;
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As an illustration an initial assessment of the cost-effectiveness of Functional Family 
Therapy (FFT) compared to treatment as usual (TAU) is presented. As the aim of the 
study is the application of the probabilistic decision analytic modelling to interventions 
aimed at reducing delinquency, the interventions compared could be substituted by 
other systemic interventions mentioned.
The article is structured as follows. The methods section provides information on 
the health economic model type and general characteristics of the model. The results 
section elaborates on the applicability of the decision analytic model and outcome 
measure to the field of systemic interventions specifying necessary adaptations to the 
health economic approach based on an initial assessment of cost-effectiveness of FFT. 
The conclusion relates our findings to the general objective of applying health economic 
methods to systemic interventions not primarily aimed at improving health.
Methods
Model structure
We constructed a probabilistic Markov cohort model (Briggs et al., 2006). Disease progression 
in common Markov models is described using transitions between ‘states’, where a subject 
can move between states or remain in the current state. The transition rates between states 
are typically estimated based on short run data. Long-term predictions are made based on 
repetition of transition cycles and assumptions based on for example literature.  
In order to keep the initial model as transparent as possible, a Markov model was 
constructed consisting of three states, i.e. A - criminal behavior, B - non criminal behavior 
and C - dead. The model structure is shown in Figure 1. All subjects in our study started in 
state A, moved to either state B or C or remained in state A and could then move between 
criminal and non-criminal states. Death acted as the absorbing state. Note that subjects 
could also remain in their present state (depicted by the u-turns). 
A - criminal
B - not criminal
C - dead
tpA2B(1-nmr)
tpB2A(1-nmr)
nmr
nmr
tpB2B(1-nmr)
tpA2A(1-nmr)
P
D
F C
reated
 w
ith d
eskP
D
F P
D
F C
reato
r X
 - Trial :: http
://w
w
w
.d
o
cudesk.co
m
Figure 1. Markov model
nmr = natural mortality rate
tpA2A = transition probability of staying in state A
tpA2B = transition probability of moving from state A to state B
tpB2A = transition probability of moving from state B to state A
tpB2B = transition probability of staying in state B
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Outcome measures and model parameters
In order to apply health economic methods meaningfully in the field of crime prevention 
and treatment, we introduce a new and neutral outcome measure of cost-effectiveness 
modified for this particular type of intervention: criminal activity free years (CAFYs). 
The CAFY was defined as a measure of time spent in a dichotomous criminal or non-
criminal state. When extensive data is available, criminal activity can e.g. be defined as 
having had police contacts or committed crimes in the past half year. For the purpose 
of demonstrating the model functioning and in the absence of extensive clinical data, 
the criminal state in this study was based on adolescent recidivism derived from clinical 
trial findings reported by Sexton and Alexander (2000). Transition probabilities differed 
according to the treatments offered. Treatment costs also differed per treatment type 
whereas all other costs (Table 1) in the different states were assumed to be independent 
of the treatment arm but dependent on the state. The cycle length used in the model 
was six months. This corresponds to the period common for follow up intervals in clinical 
trials in the field of crime prevention (Glisson et al., 2010; Henderson et al., 2009; Hogue 
et al., 2008). 
Table 1. Included types of costs 
Cost categories Direct Indirect
Health care Medical and mental health care child
(psychologist, psychiatrist, GP, specialist, 
ER, hospital (day) care, medication, youth 
welfare agency (bureau jeugdzorg)*, foster 
home*, residential institution, centre for 
addiction treatment, social worker)
Medical and mental health care parent
(psychologist, psychiatrist, GP, specialist, 
foster care*, centre for addiction treatment, 
social worker)
Outside health 
care
Travel expenses (incl.parking) 
Time spent by child on exercises as part 
of therapy*
Time spent by parent on exercises 
as part of therapy*
Productivity losses parent
(absence from work, inefficiency at 
work)
Informal care/ support child
(community centre/ church/ moskee/ 
association, care/support by family or 
acquaintances)
Criminal justice system child
(Council of child protection, Bureau 
Halt*, Police, Lawyer, Court, 
Incarceration costs)
Informal care/ support parent
(community centre/ church/ moskee/ 
association) 
* Included until age 30
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In the developed model two treatment alternatives were compared. To provide 
an example of a cost-effectiveness analysis of systemic interventions, a group receiving 
FFT therapy and a comparison group receiving TAU were evaluated. TAU refers to a 
comparable treatment, which delinquent youth would have received if they had not 
received FFT. As institutions offer diverse types of alternative therapies to FFT, TAU 
may differ between the different institutions. In one institution TAU may be MST, while 
another institution may offer Cognitive Behavioral Therapy (CBT) as an alternative to 
FFT. In our illustration subjects could not switch between FFT and TAU. 
For an extensive comparison between two systemic interventions, the model should 
include several types of cost categories. Table 1 depicts the common cost categories 
in health economic evaluations; direct and indirect costs inside and outside the health 
care system adapted to the field of crime. The included types of costs are derived 
from a combination of the costs commonly included in health economic evaluations 
and literature on cost of crime (Cohen, 2005). These costs not only pertain to costs 
incurred by the delinquent juvenile, e.g. costs due to criminal activities or treatment, 
but also to costs falling on family, caregivers and the society as a whole. For reasons of 
comparability with other interventions in health care, the model included all relevant 
societal costs in accordance with the Dutch manual for costing in economic evaluations 
(Hakkaart, Tan, & Bouwmans, 2010). 
Discount rates for future costs and effects were set consistent with guidelines for 
economic evaluations in the Netherlands (The Health Care Insurance Board, 2006). (Note 
that differential discounting is required in the Netherlands to account for the growth in 
the value of health over time. See for example Brouwer and colleagues (2005) for the 
rationale behind this. Therefore, by using these rates it was implicitly assumed here, that 
the value of a criminal activity free year (CAFY) will also increase over time, comparable 
to the rate of a QALY.) 
Data analytic procedures: Cost-effectiveness and scenario analyses
In effect studies, uncertainty is generally represented as a confidence interval, i.e. the 
magnitude of uncertainty is expressed in standard deviations of the measurement error. 
This assumes that all relevant uncertainty is measurable in a single outcome measure, and 
that the distribution of the measurement error is reasonably normal. As both assumptions 
do not apply in typical health economic evaluations, normal t-tests and other parametric 
statistics are not particularly useful in health economic modelling. Instead, probabilistic 
analysis was conducted to take the uncertainty of the model parameters into account. In 
this analysis uncertainty was simulated by running the Markov model several times using 
a large cohort of subjects, each time with slightly different parameter values. These 
values were obtained by randomly sampling from each of the parameter distributions, 
i.e. gamma distributions for costs, and Dirichlet distributions for transition parameters 
(Briggs et al., 2006). One thousand Monte Carlo simulations were performed. In each 
simulation a random draw from the parameter distributions was taken, which creates 
a unique set of cost and effect parameters. The expected costs and effects were then 
calculated and could be plotted on a cost-effectiveness plane. Four additional scenarios 
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were run to demonstrate model behavior under different assumptions. As the transition 
probabilities constitute important model parameters, a scenario was created in which 
probabilities for both interventions were equal. Subsequently, the intervention costs are 
important parameters, since systemic interventions are concerned to be relatively costly 
(Aos et al., 2004). From a societal perspective, family costs are assumed to be important, 
therefore it was investigated how exclusion of these costs would influence the results in 
the third scenario.     
Results 
The resulting health economic model for systemic interventions showed that modelling 
an intervention with a primary aim of decreasing delinquency was feasible. Based on the 
illustrative comparison of FFT versus TAU, costs and effects could be expressed in costs 
per CAFY. This section elaborates on the specific characteristics of the resulting decision 
analytic model. Obviously, the combination using different sources for the inputs of a 
model is certainly not without problems, but we stress that the emphasis here was on 
building an illustrative model and demonstrating the model functioning.  
Model structure
Estimates of long-term effects were essential to the analysis and were taken into account 
in the current model. This required some (informed) assumption regarding the endurance 
of effects of treatment also taking into account the influence that reaching a certain age 
or experiencing certain life events may have on criminal behavior (Farrington, 2003). 
For the current model, information on these parameters was taken from the literature. 
Moffitt (1993) roughly suggested that after adolescence or at approximately age 30 
subjects who are criminal during their entire life, life-course-persistent offenders, will 
remain criminal and subjects who only show criminal behavior during their adolescence, 
so-called adolescence-limited offenders, will have returned to non criminal behavior. 
This implies a stable state of criminal activity among individuals of age 30 and older. To 
illustrate the option of incorporating earlier theory and evidence on the development 
of offending and antisocial behavior we integrated parts of the long-term stabilizing 
effects described by Moffitt (1993) into the  current model framework. This effect is 
implemented in the model by extending the effectiveness of the treatment till the age 
of 30 years. Consequently youth remain in their current state after that age. Thus after 
reaching the age of 30, youth reach a stable state in their criminal behavior, which means 
the transition probabilities in the model are from then on defined by mortality rates only. 
The time horizon of the model is 50 years.
To illustrate how long-term effects may influence model results, Figure 2 and Figure 
3 present the percentage of youth in each model state over the time horizon of the 
model, for FFT and TAU respectively. Figure 2 and Figure 3 demonstrate that a stable 
state is already reached after about 1 year, which implies that the actual impact of the 
incorporation of a stabilizing effect, based on the theory of Moffit (1993) is minor in this 
model. However, as the model results are only as good as the available input used to fill 
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the model, the current results only illustrate how long-term effects could be included in 
the present model, as it is mainly based on assumptions made and empirical data are 
lacking.  
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Figure 2. Percentage of youth in model states over time for FFT
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Figure 3. Percentage of youth in model states over time for TAU
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Outcome measure: CAFY
In health economic evaluations, cost-effectiveness is most commonly estimated in cost 
per quality-adjusted life year (QALY). However, as the predominant effect of behavioral 
interventions for criminal youths is the reduction of criminal activity (Erkenningscommissie 
Gedragsinterventies Jeugd, 2011) and thus is not directly or exclusively linked to physical 
health and absence of disease, the effect measure QALY seems inadequate to capture 
the full benefit of interventions in adolescent mental health (Sindelar, Jofre-Bonet, 
French, & McLellan, 2004). Therefore, a different outcome measure that sufficiently 
captures the goals of crime prevention and treatment was required. Considering the 
societal perspective of the policymaker, a broad outcome measure, directly linked to 
the goal of a reduction in criminal activity, was chosen. As a first step in this context, we 
chose the outcome measure of criminal activity free years (CAFYs), which can be used to 
determine the (incremental) costs per CAFY, i.e. the costs per criminal activity free year. 
Using CAFYs as the effect measure enables decisions based on a non-monetary value 
that is comparable between interventions and that properly reflects the goals of the 
Ministry of Justice while fitting into the health economic modelling approach. Existing 
examples of an effectiveness measure that resembles the use of the CAFY measure, is 
the use of days re-incarcerated (McCollister et al., 2004).
As the model has two states defined as either being criminal or not being criminal, 
the transition from state A, criminal, to state B, not criminal, represents the rate of not 
being criminal after treatment. The transition of state B to state A on the other hand 
represents the rate becoming criminal after having been not criminal. It is assumed 
all youth enter the model as being criminal. The outcome of (incremental) costs per 
CAFY, was (as a first and rather simplified step) obtained by assigning different costs 
to individuals according to their current state, criminal state A or non criminal state B. 
Determining the net present value of the additional costs incurred in state A and state 
B over the full lifespan of subjects and dividing these by the amount of additional years 
the individual spends in the non criminal state B during his entire life (compared to TAU) 
yielded an estimate of incremental costs per CAFY. This process of calculating life-time 
costs and dividing these by life-time criminal-activity-free years was repeated 1000 times 
by means of simulation in order to reflect variability in input parameters. 
Model parameters: Transition probabilities
Transition probabilities were dependent on the definition of the states reflecting the 
choice of outcome measure. In the current model, criminal behavior was chosen as most 
relevant outcome measure so that the states were defined as ‘criminal’ and ‘non criminal’ 
and transition probabilities between the states could be retrieved from literature.
Several studies showed the effectiveness of FFT compared to TAU (French et al., 
2008; Gordon, Graves, & Arbuthnot, 1995; Sexton & Turner, 2010; Sexton & Alexander, 
2000, 2002). Yet, there is no consistent outcome regarding the effectiveness of FFT in 
comparison to TAU. The results based on adolescent recidivism derived from clinical trial 
findings reported  by Sexton and Alexander (2000) were most applicable and comparable 
to the formulation of our model parameters and definition of the comparison group. 
| Chapter 2 Framework for modelling the cost-effectiveness of systemic interventions |
2
| 24 25 |
So demonstrating the model, we used the effectiveness rates of that study (Sexton & 
Alexander, 2000). As the rate of recidivism based on the clinical trial reported in the 
study of Sexton and Alexander is 33 percent (Sexton & Alexander, 2000), we assumed 
this rate could be equal to the transition from state B to state A in the model and is 
therefore supposed to be equal to 33 percent. As the sum of all transition probabilities 
related to one state in the model sums up to 100 percent, the transition rate of state B to 
state B (individuals remaining in the non criminal state) is set at 67% (100% minus 33%). 
As for illustrative purposes we assumed here that the probability of individuals staying 
non-criminal (B to B) to be equal to the probability of  becoming non-criminal (A to B),the 
transition from state A to state B, was fixed at 67 percent as well. Again subtracting this 
transition rate from 100% resulted in a probability of 33% for individuals remaining in 
the criminal state (A to A). Sexton and Alexander (2000) furthermore suggested that 
“FFT reduces recidivism and/or the onset of offending between 25 and 60 percent more 
effectively than other programs”. As TAU refers to a comparable treatment, we took the 
average of this range as a reasonable and illustrative estimate of the effectiveness of 
TAU. The model therefore was constructed under the illustrative assumption that FFT 
reduces criminal activity 42.5 percent more effectively than TAU. 
Transition probabilities were assumed to be fixed over the years, as no further long 
term effectiveness is known yet.
Model parameters: Costs 
To fill in the cost parameters in the model the costs in the criminal state were retrieved 
from an ongoing trial of FFT (ZonMw, 2008). The volumes of costs in the non criminal 
state were derived from scaling volumes in the criminal state with a ratio of cost volumes 
of anti-social versus “normal” youths presented in a UK study on the financial costs of 
anti-social youths (Scott, Knapp, Henderson, & Maughan, 2001). Unit prices were taken 
from the Dutch manual for costing in economic evaluations (Hakkaart et al., 2010). In 
absence of Dutch unit costs, mean treatment costs of the interventions compared were 
derived from American costs presented in the study of Aos and colleagues (2004). These 
costs are not related to the states but depend on the intervention a youth received. 
Cost-effectiveness
As the comparison of FFT with TAU in the current model is illustrative, the model results 
solely fulfil this objective. These illustrative cost-effectiveness results from the model 
point towards lower costs of FFT when compared to TAU. Taking the mean from the 
stochastic results, the number of CAFYs for FFT exceeds the number of CAFYs for TAU 
by 6.88 and the costs of FFT appear lower than TAU with incremental cost savings 
of 8,577EUR (Table 2), positioning the intervention in the South East quadrant of the 
cost-effectiveness plane (Figure 4). Incremental cost-effectiveness from the illustrative 
model data expressed in costs per CAFY amounts to cost savings of 1,246 EUR/CAFY. 
These exemplifying results suggest that FFT produces better effects at lower cost when 
compared to TAU.
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Table 2. Scenario analyses
CAFY’s gained Cost savings
Base case 6.88 8,577
Scenario 1: transition rate FFT=TAU -0.02 -718
Scenario 2: TC FFT = TC TAU 6.85 9,112
Scenario 3: excl. family costs 6.88 6,307
FFT = Functional Family Therapy
TAU = Treatment As Usual
TC = Treatment Costs
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Figure 4. Cost-effectiveness results - Base case analysis
Scenario analyses
Scenario analysis can reveal how the results change if certain parameters are changed. 
The scenario analysis indicates that the model is particularly sensitive to changes in 
transition rates whereas the results appear rather robust to changes in other input 
parameters (Table 2). When transition rates of TAU and FFT are assumed equal (Table 
2, Scenario 1), cost savings and CAFY gains entirely vanish. Simulation then results, on 
average, in an incremental effect of zero and negligible differences in costs between 
the interventions. The results of the model thus appear to strongly depend on accurate 
estimates of transition probabilities. Variation in intervention costs does not yield 
significant differences in costs or effects (Table 2, Scenario 2), whereas exclusion of 
family costs not only results in a decrease in cost savings but also decreases the variance 
of the incremental costs (Table 2, Scenario 3). 
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Discussion and Conclusions
This study created a framework for the evaluation of interventions aimed at reducing 
criminal activity in  delinquent youth. A probabilistic Markov model approach was 
constructed allowing the assessment of the incremental cost-effectiveness of two 
systemic interventions. For illustrative purposes, the interventions considered were 
FFT and TAU. As the comparison of FFT with TAU in the current model is solely an 
example to demonstrate model functioning, the model results are illustrative in absence 
of empirical data. As a first step to come to suitable outcome measures in this field, we 
introduced the outcome measure of Criminal Activity Free Years (CAFY) in a probabilistic 
decision analytic model. The presented methodology may provide a basis for further 
development of the model and outcome measures and, ultimately, decision-making by 
both Ministries of Justice and, in particular, Health. Policymakers may compare cost and 
effects between different types of interventions aiming to reduce delinquency among 
youth. 
An advantage of using decision analytic models is that this approach enables 
calculation of hypothetical scenarios. Hence, questions of policymakers, for example 
on differences in cost-effectiveness within subgroups of youth or on the optimal age 
for intervention may be answered. Moreover, the decision uncertainty is represented 
in the model results by taking into account the uncertainty surrounding the input 
parameters of the model. The current study showed that it was feasible to apply health 
economic methodology to assess interventions aimed at reducing delinquency rates. 
The approach was developed to be consistent with health economic guidelines. To our 
knowledge, this was the first economic evaluation using decision-analytic modelling in 
the evaluation of systemic interventions for crime prevention and treatment. 
However, a number of important questions remain. First of all, the outcome 
measure presented here is clearly sector-specific. While this enables choosing between 
interventions with similar aims, it does not directly allow comparisons with other 
interventions. This problem is not unique for this context. For instance, interventions 
in elderly care or social care may not be primarily aimed at producing health as well. 
Outcome measures such as the OPUS and ICECAP have been proposed as better 
capturing the benefits of such care (Coast et al., 2008; Ryan, Netten, Skatun, & Smith, 
2006). This does raise the question, however, of how to trade-off between interventions 
when their aim is not similar and when different outcome measures were used to assess 
cost-effectiveness. This seems to be an important area for future research. 
Secondly, we proposed the measure of CAFY as a first step to demonstrate how 
interventions aimed to reduce delinquency could be evaluated within a probabilistic 
decision model. If such interventions were to be evaluated more systematically using 
methodology like the one presented here, clearly, the outcome measure deserves more 
attention. The outcome measure of the CAFY is a very simple and crude one. One could 
compare it to ‘natural units’ used in cost-effectiveness analysis like gained life years and 
event free life years. An important problem with these measures and the CAFY is that 
they do not reflect the seriousness of the events (e.g. living in a poor or good health 
state or, in this case, engaging in many and severe criminal activities or a few minor 
felonies). However, the definition of criminal activity free could be based on different 
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measures, like the number of police contacts or youth self-report of committed crimes. 
Since not all committed crime, irrespective of the seriousness of the crime, is reported 
to the police, the difference in definition could give different effectiveness and cost-
effectiveness results. Preference weighted measures (like the QALY) would be preferred 
in this context. Such measures could add a weight to different types of criminal activities 
and be more comprehensive in terms of the benefits they include (which could even 
entail a mix of health and crime-related outcomes). 
Reducing delinquent behavior is an important outcome of systemic interventions, 
but multiple other outcomes may be relevant as well, among which for example 
the ability to live at home after treatment, school attendance or family functioning 
(Henggeler, 1999; Sindelar et al., 2004). As these multiple outcomes are not considered 
in the current model, it could be valuable to extend the model or broaden the outcome 
measure.
Before further use, the model would require improvement, since our analysis had a 
number of limitations. First, the model was limited to three states. Although a model is 
always a simplification of reality, and the current model even was an illustration, it should 
be investigated whether three states are sufficient to provide reasonable estimations 
of reality. Secondly, the states used now were dichotomous (criminal or non-criminal 
behavior). The severity of criminal offenses is likely to be important as well, also as a 
predictor of future criminal activity (Farrington, 2003). The frequency or the types of 
crime could be an important differentiating factor to discriminate more detailed states 
(Farrington, 2003). Using more differentiated states would therefore add validity to the 
model. However, a necessary condition for the formulation of a more complex model is the 
availability of more and detailed trial data. Third, an individual’s history of offenses could 
be used to predict future behavior and, thus, it may be useful to relax the ‘memoryless’ 
feature of the Markov model (Briggs et al., 2006). This feature encompasses that once a 
subject has moved from one state to another, the Markov model will have ‘no memory’ 
regarding which state the subject has come from or the timing of that transition. Using 
the history of earlier offences in the model could also improve the resulting estimates. 
The incorporation of long-term effects in the model was based on the coarse assumption 
individuals reach a stable state of criminal behavior after an age of 30 (Moffitt, 1993). 
However, the impact of using this theory in the current model was minor. In future 
research one could consider incorporating other relevant theories like the one used 
here (Moffitt, 1993) to improve long-term effect modelling. Various other theories and 
studies about the development of offending and antisocial behavior exist (Farrington, 
2003), that could be used to incorporate long-term effects into the model. For example, 
Sampson and Laub (1993) suggest that offending depends on the strength of bonding 
to society, like bonding to family, peers, school and social institutions (Moffitt, 1993). 
In addition, an early age of onset predicts a relatively long criminal career (Farrington, 
2003; Loeber & Farrington, 2000) and several risk factors for the early onset of offending 
are acknowledged (Farrington, 2003). Besides using studies like those mentioned, a 
stabilizing effect could be modelled more smoothly over time or could be based on 
empirical, long-term follow-up data to add more detail to modelling long-term effects. 
Furthermore, Value of Information (VoI) analyses should explore the additional value of 
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further research to characterize the uncertainty of the model inputs, including long-term 
effects (Briggs et al., 2006). Fourth, the cost parameters in the model are depicted from 
a combination of costs used in health economic evaluations and literature on cost of 
crime. However, victim costs and intangible costs, which include direct economic losses 
of the victims and indirect losses suffered by these victims, respectively, are not taken 
into account (McCollister, French, & Fang, 2010). Addition of these costs could be of 
value. Finally, model parameters were solely based on the limited evidence base of 
available literature and where retrieved out of different literature sources. Ideally, these 
parameters would be retrieved from more comprehensive empirical data. For example, 
the transition probabilities could be linked to the presence or absence of police contacts, 
contacts with judicial institutions or committed crimes. Availability of additional data can 
refine the input data of the model and increase the validity of the model structure and 
the accuracy of the results. 
Concluding, we used the methods commonly employed in health economic 
evaluations to create a framework for determining the value for money of interventions 
targeted at reducing youth delinquency. The results are encouraging, but important 
further steps still need to be taken. A first next step may be the collection of empirical 
data to test the presented methodology. We further suggest the construction of a 
multidimensional outcome measure that enables researchers to capture the multiple 
dimensions of the treatment goals, in a preference-weighted manner. A final matter that 
deserves attention is the value we assign to outcomes such as reduced delinquency. 
Calculating cost-effectiveness is especially useful when the results can be judged against 
some ‘threshold’ value. What this should be in this context remains unclear as yet. 
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Abstract
Objectives: To investigate whether a value of information analysis, commonly applied 
in health care evaluations, is feasible and meaningful in the field of crime prevention. 
Methods: Interventions aimed at reducing juvenile delinquency are increasingly being 
evaluated according to their cost-effectiveness. Results of cost-effectiveness models are 
subject to uncertainty in their cost and effect estimates. Further research can reduce 
that parameter uncertainty. The value of such further research can be estimated using 
a value of information analysis, as illustrated in the current study. We built upon an 
earlier published cost-effectiveness model that demonstrated the comparison of two 
interventions aimed at reducing juvenile delinquency. Outcomes were presented as 
costs per criminal activity free year. 
Results: At a societal willingness-to-pay of €71,700 per criminal activity free year, further 
research to eliminate parameter uncertainty was valued at €176 million. Therefore, in 
this illustrative analysis, the value of information analysis determined that society should 
be willing to spend a maximum of €176 million in reducing decision uncertainty in the 
cost-effectiveness of the two interventions. Moreover, the results suggest that reducing 
uncertainty in some specific model parameters might be more valuable than in others. 
Conclusions: Using a value of information framework to assess the value of conducting 
further research in the field of crime prevention proved to be feasible. The results 
were meaningful and can be interpreted according to health care evaluation studies. 
This analysis can be helpful in justifying additional research funds to further inform the 
reimbursement decision in regard to interventions for juvenile delinquents.
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Introduction
In order to guide policy decisions, it would be helpful to know the cost-effectiveness of 
interventions aimed at reducing juvenile delinquency. So far, cost-effectiveness analyses 
have informed an increasing number of reimbursement decisions in mental health-care 
(Evers, Salvador-Carulla, Halsteinli, McDaid, & MHEEN Group, 2007; Knapp et al., 2008). 
Accordingly, the number of cost-effectiveness analyses in the field of crime prevention is 
increasing (Barrett & Byford, 2012; Cary, Butler, Baruch, Hickey, & Byford, 2013; French 
et al., 2008; Knapp et al., 2008; McCollister et al., 2003a; McCollister et al., 2003b; 
McCollister, French, Prendergast, Hall, & Sacks, 2004; Romeo, Byford, & Knapp, 2005; 
Soeteman & Busschbach, 2008). 
The inputs in a cost-effectiveness analysis can be uncertain, as available 
information about the costs and effects of interventions is rarely perfect. As a result, 
the decision whether or not to reimburse an intervention is marked by uncertainty. 
When a decision to reimburse an intervention turns out to be incorrect, it could lead 
to suboptimal interventions being approved. These interventions create costs in terms 
of foregone benefits and resources (Briggs, Claxton, & Sculpher, 2006; Claxton, 2008; 
Claxton, Neumann, Araki, & Weinstein, 2001; Claxton, Sculpher, & Drummond, 2002; 
Oostenbrink, Al, Oppe, & Rutten-van Mölken, 2008). Further research may eliminate this 
uncertainty and optimize the reimbursement decision. 
This study aims to estimate the added value of future cost-effectiveness research. 
This type of analysis is referred to as a ‘value of information’ analysis and was introduced 
as part of statistical decision theory (Pratt, Raiffa, & Schlaifer, 1995; Raiffa, 1968). It has 
already been applied in other research areas, such as engineering and environmental 
risk analysis (Yokota & Thompson, 2004), before being introduced into health technology 
assessment (Briggs et al., 2006; Claxton, 1999, 2008; Claxton et al., 2001; Claxton et 
al., 2002; Oostenbrink et al., 2008), where the application of this analysis is now widely 
adopted, as well as in the field of mental health care (Mohseninejad, van Baal, van den 
Berg, Buskens, & Feenstra, 2013; Soeteman, Busschbach, Verheul, Hoomans, & Kim, 
2011).
A value of information analysis reveals the value of conducting additional research 
and identifies the type of research that would be most useful. Its results can inform 
about further research on specific parameters, and more precisely inform the decision 
about which intervention should be reimbursed (Myers et al., 2011). Furthermore, a 
value of information analysis can be used to prioritize future research, for example by 
highlighting the merits of certain types of research which might add to the reduction of 
the parameter uncertainty in cost-effectiveness analysis (Carlson et al., 2013; Oostenbrink 
et al., 2008; Sculpher & Claxton, 2005). The potential value of further research could 
then be weighed against the costs of conducting this research in order to determine 
whether it is worthwhile (i.e. Briggs et al., 2006; Claxton, 2008).
Because a value of information analysis has not yet been applied in the field of 
crime prevention, we will present an example of this analysis based on an existing 
cost-effectiveness model in crime prevention and treatment (Schawo et al., 2012). We 
used two interventions aimed at reducing juvenile delinquency in the Netherlands, in 
adolescents aged 12-18 years. These interventions can be applied to prevent juvenile 
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delinquency or used to prevent juveniles committing crimes in future, for example after 
an adolescent has been punished under the juvenile criminal laws. Juvenile law in the 
Netherlands applies to adolescents aged 12-17 years (van der Laan, 2006). Not only the 
criminal act itself is important, but there is a strong focus on for example the background 
and moral development of the adolescent (van der Laan, 2006). 
As the present study was set up as an illustration, data was used solely to demonstrate 
the method. We did not aim to test the superiority of one of the interventions that were 
used to illustrate the method. Therefore, this article merely presents a demonstration 
of the relevance of a value of information analysis in the field of crime prevention and 
treatment. The presented input data and results should be interpreted in this context. 
We will start with a short summary of an earlier illustrative cost-effectiveness analysis 
(Schawo et al., 2012), and then introduce and illustrate the value of information analysis. 
Methods
Interventions
We compared two interventions aimed at reducing juvenile delinquency. The ‘Kursushuis’ 
intervention (translated and referred to as the Course House) consists of a domestic 
foster home where several adolescents live for about 10 months and professional care 
is at close hand. The treatment costs and effects were described by Slot et al. (Slot, 
Jagers, & Beumer, 1992). The second intervention is a systemic intervention named 
Functional Family Therapy (FFT), which lasts about 4 to 6 months. The costs and effects 
of this intervention were obtained from a multicentre quasi-experimental study in 
the Netherlands (van der Veldt, Eenshuistra, & Campbell, 2011). The Medical Ethical 
Committee of the VU University Amsterdam approved this study (number 2008/152).
Cost-effectiveness model 
The Markov model that was used for the value of information analysis consists of three 
mutually exclusive model states: A) criminal behavior, B) no criminal behavior, and C) dead 
(Schawo et al., 2012) (Figure 1). The time horizon of the model was 20 years, with a cycle 
length of six months (Schawo et al., 2012). A societal perspective was taken and results 
were expressed as costs per Criminal Activity Free Year (CAFY) (Schawo et al., 2012). 
In line with health economic guidelines (The Health Care Insurance Board, 2006), 
the input parameters in the model were threefold. The first group of parameters were 
the transition probabilities. These reflect the probability that an adolescent transitions 
through the states. The measure of time an adolescent spends in a non-criminal state is 
used to estimate a CAFY. Criminal activity was based on the adolescents’ self-reported 
contact with the police in connection with he/she having committed one or several 
crimes; having had no contacts was defined as criminal-activity free and having had one 
or more contacts as criminally active. Transition probabilities were extrapolated until 
the age of 30, as we integrated parts of the long-term stabilizing effects described by 
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Moffitt (Moffitt, 1993; Schawo et al., 2012). Dying because of committing crimes was not 
reflected in the CAFY. Adolescents were assumed to face a risk of death equivalent to 
the age specific mortality rates in the general population (Statistics Netherlands, 2015b). 
The second group consisted of costs of health-care use, productivity losses, and other 
societal costs such as costs of the criminal justice system. Both costs outside health 
care, and health care costs were included, such as the costs of visiting a psychiatrist or 
psychologist. As the family system is involved in the interventions provided, we included 
both the costs of the adolescent and those of one of the parents. The model state costs 
were fixed over time until the adolescent was 23 years. It was assumed that from that age 
onwards not all cost categories (such as a family guardian or foster care) would remain 
relevant. The third group comprised the intervention costs. The costs of one completed 
FFT treatment was calculated to be approximately €10,900 per adolescent, whereas the 
Course House was about €37,800 (retrieved from Slot et al. (Slot et al., 1992)). Both costs 
were extrapolated to 2013 Euro’s accounting for inflation based on the consumer price 
index (Statistics Netherlands, 2015a). The cost and effects in the model were discounted 
(i.e. Brouwer, van Hout, & Rutten, 2000; van Hout, 1998), according to the guidelines 
for economic evaluations in the Netherlands (The Health Care Insurance Board, 2006).
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Figure 1. Markov model
nmr = natural mortality rate
tpA2A = transition probability of staying in state A
tpA2B = transition probability of moving from state A to state B
tpB2A = transition probability of moving from state B to state A
tpB2B = transition probability of staying in state B
To represent the uncertainty of each model parameter, we assigned parameter 
distributions (Table I in Supplemental Material). In a probabilistic analysis, uncertainty 
was simulated by running the model 10,000 times using a cohort of subjects and each 
time taking different parameter estimates from the parameter distributions (Briggs et 
al., 2006; Claxton, 2008). These 10,000 unique sets of parameter values were used 
to estimate the mean expected cost-effectiveness. For further details on the cost-
effectiveness model, we refer to Schawo et al. (Schawo et al., 2012). 
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Discussion
While cost-effectiveness analyses are increasingly being used in the field of crime 
prevention, the value of further research has not yet been estimated for comparison 
between interventions aimed at reducing juvenile delinquency. An earlier developed 
cost-effectiveness model was used to estimate this value of further research. This study 
demonstrated that it was feasible to estimate the value of conducting further research 
in this context, using a value of information framework common in health economic 
evaluations. The results can be interpreted as similar to cost/QALY (Quality-Adjusted 
Life Year) studies in health care evaluation. 
In this value of information analysis, the results indicated the parameters for which 
further research was valuable. Our findings show particular uncertainty in three groups 
of parameters: the transition probabilities of the Course House and of FFT, and to a 
lesser extent, the intervention costs of the Course House and the direct non health-care 
costs in both model states. Performing additional research in the suggested fields can 
reduce parameter uncertainty, and hence, can reduce decision uncertainty. 
Therefore, the results of a value of information analysis can prioritize further research 
to optimize the final reimbursement decision, thereby increasing the probability that 
adolescents will be assigned to the intervention that is cost-effective, compared with 
the alternative. Given this information, future interventions could be reimbursed (or not), 
and they could also be approved ‘only in research’ (OIR) (i.e. further research is required 
before the intervention can be approved) or ‘approved with research’ (AWR) (i.e. research 
can be conducted while the intervention is approved) (Claxton et al., 2012; McKenna 
& Claxton, 2011). For example, from this study we can conclude that given a WTP of 
€40,000 per CAFY, the Course House could be ‘approved with research’. The Course 
House would then be reimbursed while further research would be required, for example 
on the effectiveness of the Course House. Current practice in adolescent care in the 
Netherlands illustrates this approval condition: the Netherlands Youth Institute identifies 
effective youth interventions, while still conducting research on the effectiveness of some 
of these interventions (Netherlands Youth Institute, 2014). However, approval might 
lead to irrecoverable costs when the approval is revised due to subsequent research 
revealing that the Course House was not as effective as expected. Then, approval ‘only 
in research’ might be preferred, because commitment to future costs is avoided until the 
results of further research are known. Approval might even be dependent on any change 
in the effective price of an intervention (Claxton et al., 2012; Walker, Sculpher, Claxton, 
& Palmer, 2012).  
This study was a first attempt to apply a value of information framework to the 
field of crime prevention and treatment of juvenile delinquents. Therefore, some 
considerations should be kept in mind. The value of information analysis estimates the 
monetary value of eliminating all or part of the parameter uncertainty of the presented 
model. However, two other sources of uncertainty can influence the results: structural 
and methodological uncertainty (Bojke, Claxton, Sculpher, & Palmer, 2009; Briggs, 
2000). Structural uncertainty relates to structural aspects of the model (Bilcke, Beutels, 
Brisson, & Jit, 2011; Bojke et al., 2009; Haij Ali Afzali & Karnon, 2015), such as the 
conceptual framework or the transitions between the model states (Haij Ali Afzali & 
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Karnon, 2015), and it can lead to different estimated model outcomes (i.e. Frederix et 
al., 2014). This structural uncertainty is likely to be present in our model. For example, 
we did not account for the severity of crimes in the model states or the elevated risk 
of death for adolescents in the criminal state (i.e. Chassin, Piquero, Losoya, Mansion, 
& Schubert, 2013; Teplin, McClelland, Abram, & Mileusnic, 2005). The uncertainty of 
these aspects was not represented in the current value of information analysis. Future 
cost-effectiveness models in the field of crime prevention should therefore carefully 
characterize the structural uncertainty (Haij Ali Afzali & Karnon, 2015), and account for 
it when possible, for example by parameterization (Bilcke et al., 2011; Haij Ali Afzali & 
Karnon, 2015) or model averaging (Bojke et al., 2009; Haij Ali Afzali & Karnon, 2015; 
Jackson, Bojke, Thompson, Claxton, & Sharples, 2011). The second additional source of 
uncertainty is methodological uncertainty, which relates to the analytical method chosen 
(Bilcke et al., 2011; Briggs, 2000). Our model also represents some methodological 
uncertainties, such as whether or not to include the costs of crime in the model (i.e. 
McCollister, French, & Fang, 2010). Here, three methodological uncertainties in our 
model are discussed in more detail. These uncertainties could be resolved through, for 
example, formulating guidelines (i.e. Bilcke et al., 2011; Bojke et al., 2009) to model 
cost-effectiveness research in the field of crime prevention.
The first methodological uncertainty concerns the societal perspective used in the 
model, which means that we included the costs and effects relevant to society. When 
considering this perspective in health care, the focus is merely on the patient, whereas 
this will be different in the area of crime prevention and treatment (i.e. van Zutphen, 
Goderie, & Janssen, 2014). In this study, we already included the direct and indirect costs 
of one parent, as well as direct non medical costs of the adolescent, such as the costs 
of contact with the police. Other costs that we did not account for, but are nevertheless 
relevant in the field of crime prevention are: the effect of the intervention reflected in 
both costs and effects, such as increased wellbeing and reduced productivity losses 
(i.e. van Zutphen et al., 2014), in regard to family members (e.g. parents or siblings of 
the adolescents). Further additional categories are reduced victim costs and increased 
victim wellbeing, the reduction of the number of out-of-home placements, the reduction 
of the costs of committed crimes to society, reduced costs of avoided crimes to society 
and the value of reduced fear of crime (i.e. Cohen & Piquero, 2009; van Zutphen et al., 
2014).
The second methodological uncertainty deals with the WTP value for a CAFY. 
Although we used the WTP values of Cohen et al. (Cohen & Piquero, 2009; Cohen et 
al., 2010) to illustrate the use of WTP in crime prevention, WTP to prevent a crime like 
burglary is definitely not equal to WTP per CAFY. Therefore, it is important to carefully 
estimate the WTP value per CAFY. In this study, for example, we could have weighted 
the WTP values of Cohen et al. (Cohen & Piquero, 2009; Cohen et al., 2010) by the 
frequency of the crimes as yearly committed by the adolescents in this study, or by the 
number of yearly registered crimes in the Netherlands. For clarity reasons and due to 
a lack of more detailed data regarding the crimes committed, we chose not to use a 
weighted WTP value. Furthermore, for the WTP values used, it is not exactly known 
which components of crime, such as investigation, prosecution, witnesses, legal aid, 
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prevention programs, the costs to victims, and the valuation of fear (Cohen & Piquero, 
2009) are included in this valuation (Cohen & Piquero, 2009; Cohen, Rust, Steen, & Tidd, 
2004). Therefore, further research is needed into which categories of costs of crime 
are included in a WTP value, before determining what society is willing to pay for one 
CAFY. The cost categories included in the cost-effectiveness model should be reflected 
in the WTP value and vice versa. Also, other estimations of the societal WTP might be 
considered. These could, for example, be based on the cost of crime using a bottom-up 
approach or a breaking-down approach (Moolenaar, 2009). These methods take into 
account only the costs of crime, not the willingness to reduce crime levels. 
Third, to estimate a WTP per CAFY, it should be known what type of criminal activity 
is avoided in a CAFY. The seriousness of the crime, the number of times the crime is 
committed and the types of criminal activity can also be taken into account in defining 
criminal activity. Furthermore, it is important to decide on how to measure criminal activity. 
The CAFY used in our study was based on the adolescents’ self-reported contact with 
the police. However, criminal activity may as well be determined on the basis of police 
registries (Slot et al., 1992), contacts with other judicial institutions (McCollister et al., 
2003a; McCollister et al., 2003b; McCollister et al., 2004), rates of reconviction (Barrett 
& Byford, 2012), or a delinquency score (French et al., 2008). Different definitions of 
criminal activity can influence the model results. For example not all committed crimes 
are recorded in police registrations, while self-reported measures could yield socially 
desirable answers. Using the CAFY in further research thus requires a clear definition of 
criminal activity.
A final remark on this analysis concerns the interventions chosen. FFT and the 
Course House were chosen to illustrate the analysis in the field of crime prevention. The 
interventions under study, however, could be replaced by other interventions aimed at 
reducing juvenile delinquency, such as Multisystemic Therapy, Multidimensional Foster 
Treatment Care or Multidimensional Family Therapy (Netherlands Youth Institute, 2014). 
Contrary to a broader range of cost-effectiveness studies in the UK and US (i.e. Aos, 
Lieb, Mayfield, Miller, & Pennucci, 2004; Cary et al., 2013), in the Netherlands, to the 
best of our knowledge, the cost-effectiveness of such interventions has not yet been 
investigated, except for a cost-benefit analyses of ‘Maatregel Inrichting Stelstelmatige 
Daders’ or a case study into ‘Strafrechtelijke Opvang Verslaafden’ (van Zutphen et al., 
2014; Versantvoort et al., 2005), which are both aimed at adults. Furthermore, in studying 
interventions in this field, the context of the interventions under study is highly important. 
In our illustration, we assumed that in practice, the interventions would be applied 
completely equivalently. However, preferences for an intervention may influence the 
choice for a certain intervention in reality, such as earlier experience with an intervention, 
specific characteristics of an adolescent, or the availability of the intervention itself. In 
our illustration, FFT may be, for example, used more often to avoid committing crimes, 
whereas the Course House could be used as an addition to a punishment under juvenile 
justice law, where the adolescent has already committed a crime. There may then be a 
higher probability of recidivism if the adolescents already have a history of committing 
crimes (Donker & de Bakker, 2012). These non-equivalent baseline situations may 
influence the measured effectiveness of the intervention. Moreover, the situation after 
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treatment may also be different. This may affect the acceptance of possible or required 
further care (i.e. Donker & de Bakker, 2012), and therefore may influence the final degree 
of committing crimes in the future. In modelling the cost-effectiveness of interventions in 
the field of crime prevention, the application of interventions in practice should therefore 
be taken into account in a cost-effectiveness model, or at least, this should be clarified 
when modelling the cost-effectiveness of such interventions. 
In conclusion, an analysis to estimate the value of performing further research had 
not yet been conducted in the field of crime prevention. The findings of the current 
study illustrate how such an analysis might be estimated and interpreted in this field. 
Future investment in cost-effectiveness research on interventions aimed at reducing 
juvenile delinquency could use this value of information framework to efficiently conduct 
further cost-effectiveness research.
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Supplemental Material
Table I. Model parameters and parameter distributions
EVPPI group of parameters Parameters       
  Transition probabilities Probability Events Complements   Distribution Reference
transition probabilities FFT
FFT       
tpA2A 0.23 6 20  Dirichlet Multicentre trial 
tpA2B 0.77 20 6  Dirichlet Multicentre trial 
tpB2A 0.37 7 12  Dirichlet Multicentre trial 
tpB2B 0.63 12 7  Dirichlet Multicentre trial 
transition probabilities Course House
Course House       
tpA2A 0.39 13 20  Dirichlet Slot et al. (1992)
tpA2B 0.61 20 13  Dirichlet Slot et al. (1992)
tpB2A 0.24 4 13  Dirichlet Slot et al. (1992)
tpB2B 0.76 13 4  Dirichlet Slot et al. (1992)
 Intervention costs Mean SE mean* alpha beta Distribution Reference
intervention costs FFT FFT €10,900 €10,900 1 10900 Gamma Costdata mental health institutions
intervention costs Course House Course House €37,800 €37,800 1 37800 Gamma Slot et al. (1992)
   * SE was not known, therefore taken conservative and set equal to mean
Model state costs Mean SE mean alpha beta Distribution Reference
Criminal state (A)       
direct health-care 
costs criminal
Direct health-care - adolescent
Psychiatrist €112 €67 2.8 39.9 Gamma Multicentre trial 
Psychologist €183 €103 3.2 57.5 Gamma Multicentre trial 
Psychiatric nurse €47 €47 1.0 47.2 Gamma Multicentre trial 
Social worker €113 €78 2.1 54.2 Gamma Multicentre trial 
GP €43 €26 2.7 15.6 Gamma Multicentre trial 
GP at school €3 €3 1.0 3.0 Gamma Multicentre trial 
Pediatrician €0 €0 0.0 0.0 Gamma Multicentre trial 
Medical specialist €8 €1 100.0 0.1 Gamma Multicentre trial 
Alternative healer €0 €0 0.0 0.0 Gamma Multicentre trial 
Family guardian €0 €0 0.0 0.0 Gamma Multicentre trial 
Youth welfare agency €142 €75 3.6 39.5 Gamma Multicentre trial 
ER €66 €50 1.7 38.4 Gamma Multicentre trial 
Foster care €0 €0 0.0 0.0 Gamma Multicentre trial 
Residential institution €25 €25 1.0 25.3 Gamma Multicentre trial 
Day hospitalization €0 €0 0.0 0.0 Gamma Multicentre trial 
Hospitalization €1,438 €1,438 1.0 1437.5 Gamma Multicentre trial 
Centre for addiction treatment €0 €0 0.0 0.0 Gamma Multicentre trial 
Direct health-care - parent
Psychiatrist €61 €61 1.0 61.1 Gamma Multicentre trial 
Psychologist €55 €47 1.4 40.5 Gamma Multicentre trial 
Psychiatric nurse €0 €0 0.0 0.0 Gamma Multicentre trial 
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Model state costs Mean SE mean alpha beta Distribution Reference
Criminal state (A)       
direct health-care
costs criminal
Social worker €6 €6 1.0 5.9 Gamma Multicentre trial 
GP €94 €71 1.7 53.9 Gamma Multicentre trial 
Medical officer €12 €7 3.3 3.7 Gamma Multicentre trial 
Medical specialist €21 €15 2.0 10.9 Gamma Multicentre trial 
Alternative healer €9 €9 1.0 9.1 Gamma Multicentre trial 
Family guardian €0 €0 0.0 0.0 Gamma Multicentre trial 
Centre for addiction treatment €80 €80 1.0 79.7 Gamma Multicentre trial 
direct non health-care 
costs criminal
Direct non health-care - adolescent 
Council of child protection €25 €16 2.3 10.7 Gamma Multicentre trial 
Bureau Halt €44 €27 2.8 15.9 Gamma Multicentre trial 
Police €90 €37 6.0 15.0 Gamma Multicentre trial 
Lawyer €57 €57 1.0 57.1 Gamma Multicentre trial 
Court €29 €29 1.0 28.6 Gamma Multicentre trial 
Social rehabilitation €171 €111 2.4 71.4 Gamma Multicentre trial 
Incarceration costs €0 €0 0.0 0.0 Gamma Multicentre trial 
indirect non health-care 
costs criminal
Indirect non health-care - adolescent
Time spent on exercises as part of intervention €3 €2 1.9 1.6 Gamma Multicentre trial 
Indirect non health-care - parent
Absence from work €1,317 €835 2.5 528.8 Gamma Multicentre trial 
Inefficiency at work €4,450 €2,775 2.6 1730.4 Gamma Multicentre trial 
Productivity losses due to unpaid support €0 €0 0.0 0.0 Gamma Multicentre trial 
Productivity losses due to paid support €0 €0 0.0 0.0 Gamma Multicentre trial 
Time spent on exercises as part of intervention €2 €2 1.0 2.1 Gamma Multicentre trial 
 Non Criminal state (B)       
direct health-care
costs non criminal
Direct health-care - adolescent
Psychiatrist €31 €17 3.3 9.2 Gamma Multicentre trial 
Psychologist €78 €45 3.1 25.4 Gamma Multicentre trial 
Psychiatric nurse €0 €0 0.0 0.0 Gamma Multicentre trial 
Social worker €60 €45 1.8 33.9 Gamma Multicentre trial 
GP €42 €15 8.3 5.1 Gamma Multicentre trial 
GP at school €0 €0 0.0 0.0 Gamma Multicentre trial 
Pediatrician €0 €0 0.0 0.0 Gamma Multicentre trial 
Medical specialist €12 €8 2.0 5.6 Gamma Multicentre trial 
Alternative healer €0 €0 0.0 0.0 Gamma Multicentre trial 
Family guardian €16 €12 1.9 8.4 Gamma Multicentre trial 
Youth welfare agency €47 €27 3.0 15.7 Gamma Multicentre trial 
ER €30 €2 289.6 0.1 Gamma Multicentre trial 
Foster care €0 €0 0.0 0.0 Gamma Multicentre trial 
Residential institution €247 €247 1.0 246.6 Gamma Multicentre trial 
Day hospitalization €0 €0 0.0 0.0 Gamma Multicentre trial 
Hospitalization €9 €9 1.0 9.4 Gamma Multicentre trial 
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Model state costs Mean SE mean alpha beta Distribution Reference
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Model state costs Mean SE mean alpha beta Distribution Reference
Non Criminal state (B)       
direct health-care 
costs non criminal
Centre for addiction treatment €0 €0 0.0 0.0 Gamma Multicentre trial 
Direct health-care - parent
Psychiatrist €0 € 0 0.0 0.0 Gamma Multicentre trial 
Psychologist €80 € 40 3.9 20.3 Gamma Multicentre trial 
Psychiatric nurse €0 € 0 0.0 0.0 Gamma Multicentre trial 
Social worker €17 € 17 1.0 16.8 Gamma Multicentre trial 
GP €18 € 7 5.9 3.0 Gamma Multicentre trial 
Medical officer €6 € 6 1.0 6.1 Gamma Multicentre trial 
Medical specialist €39 € 2 292.4 0.1 Gamma Multicentre trial 
Alternative healer €0 € 0 0.0 0.0 Gamma Multicentre trial 
Family guardian €27 € 19 1.9 14.3 Gamma Multicentre trial 
Centre for addiction treatment €0 € 0 0.0 0.0 Gamma Multicentre trial 
direct non health-care 
costs non criminal
Direct non health-care - adolescent
Council of child protection €0 €0 0.0 0.0 Gamma Multicentre trial 
Bureau Halt €12 €9 1.6 7.2 Gamma Multicentre trial 
Police €25 €15 3.0 8.4 Gamma Multicentre trial 
Lawyer €0 €0 0.0 0.0 Gamma Multicentre trial 
Court €0 €0 0.0 0.0 Gamma Multicentre trial 
Social rehabilitation €36 €29 1.6 23.0 Gamma Multicentre trial 
Incarceration costs €0 €0 0.0 0.0 Gamma Multicentre trial 
indirect non health-care 
costs non criminal
Indirect non health-care - adolescent
Time spent on exercises as part of intervention €4 €4 1.2 3.4 Gamma Multicentre trial 
Indirect non health-care – parent 
Absence from work €1,020 €558 3.3 305.9 Gamma Multicentre trial 
Inefficiency at work €3,866 €1,503 6.6 584.5 Gamma Multicentre trial 
Productivity losses due to unpaid support €0 €0 0.0 0.0 Gamma Multicentre trial 
Productivity losses due to paid support €0 €0 0.0 0.0 Gamma Multicentre trial 
Time spent on exercises as part of intervention €8 €5 2.7 2.8 Gamma Multicentre trial 
Italics - costs not relevant from 23 years onwards
EVPPI, Expected Value of Partial Perfect Information; FFT, Functional Family Therapy; SE, Standard error
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Model state costs Mean SE mean alpha beta Distribution Reference
Non Criminal state (B)       
direct health-care 
costs non criminal
Centre for addiction treatment €0 €0 0.0 0.0 Gamma Multicentre trial 
Direct health-care - parent
Psychiatrist €0 € 0 0.0 0.0 Gamma Multicentre trial 
Psychologist €80 € 40 3.9 20.3 Gamma Multicentre trial 
Psychiatric nurse €0 € 0 0.0 0.0 Gamma Multicentre trial 
Social worker €17 € 17 1.0 16.8 Gamma Multicentre trial 
GP €18 € 7 5.9 3.0 Gamma Multicentre trial 
Medical officer €6 € 6 1.0 6.1 Gamma Multicentre trial 
Medical specialist €39 € 2 292.4 0.1 Gamma Multicentre trial 
Alternative healer €0 € 0 0.0 0.0 Gamma Multicentre trial 
Family guardian €27 € 19 1.9 14.3 Gamma Multicentre trial 
Centre for addiction treatment €0 € 0 0.0 0.0 Gamma Multicentre trial 
direct non health-care 
costs non criminal
Direct non health-care - adolescent
Council of child protection €0 €0 0.0 0.0 Gamma Multicentre trial 
Bureau Halt €12 €9 1.6 7.2 Gamma Multicentre trial 
Police €25 €15 3.0 8.4 Gamma Multicentre trial 
Lawyer €0 €0 0.0 0.0 Gamma Multicentre trial 
Court €0 €0 0.0 0.0 Gamma Multicentre trial 
Social rehabilitation €36 €29 1.6 23.0 Gamma Multicentre trial 
Incarceration costs €0 €0 0.0 0.0 Gamma Multicentre trial 
indirect non health-care 
costs non criminal
Indirect non health-care - adolescent
Time spent on exercises as part of intervention €4 €4 1.2 3.4 Gamma Multicentre trial 
Indirect non health-care – parent 
Absence from work €1,020 €558 3.3 305.9 Gamma Multicentre trial 
Inefficiency at work €3,866 €1,503 6.6 584.5 Gamma Multicentre trial 
Productivity losses due to unpaid support €0 €0 0.0 0.0 Gamma Multicentre trial 
Productivity losses due to paid support €0 €0 0.0 0.0 Gamma Multicentre trial 
Time spent on exercises as part of intervention €8 €5 2.7 2.8 Gamma Multicentre trial 
Italics - costs not relevant from 23 years onwards
EVPPI, Expected Value of Partial Perfect Information; FFT, Functional Family Therapy; SE, Standard error
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Table II. pEVPI and pEVPPI for a range of WTP values
WTP
transition 
probabilities 
FFT
transition 
probabilities 
Course House
direct health-
care costs 
criminal
direct health-
care costs 
non criminal
direct non 
health-care 
costs criminal
direct non 
health-care 
costs non 
criminal
indirect non 
health-care 
costs criminal
indirect non 
health-care 
costs non 
criminal
intervention 
costs FFT
intervention 
costs Course 
House
pEVPI
€0 €0 €0 €0 €0 €0 €0 €0 €0 €1,798,900 €5,646,700 €11,911,500
€5,000 €23,000 €0 €0 €0 €1,700 €0 €2,300 €0 €2,462,300 €9,568,600 €18,197,300
€10,000 €919,600 €1,990,500 €0 €0 €12,400 €0 €13,300 €0 €3,351,400 €14,051,900 €28,674,800
€15,000 €6,402,400 €11,155,100 €0 €0 €21,200 €900 €41,300 €0 €4,519,500 €19,242,800 €42,195,800
€20,000 €16,263,300 €24,720,800 €600 €0 €29,800 €0 €107,000 €0 €6,029,400 €25,103,700 €57,847,600
€25,000 €28,832,200 €40,322,400 €8,900 €0 €34,300 €0 €255,400 €0 €7,980,200 €31,601,900 €74,913,300
€30,000 €42,919,000 €57,149,700 €16,900 €0 €60,400 €0 €609,000 €10,700 €10,567,700 €38,703,200 €92,970,400
€35,000 €57,863,500 €74,630,700 €41,300 €0 €264,800 €10,700 €1,761,100 €559,100 €14,004,000 €46,337,600 €111,815,800
€40,000 €70,749,600 €89,965,700 €590,500 €357,800 €1,546,500 €1,089,900 €3,732,300 €2,326,300 €15,926,700 €51,773,800 €128,621,700
€45,000 €73,470,900 €95,078,000 €0 €0 €185,800 €24,000 €374,800 €21,300 €8,788,000 €47,140,300 €135,339,200
€50,000 €76,407,100 €100,394,600 €0 €0 €75,900 €32,500 €20,300 €0 €3,432,200 €42,879,500 €142,393,000
€55,000 €79,537,400 €105,903,400 €0 €0 €42,900 €35,000 €800 €0 €427,800 €38,985,800 €149,713,600
€60,000 €82,789,400 €111,483,800 €0 €0 €25,100 €37,500 €0 €0 €0 €35,421,100 €157,238,100
€65,000 €86,144,500 €117,144,600 €0 €0 €14,200 €40,000 €0 €0 €0 €32,177,300 €164,940,500
€70,000 €89,582,300 €122,808,500 €0 €0 €9,400 €42,500 €0 €0 €0 €29,245,900 €172,780,800
€75,000 €93,083,900 €128,578,700 €0 €0 €7,300 €44,900 €0 €0 €0 €26,603,300 €180,738,000
€80,000 €96,638,800 €134,392,600 €0 €0 €6,700 €47,400 €0 €0 €0 €24,164,400 €188,804,300
€85,000 €100,232,100 €140,405,200 €0 €0 €6,100 €49,900 €0 €0 €0 €21,956,200 €196,955,500
€90,000 €103,864,300 €146,115,500 €0 €0 €5,400 €52,300 €0 €0 €0 €19,947,500 €205,186,900
€95,000 €107,525,900 €152,098,000 €0 €0 €4,800 €54,700 €0 €0 €0 €18,102,800 €213,485,700
€100,000 €111,211,000 €157,921,800 €0 €0 €4,100 €57,200 €0 €0 €0 €16,420,600 €221,852,400
WTP, willingness-to-pay; FFT, Functional Family Therapy; pEVPI, population Expected Value of Perfect 
Information; pEVPPI, population Expected Value of Partial Perfect Information
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€55,000 €79,537,400 €105,903,400 €0 €0 €42,900 €35,000 €800 €0 €427,800 €38,985,800 €149,713,600
€60,000 €82,789,400 €111,483,800 €0 €0 €25,100 €37,500 €0 €0 €0 €35,421,100 €157,238,100
€65,000 €86,144,500 €117,144,600 €0 €0 €14,200 €40,000 €0 €0 €0 €32,177,300 €164,940,500
€70,000 €89,582,300 €122,808,500 €0 €0 €9,400 €42,500 €0 €0 €0 €29,245,900 €172,780,800
€75,000 €93,083,900 €128,578,700 €0 €0 €7,300 €44,900 €0 €0 €0 €26,603,300 €180,738,000
€80,000 €96,638,800 €134,392,600 €0 €0 €6,700 €47,400 €0 €0 €0 €24,164,400 €188,804,300
€85,000 €100,232,100 €140,405,200 €0 €0 €6,100 €49,900 €0 €0 €0 €21,956,200 €196,955,500
€90,000 €103,864,300 €146,115,500 €0 €0 €5,400 €52,300 €0 €0 €0 €19,947,500 €205,186,900
€95,000 €107,525,900 €152,098,000 €0 €0 €4,800 €54,700 €0 €0 €0 €18,102,800 €213,485,700
€100,000 €111,211,000 €157,921,800 €0 €0 €4,100 €57,200 €0 €0 €0 €16,420,600 €221,852,400
WTP, willingness-to-pay; FFT, Functional Family Therapy; pEVPI, population Expected Value of Perfect 
Information; pEVPPI, population Expected Value of Partial Perfect Information
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Abstract
Objectives: Our aim was to demonstrate the feasibility of the univariate and generalized 
propensity score (PS) method in subgroup analysis of outcomes research. 
Methods: First, to estimate subgroup effects, we tested the performance of 2 different PS 
methods, using Monte Carlo simulations: 1) the univariate PS with additional adjustment 
on the subgroup; and 2) the generalized PS, estimated by crossing the treatment options 
with a subgroup variable. The subgroup effects were estimated in a linear regression 
model using the 2 PS adjustments. We further explored whether the subgroup variable 
should be included in the univariate PS. Second, the 2 methods were compared using 
data from a large effectiveness study on psychotherapy in personality disorders. Using 
these data we tested the differences between short and long-term treatment , with the 
severity of patients’ problems defining the subgroups of interest.  
Results: The Monte Carlo simulations showed minor differences between both PS 
methods, with the bias and mean squared error overall marginally lower for the 
generalized PS. When considering the univariate PS, the subgroup variable can be 
excluded from the PS estimation and only adjusted for in the outcome equation. When 
applied to the psychotherapy data, the univariate and generalized PS estimations gave 
similar results.  
Conclusions: The results support the use of the generalized PS as a feasible method, 
compared to the univariate PS, to find certain subgroup effects in non-randomized 
outcomes research. 
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Introduction
In non-randomized studies, the propensity score (further denoted as PS) method has 
gained popularity as a statistical method to overcome selection bias due to differences 
in observed pre-treatment variables of patient groups (Winship & Mare, 1992) and the 
“dimensionality” problem of alternative methods such as stratification and matching 
(D'Agostino, 1998). The univariate propensity score (Rosenbaum & Rubin, 1983) is a valid 
solution to compare 2 treatment categories (Bartak et al., 2009; Rubin, 1974), whereas 
the generalized PS can be used if  >2 treatment categories are compared (Feng, Zhou, 
Zou, Fan, & Li, 2012; Imbens, 2000; Spreeuwenberg et al., 2010). An equal distribution 
on the covariates is assumed after adjustment on the PS (Austin, 2009; Rubin, 1997; 
Spreeuwenberg et al., 2010). Although the PS can control for overt bias due to (many) 
observed pre-treatment variables (Rosenbaum, 1991; Rubin, 1997), hidden bias could 
still be present (Rosenbaum, 1991).
The PS is predominantly used to estimate treatment effects (Austin, 2011; Hirano, 
Imbens, & Ridder, 2003). However, it may also be important to define which treatment is 
specifically effective for a (sub)group of patients (Norcross & Wampold, 2011). Treatment 
options can then be applied more efficiently by directly allocating  a group of patients to 
a relevant treatment. For instance, one could argue that long-term psychotherapy is more 
effective than short-term psychotherapy for patients having severe problems. Because 
the patients are not randomly assigned to the treatment options, patients having either 
mild or severe problems can differ on the observed pre-treatment variables. Therefore, 
there is a need to apply PS modelling methods when  studying subgroup effects. 
Several authors have described methods to estimate treatment effects for particular 
subgroups while using the univariate PS. Rosenbaum and Rubin already recommended 
sub-classifying or matching on additional covariates to identify differences in treatment 
effect between subgroups. To reduce bias in the estimated treatment effect, Rubin and 
Thomas (2000) and Stürmer and colleagues (2006) advised that  the covariate together 
with the PS be included when estimating the treatment effect. Such an additional 
covariate could define subgroups. The treatment effect can also vary according to 
quantiles of the PS estimations. Effect modification (e.g. interaction effects) can result in 
different estimated treatment effects for different PS quantiles (Glynn, Schneeweiss, & 
Sturmer, 2006; Kurth et al., 2006; Lunt et al., 2009; Sturmer, Rothman, & Glynn, 2006; 
Ye, Bond, Schmidt, Mulia, & Tam, 2012). However, it is not possible to relate a specific 
subgroup to the PS quantiles. More recently, Liem and colleagues (2010) determined the 
treatment effect for subgroups by adding interaction terms in a multivariable adjusted 
model in which the PS was also included. Another method was described by Radice and 
colleagues (2012) and Kreif and colleagues (2012) who estimated the univariate PS within 
each subgroup separately. Yet, only the univariate PS was used in subgroup analyses and 
the PS was not made multiple, as a generalized PS, by crossing the treatment options 
with a subgroup variable. 
Because the univariate PS is mainly used in subgroup analyses,  this study 
investigated whether a generalized PS could be used to estimate subgroup effects in 
outcomes research, and compared it to using a univariate PS. We first used Monte Carlo 
simulations to investigate whether and how the generalized or univariate PS could be 
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used to estimate subgroup effects. These 2 PS estimations were subsequently compared 
using data from a Dutch research project on psychotherapy effectiveness: SCEPTRE 
(Study on Cost-Effectiveness of Personality Disorder TREatment) (Bartak et al., 2010). 
Methods
First, we describe the univariate propensity score (PS), the generalized PS and the 
simulation study in which we tested these methods. Then, we describe the case study 
where we compare  the 2 PS methods. To estimate the treatment effects for subgroups 
of patients, we used the 2 PS estimations in covariate adjustment, as this method is the 
most frequently used PS method in the medical literature (Austin, 2009; Shah, Laupacis, 
Hux, & Austin, 2005; Stürmer et al., 2006; Weitzen, Lapane, Toledano, Hume, & Mor, 
2004) because it leaves the sample size intact. 
Univariate PS method
The univariate PS is defined according to Rosenbaum and Rubin (Rosenbaum & Rubin, 
1983) as:
PS(x)=pr D=1|X=x (1)
where if D = 1 the PS defines the conditional probability of assignment to the treatment 
of interest, given a set of observed covariates (X) (Rosenbaum & Rubin, 1983). The 
ignorability assumption defines that the potential outcomes and the treatment assignment 
are independent given the observed covariates (X) (Rosenbaum & Rubin, 1983; Rubin, 
1997). The PS was estimated in a univariate logistic regression function (Hirano & Imbens, 
2001). To estimate the treatment effect for subgroups of patients, this PS estimation was 
used as an extra predictor in a linear regression model with treatment outcome (Y) as the 
dependent variable: 
0 1 3 4β β β β= + + Ζ +OUTCOME D DZ (2)
The treatment groups (D), subgroups (Z) and the interaction between these (DZ) were the 
independent variables, and the effects of interest (Liem et al., 2010). 
Generalized PS method
The generalized PS is an extension of the univariate PS defined by Rosenbaum and Rubin 
(Rosenbaum & Rubin, 1983) and is further defined by Imbens (2000). To calculate the 
generalized PS used in this study, we estimated the joint conditional probability of the 
treatment assignment (D) and subgroup (Z) given all covariates (X): 
PS(d,z,x)=pr D=d,Z=z|X=x (3)
Using 2 treatment options and 2 subgroups, the PS was estimated for 4 groups. The 
assumption on the strongly ignorable treatment assignment is crucial (Imbens, 2000; 
Rosenbaum & Rubin, 1983; Rubin, 1997). When this assumption was adjusted to the 
combined categories on which the generalized PS was estimated, the joint distributions of 
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the potential outcomes and the covariates X should be equal between the 4 groups (Fujii, 
Henmi, & Fujita, 2012). The generalized PS was estimated in a multinomial regression 
model. To estimate the treatment effects, 3 estimated generalized PSs and 3 dummy 
variables indicating group membership (G) were adjusted for in a regression model with 
treatment outcome (Y) as the dependent variable: 
0 1 1 2 2 3 3 4 1 5 2 6 3OUTCOME PS PS PS G G Gβ β β β β β β= + + + + + + (4)
The coefficients related to the 3 dummy variables were the effects of interest.
Monte Carlo simulation study
A Monte Carlo simulation study was designed to test the 2 PS estimations. Therefore, we 
simulated 2 treatment categories, a subgroup variable with 2 categories and 3 additional 
variables that served as covariates. These 3 covariates were continuous variables (such 
as age, length, or body weight) related to (a) only the treatment assignment, (b) both 
treatment assignment and outcome, such that it is a true confounder (Brookhart et al., 
2006), or (c) outcome alone (Table 1). 
Table 1. Variables and characteristics of Monte Carlo simulation*
Variables Type Function
X1 Covariate Multivariate normal distribution (0, 1) 
X2 Covariate Multivariate normal distribution (0, 1)
X3 Covariate Multivariate normal distribution (0, 1)
Z Covariate – forms subgroups Bernoulli distribution (1, 0.4)
D Treatment assignment Defined in treatment assignment, values 0 or 1
Y Outcome Defined in outcome
ε ε1 2, Error terms Multivariate normal distribution (0, 1)
Treatment assignment
Scenario 1: ε+ + 10.5 1 0.5 2f X X ; if f<0, D=0; otherwise D=1
Scenario 2: ε+ + 10.5 1 0.5 2 0,3Z+f X X  ; if f<0, D=0; otherwise D=1
Outcome
α α α ε+ + + 1 2 3 20.5 2 0.5 3 D+ DZ+Y X X Z ; linear regression model 
where α α α= = =1 2 30.7, 0.4, 0.2
Characteristics that define simulated datasets Categories
Correlation between covariates (X1-X3) 0; 0.3; 0.7
Correlation Z – covariates (X1-X3) yes; no
Sample size 250; 500; 1000
Variables selected in PS
Univariate PS
Generalized PS
X2,X3;  X1,X2,X3;  X2,X3,Z;  X1,X2,X3,Z;  
X1,X2;  X1,X2,Z;  X2;  X2,Z 
X2,X3;  X1,X2,X3;  X1,X2;  X2
* The parameter values related to the different variables in the description of the treatment assignment and 
outcome are arbitrary.
PS indicates propensity score
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The covariates were multivariate normally distributed with a mean of zero and 
variance of 1, except for the subgroup, that followed a Bernoulli distribution with, for 
example, a probability of having severe problems of 0.4 (Table 1). The outcome was 
simulated from a linear regression model and its error term was multivariate normally 
distributed, just as for the error terms of the treatment assignment (Table 1). The 
correlation between the error terms was set to zero as only overt bias was simulated. 
We simulated 2 scenarios: in scenario 1 the subgroup was not related to the treatment 
assignment, whereas in scenario 2, this relationship was simulated. In both the scenarios, 
the subgroup was related to the outcome (Table 1). Within each scenario we varied the 
simulated data on 3 levels of the correlation between the covariates, on the presence 
or absence of a correlation with the subgroup, and on 3 different sample sizes (Table 1). 
Under each combination of characteristics of the simulated data, 1,000 datasets were 
created, which resulted in 18,000 datasets per scenario. 
In the literature there is no consensus on how to select the variables in PS 
estimation (Austin, Grootendorst, & Anderson, 2007; Brookhart et al., 2006). Therefore, 
we varied the inclusion of variables in the PS estimations (Table 1).  For the univariate 
PS, we investigated whether the subgroup variable should be in- or excluded in the PS 
estimation. The subgroup variable cannot be selected for the generalized PS, as it is part 
of its definition (Table 1). 
To evaluate the performance of the 2 PS methods in the simulation study, we 
estimated the bias, mean squared error (MSE) and SE of the relevant effects over the 
total number of simulations. In Eq. (2) the relevant effects were the treatment effect, the 
effect of the subgroups and the interaction term. In Eq. (4), these were the coefficients 
related to each dummy variable. Because we were interested in 3 coefficients per 
regression model [Eqs (2) or (4)] and these coefficients were not comparable one-to-
one, we averaged the bias, MSE and SE over the 3 relevant coefficients per regression 
model [Eqs (2) or (4)]. We then used this value for the bias, MSE and SE per PS method 
to compare the PS methods. 
Case study
Our sample consisted of a total of 841 patients with personality disorders(Association, 
2000) who had enrolled for different types of psychotherapy in 6 mental health care 
institutes in The Netherlands. The patients were selected for either short-term (up to 6 mo) 
or long-term (> 6 mo) psychotherapy in various settings (Bartak, Andrea, Spreeuwenberg, 
Thunnissen, et al., 2011; Bartak, Andrea, Spreeuwenberg, Ziegler, et al., 2011; Bartak et 
al., 2010; Soeteman et al., 2011). The mean age was 34.12 (SD 9.83, range 17 – 62y) 
and 68.6 % were female. To compare the PS methods, we investigated whether the 
treatment effect was modified by the severity of problems, that is, having mild or severe 
problems. Although we were aware of more recent possible classifications of severity 
(Crawford, Koldobsky, Mulder, & Tyrer, 2011), for comparison  purposes we differentiated 
between the patients having personality difficulties or a simple personality disorder versus 
patients having complex or more severe personality disorders based on a classification of 
personality disorders by Tyrer and colleagues (2004; 1996).  
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The primary outcome measure was psychiatric symptomatology and was measured 
with the Global Severity Index (GSI), which is the mean score of the 53 items of the Brief 
Symptom Inventory (Arrindell & Ettema, 2003; Derogatis, 1986). The GSI ranges from 0 to 
4, with higher scores indicating more problems. Three treatment institutes conducted their 
follow-up measures on the GSI at 12, 24, 36 and 60 months after baseline. The 3 remaining 
treatment institutions conducted their follow-up measures at the end of treatment, 6 and 
12 months after end of treatment, and again at 36 and 60 months after baseline. As in 
an earlier study by  Spreeuwenberg and colleagues (2010) we used the mean GSI score 
of all follow-up measures as a primary outcome measure (range 0.01 - 3.17) (American 
Psychiatric Association, 2000). We excluded 114 cases that had  missing values on one of 
the potential confounders, leaving 727 patients in the final sample. The excluded cases 
were not significantly different on the outcome GSI. 
The potential confounders were assessed at baseline, that is, age, gender, civil status, 
living situation, care of children, employment, level of education, duration of psychological 
complaints, treatment history, alcohol and drug abuse, motivation, treatment preferences, 
level of psychiatric symptomatology, level of personality pathology, interpersonal 
functioning, social role functioning, quality of life, number of Diagnostic and Statistical 
Manual (DSM)-IV Axis II cluster A personality disorders, number of DSM-IV Axis II cluster 
B personality disorders, number of DSM-IV Axis II cluster C personality disorders, and 
psychological capacities. For specific details of this study, we refer the reader to the 
literature (Bartak, Andrea, Spreeuwenberg, Thunnissen, et al., 2011; Bartak, Andrea, 
Spreeuwenberg, Ziegler, et al., 2011; Bartak et al., 2010).
Computation
The analyses were performed with IBM SPSS for Windows, version 20 (SPSS Inc., 
Chicago, IL). All simulations were performed in R programming language, version 2.13.0 
(R Development Core Team, 2010). 
Results
Monte Carlo simulation results
We evaluated the bias, MSE and standard error of the relevant effects in the simulation 
study (see Table I, Supplemental Material for the bias, MSE and SE in scenario 1; for 
scenario 2, see Table II, Supplemental Material). Because taking an average over 3 
estimated bias values related to the 3 relevant coefficients per PS method can average 
out positive and negative bias values, the MSE was used to find which PS estimations 
was most efficient (Table 2). In almost all simulated datasets within scenario 1, when the 
subgroup was not related to the treatment assignment, the MSE was closest to zero if 
the variables related to the outcome only were included in the univariate PS and the 
generalized PS (Table 2). If the subgroup was related to the treatment assignment, as 
in scenario 2, the MSE was closest to zero when the variables related to the outcome 
were included in the PS model in all simulated datasets (Table 2). In both the scenarios, 
including the subgroup variable in the univariate, PS estimation gave larger MSE values. 
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Table 2. MSE of simulations 
Sample
size
Correlation 
covariates 
X1, X2, X3
Correlation 
Z - 
X1,X2,X3
 Variables in propensity score (PS) model
Univariate PS Generalized PS
X2, X3 X1, X2, X3 X2, X3, Z X1, X2, X3, Z X1, X2 X1, X2, Z X2 X2, Z X2, X3 X1, X2, X3 X1, X2 X2
Scenario 1*
N = 250 0 Absent MSE 0.0523 0.0579 0.0642 0.0605 0.0600 0.0624 0.0541 0.0664 0.0329 0.0351 0.0428 0.0411
Present MSE 0.0524 0.0561 0.0641 0.0583 0.0608 0.0630 0.0551 0.0674 0.0342 0.0367 0.0451 0.0424
0.3 Absent MSE 0.0491 0.0562 0.0618 0.0608 0.0585 0.1322 0.0569 0.0675 0.0348 0.0375 0.0449 0.0472
Present MSE 0.0556 0.0683 0.0687 0.0724 0.0682 0.0722 0.0673 0.0709 0.0356 0.0381 0.0578 0.0725
0.7 Absent MSE 0.0481 0.0518 0.0593 0.0592 0.0560 0.0635 0.0561 0.0664 0.0365 0.0391 0.0422 0.0456
Present MSE 0.0657 0.0792 0.0926 0.0907 0.0741 0.0884 0.0805 0.0892 0.0476 0.0514 0.0719 0.0993
N = 500 0 Absent MSE 0.0261 0.0294 0.0330 0.0311 0.0312 0.0329 0.0278 0.0350 0.0162 0.0183 0.0218 0.0209
Present MSE 0.0292 0.0264 0.1095 0.0306 0.0297 0.0310 0.0277 0.0334 0.0163 0.0186 0.0227 0.0213
0.3 Absent MSE 0.0245 0.0285 0.0318 0.0311 0.0285 0.0311 0.0285 0.0344 0.0174 0.0185 0.0217 0.0248
Present MSE 0.0294 0.0381 0.0328 0.0394 0.0385 0.0400 0.0403 0.0350 0.0172 0.0186 0.0361 0.0519
0.7 Absent MSE 0.0270 0.0248 0.0313 0.0315 0.0254 0.0299 0.0268 0.0326 0.0183 0.0198 0.0215 0.0250
Present MSE 0.0331 0.0432 0.0489 0.0494 0.0396 0.0469 0.0493 0.0450 0.0238 0.0249 0.0455 0.0776
N = 1000 0 Absent MSE 0.0132 0.0148 0.0160 0.0154 0.0149 0.0155 0.0136 0.0164 0.0081 0.0090 0.0110 0.0105
Present MSE 0.0130 0.0146 0.0160 0.0152 0.0154 0.0161 0.0138 0.0168 0.0085 0.0081 0.0099 0.0094
0.3 Absent MSE 0.0124 0.0141 0.0158 0.0153 0.0145 0.0157 0.0156 0.0184 0.0087 0.0090 0.0108 0.0144
Present MSE 0.0162 0.0214 0.0174 0.0227 0.0232 0.0245 0.0262 0.0195 0.0084 0.0093 0.0235 0.0394
0.7 Absent MSE 0.0121 0.0131 0.0153 0.0964 0.0123 0.0145 0.0146 0.0174 0.0093 0.0095 0.0103 0.0149
Present MSE 0.0174 0.0256 0.0270 0.0290 0.0237 0.0277 0.0354 0.0238 0.0116 0.0122 0.0312 0.0643
Scenario 2*
N = 250 0 Absent MSE 0.0537 0.0575 0.0994 0.0678 0.0591 0.0698 0.0545 0.1030 0.0329 0.0344 0.0436 0.0414
Present MSE 0.0576 0.0622 0.1116 0.0770 0.0643 0.0787 0.0595 0.1152 0.0348 0.0362 0.0445 0.0430
0.3 Absent MSE 0.0525 0.0604 0.1117 0.0850 0.0618 0.0876 0.0589 0.1106 0.0343 0.0374 0.0458 0.0453
Present MSE 0.0605 0.0717 0.1382 0.0763 0.0745 0.0778 0.0739 0.1252 0.0375 0.0404 0.0627 0.0750
0.7 Absent MSE 0.0512 0.0558 0.0944 0.0872 0.0562 0.0883 0.0577 0.0977 0.0373 0.0388 0.0428 0.0465
Present MSE 0.0684 0.0809 0.1901 0.1042 0.0798 0.1045 0.0865 0.1732 0.0490 0.0531 0.0765 0.1042
N = 500 0 Absent MSE 0.0289 0.0330 0.0682 0.0427 0.0335 0.0433 0.0294 0.0696 0.0177 0.0186 0.0220 0.0210
Present MSE 0.0269 0.0295 0.0660 0.0383 0.0302 0.0390 0.0275 0.0666 0.0163 0.0171 0.0208 0.0199
0.3 Absent MSE 0.0245 0.0279 0.0702 0.0467 0.0287 0.0478 0.0287 0.0675 0.0172 0.0183 0.0214 0.0245
Present MSE 0.0317 0.0394 0.0943 0.0390 0.0404 0.0392 0.0413 0.0784 0.0183 0.0196 0.0376 0.0517
0.7 Absent MSE 0.0259 0.0283 0.0634 0.0560 0.0287 0.0565 0.0303 0.0652 0.0187 0.0194 0.0209 0.0249
Present MSE 0.0370 0.0443 0.1483 0.0633 0.0445 0.0639 0.0528 0.1207 0.0254 0.0268 0.0471 0.0777
N = 1000 0 Absent MSE 0.0128 0.0145 0.0453 0.0219 0.0149 0.0224 0.0133 0.0463 0.0083 0.0089 0.0105 0.0101
Present MSE 0.0145 0.0161 0.0502 0.0249 0.0166 0.0254 0.0148 0.0511 0.0088 0.0093 0.0114 0.0107
0.3 Absent MSE 0.0127 0.0146 0.0523 0.0308 0.0150 0.0315 0.0160 0.0491 0.0087 0.0092 0.0108 0.0141
Present MSE 0.0173 0.0220 0.0713 0.0203 0.0230 0.0205 0.0260 0.0555 0.0090 0.0098 0.0256 0.0404
0.7 Absent MSE 0.0121 0.0129 0.0468 0.0384 0.0131 0.0387 0.0153 0.0470 0.0090 0.0094 0.0102 0.0141
Present MSE 0.0189 0.0247 0.1193 0.0395 0.0260 0.0399 0.0356 0.0893 0.0124 0.0134 0.0342 0.0651
*Results in italic indicate MSE was closest to zero.
MSE indicates mean squared error; PS, propensity score. 
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Table 2. MSE of simulations 
Sample
size
Correlation 
covariates 
X1, X2, X3
Correlation 
Z - 
X1,X2,X3
 Variables in propensity score (PS) model
Univariate PS Generalized PS
X2, X3 X1, X2, X3 X2, X3, Z X1, X2, X3, Z X1, X2 X1, X2, Z X2 X2, Z X2, X3 X1, X2, X3 X1, X2 X2
Scenario 1*
N = 250 0 Absent MSE 0.0523 0.0579 0.0642 0.0605 0.0600 0.0624 0.0541 0.0664 0.0329 0.0351 0.0428 0.0411
Present MSE 0.0524 0.0561 0.0641 0.0583 0.0608 0.0630 0.0551 0.0674 0.0342 0.0367 0.0451 0.0424
0.3 Absent MSE 0.0491 0.0562 0.0618 0.0608 0.0585 0.1322 0.0569 0.0675 0.0348 0.0375 0.0449 0.0472
Present MSE 0.0556 0.0683 0.0687 0.0724 0.0682 0.0722 0.0673 0.0709 0.0356 0.0381 0.0578 0.0725
0.7 Absent MSE 0.0481 0.0518 0.0593 0.0592 0.0560 0.0635 0.0561 0.0664 0.0365 0.0391 0.0422 0.0456
Present MSE 0.0657 0.0792 0.0926 0.0907 0.0741 0.0884 0.0805 0.0892 0.0476 0.0514 0.0719 0.0993
N = 500 0 Absent MSE 0.0261 0.0294 0.0330 0.0311 0.0312 0.0329 0.0278 0.0350 0.0162 0.0183 0.0218 0.0209
Present MSE 0.0292 0.0264 0.1095 0.0306 0.0297 0.0310 0.0277 0.0334 0.0163 0.0186 0.0227 0.0213
0.3 Absent MSE 0.0245 0.0285 0.0318 0.0311 0.0285 0.0311 0.0285 0.0344 0.0174 0.0185 0.0217 0.0248
Present MSE 0.0294 0.0381 0.0328 0.0394 0.0385 0.0400 0.0403 0.0350 0.0172 0.0186 0.0361 0.0519
0.7 Absent MSE 0.0270 0.0248 0.0313 0.0315 0.0254 0.0299 0.0268 0.0326 0.0183 0.0198 0.0215 0.0250
Present MSE 0.0331 0.0432 0.0489 0.0494 0.0396 0.0469 0.0493 0.0450 0.0238 0.0249 0.0455 0.0776
N = 1000 0 Absent MSE 0.0132 0.0148 0.0160 0.0154 0.0149 0.0155 0.0136 0.0164 0.0081 0.0090 0.0110 0.0105
Present MSE 0.0130 0.0146 0.0160 0.0152 0.0154 0.0161 0.0138 0.0168 0.0085 0.0081 0.0099 0.0094
0.3 Absent MSE 0.0124 0.0141 0.0158 0.0153 0.0145 0.0157 0.0156 0.0184 0.0087 0.0090 0.0108 0.0144
Present MSE 0.0162 0.0214 0.0174 0.0227 0.0232 0.0245 0.0262 0.0195 0.0084 0.0093 0.0235 0.0394
0.7 Absent MSE 0.0121 0.0131 0.0153 0.0964 0.0123 0.0145 0.0146 0.0174 0.0093 0.0095 0.0103 0.0149
Present MSE 0.0174 0.0256 0.0270 0.0290 0.0237 0.0277 0.0354 0.0238 0.0116 0.0122 0.0312 0.0643
Scenario 2*
N = 250 0 Absent MSE 0.0537 0.0575 0.0994 0.0678 0.0591 0.0698 0.0545 0.1030 0.0329 0.0344 0.0436 0.0414
Present MSE 0.0576 0.0622 0.1116 0.0770 0.0643 0.0787 0.0595 0.1152 0.0348 0.0362 0.0445 0.0430
0.3 Absent MSE 0.0525 0.0604 0.1117 0.0850 0.0618 0.0876 0.0589 0.1106 0.0343 0.0374 0.0458 0.0453
Present MSE 0.0605 0.0717 0.1382 0.0763 0.0745 0.0778 0.0739 0.1252 0.0375 0.0404 0.0627 0.0750
0.7 Absent MSE 0.0512 0.0558 0.0944 0.0872 0.0562 0.0883 0.0577 0.0977 0.0373 0.0388 0.0428 0.0465
Present MSE 0.0684 0.0809 0.1901 0.1042 0.0798 0.1045 0.0865 0.1732 0.0490 0.0531 0.0765 0.1042
N = 500 0 Absent MSE 0.0289 0.0330 0.0682 0.0427 0.0335 0.0433 0.0294 0.0696 0.0177 0.0186 0.0220 0.0210
Present MSE 0.0269 0.0295 0.0660 0.0383 0.0302 0.0390 0.0275 0.0666 0.0163 0.0171 0.0208 0.0199
0.3 Absent MSE 0.0245 0.0279 0.0702 0.0467 0.0287 0.0478 0.0287 0.0675 0.0172 0.0183 0.0214 0.0245
Present MSE 0.0317 0.0394 0.0943 0.0390 0.0404 0.0392 0.0413 0.0784 0.0183 0.0196 0.0376 0.0517
0.7 Absent MSE 0.0259 0.0283 0.0634 0.0560 0.0287 0.0565 0.0303 0.0652 0.0187 0.0194 0.0209 0.0249
Present MSE 0.0370 0.0443 0.1483 0.0633 0.0445 0.0639 0.0528 0.1207 0.0254 0.0268 0.0471 0.0777
N = 1000 0 Absent MSE 0.0128 0.0145 0.0453 0.0219 0.0149 0.0224 0.0133 0.0463 0.0083 0.0089 0.0105 0.0101
Present MSE 0.0145 0.0161 0.0502 0.0249 0.0166 0.0254 0.0148 0.0511 0.0088 0.0093 0.0114 0.0107
0.3 Absent MSE 0.0127 0.0146 0.0523 0.0308 0.0150 0.0315 0.0160 0.0491 0.0087 0.0092 0.0108 0.0141
Present MSE 0.0173 0.0220 0.0713 0.0203 0.0230 0.0205 0.0260 0.0555 0.0090 0.0098 0.0256 0.0404
0.7 Absent MSE 0.0121 0.0129 0.0468 0.0384 0.0131 0.0387 0.0153 0.0470 0.0090 0.0094 0.0102 0.0141
Present MSE 0.0189 0.0247 0.1193 0.0395 0.0260 0.0399 0.0356 0.0893 0.0124 0.0134 0.0342 0.0651
*Results in italic indicate MSE was closest to zero.
MSE indicates mean squared error; PS, propensity score. 
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When comparing the univariate and generalized PS methods, in which only the 
covariates related to the outcome were included, the MSE was smaller for the generalized 
PS in all simulated datasets in scenario 1 and scenario 2 (Table 2). 
In addition, if the sample size increased, the MSE decreased in all simulations. 
If the correlation increased when there was a correlation between the subgroup and 
covariates, the MSE increased. However, if the correlation between the subgroup and 
covariates was absent, the MSE showed a rather inconsistent pattern. Comparing the 
simulations when the correlation between the subgroup and covariates was either 
present or absent, gave overall lower MSE values if this correlation was absent. 
Univariate PS: case study
The univariate PS was applied according to the protocol described by Bartak and 
colleagues (Bartak et al., 2009). In total, 28 covariates related to outcome (P = 0.10) were 
selected in the PS estimation. We added four sociodemographic variables as these are 
considered highly relevant in psychotherapy research (Bartak et al., 2009). The subgroup 
of interest, that is, the severity of problems, was related to treatment assignment (χ²(1)= 
10.80, P =.001) and to the outcome (B = .318, P = .000; in a linear regression on the 
outcome). Thus, in applying the PS methods in the case study, we followed the results of 
scenario 2: for the univariate PS, we excluded the variable that reflected the severity of 
problems from the PS estimation. 
The PS was estimated in a logistic regression analysis on the treatment assignment 
and no interaction terms between the covariates were added. The distributions of the 
estimated PS scores showed considerable overlap (Figure 1). A lack of overlap would 
yield imprecise estimates of the treatment effect (Spreeuwenberg et al., 2010).
The PS was then added to a regression model on the outcome GSI, in which 
treatment duration, severity of problems, and an interaction term were the independent 
variables:
β β β β β= + + + + ⋅0 1 2 3 4OUTCOME PS Treatment Severity Treatment Severity (5)
If patients had mild problems, long-term treatment yielded more favorable results than 
short-term treatment (standardized coefficient of 0.092; Table 3). For patients having 
severe problems, both treatment options were equally effective:  for patients having 
severe problems in the short-term treatment the standardized coefficient was 0.240, 
whereas for the long-term treatment, the final standardized coefficient was 0.248. The 
interaction effect was, however, not significant. Excluding this coefficient indicated that 
long-term treatment was preferred for patients with severe problems (Table 3). 
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Figure 1. Boxplots of the overlap of the univariate propensity score (PS) distributions
Circle is a mild outlier (defined when the value > 3rd quartile + 1.5 • interquartile range or < 1st quartile 
- 1.5 • interquartile range).
Aterisk is an extreme outlier (defined when the value > 3rd quartile + 3 • interquartile range or < 1st 
quartile - 3 • interquartile range). 
Table 3. Linear regression on GSI outcome 
Variables (N=727) B 95% CI Standardized coefficient
Using the univariate PS
Intercept 0.512** 0.408 – 0.614 -
Long duration treatment group 0.106* 0.006 – 0.206 0.092
Severe problems 0.366** 0.168 – 0.564 0.240
Interaction -0.147 -0.382 – 0.088 -0.084
Using the generalized PS
Intercept 0.536** 0.426 - 0.646 -
Short duration – mild problems Reference - -
Short duration – severe problems 0.348** 0.091 – 0.605 0.129
Long duration – mild problems 0.113* 0.011 – 0.215 0.099
Long duration – severe problems 0.244** 0.064 – 0.424 0.139
*p<0.05. 
**p<0.01.
CI indicate confidence interval; GSI, Global Severity Index; PS, propensity score.
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Generalized PS: case study
The generalized PS was applied according to the protocol described by Spreeuwenberg 
and colleagues (2010) The generalized PS was estimated as a combination variable of 
treatment duration and severity of problems: short-term treatment for patients having 
mild problems (reference category, N=268), short-term treatment for patients having 
severe problems (N=34), long-term treatment for patients having mild problems (N=338) 
and long-term treatment for patients having severe problems (N=87). The same list of 
covariates selected in the univariate PS was included in the generalized PS estimation. 
Here, we followed the simulation results of scenario 2. The PS was estimated by 
multinomial regression analysis, with the combination variable of treatment duration and 
severity of problems as dependent variable and not including interaction terms between 
the covariates. However, the number of cases in 2 groups was small and validity of the 
model fit was therefore uncertain (Austin, 2009; Shah et al., 2005; Stürmer et al., 2006; 
Weitzen et al., 2004). Because the four estimated generalized PSs add up to 1 and are 
complementary, only 3 of 4 were used in further analyses. As required when using the 
PS, the ranges of the estimated PS scores showed overlap (Figure 2). 
In the final regression model on the outcome GSI, 3 generalized PSs and 3 dummies 
indicating group membership were included [Eq. (6)]:
β β β β β β β= + + + + + +0 1 1 2 2 3 3 4 1 5 2 6 3OUTCOME PS PS PS LongMild ShortSevere LongSevere
These results indicated that long- term treatment was more favorable for patients 
having mild problems. For patients having severe problems, both treatment options 
were almost  equally effective, just as was presented when the univariate PS was applied 
while taking the interaction effect into account (Table 3). 
To compare the relative effects of this model to the results of using the univariate 
PS, we used the standardized coefficients. These coefficients can be interpreted 
independent of the intercept and PS scores added in each model. The coefficient for 
patients having severe problems in short-term treatment was 0.240 using the univariate 
versus 0.129 using the generalized PS. The coefficient of patients having mild problems 
in long-term treatment was almost equal: 0.092 using the univariate PS versus 0.099 
using the generalized PS. For patients having severe problems in long-term treatment 
we combined the standardized coefficients of the model in which the univariate PS was 
applied and compared it to the corresponding coefficient in the model of the generalized 
PS. For these patients, the combined coefficient was 0.248 using the univariate versus 
0.139 using the generalized PS (Table 3). 
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Discussion
The present study illustrates the use of the univariate and generalized PS in subgroup 
analyses in non-randomized outcomes research, and describes how the generalized 
PS could be used in subgroup analysis. The results indicate that the generalized PS 
– estimated by crossing the treatment options with a subgroup variable – could be a 
feasible option and should be seriously considered when assessing subgroup effects 
while correcting for observed pre-treatment differences. In the Monte Carlo simulation 
study, the generalized PS gave  more efficient results overall than the univariate PS, 
regardless of whether there was a relationship between the subgroup and treatment 
assignment. In both PS methods, the variables related to the outcome should be 
included in the PS estimation. These results follow earlier studies of Brookhart and 
colleagues (2006) and Austin and colleagues (2007) in selecting only the covariates 
related to the outcome. Furthermore, when the univariate PS was used, the subgroup of 
interest should be excluded from the PS estimation. Applying the 2 PSs estimations on 
real-world data produced almost equal model results, illustrating the modifying effect of 
the severity of problems on the differential effectiveness of 2 psychotherapy treatment 
arms. 
In applying the generalized PS when analyzing subgroups effects, a researcher should 
take into account additional characteristics of their datasets. Firstly, the characteristics of 
the subgroup variable should be taken into account. For example, the independence of 
irrelevant alternatives (IIA) assumption can be violated. This assumption will be violated 
if, for example, short-term psychotherapy  for patients having mild problems is no 
longer available and this  influences the relative risks of the remaining categories. We 
tested this assumption in our study and it was not violated. However, when it is violated, 
a nested structure can overcome this violation by first defining the probability that a 
patient belongs to a particular subgroup and is subsequently assigned to a treatment 
option. Fuji and colleagues (2012) focused on a 2-stage structure (i.e. a nested structure), 
in which patients could be assigned sequentially to 2 treatment options,  each consisting 
of 2 sub-options. Yet, if for example a patient characteristic evolves after treatment, it 
could mediate the relationship between the independent and dependent variable (i.e. a 
mediator) and should be analyzed differently from the proposed methods (VanderWeele 
& Vansteelandt, 2009). 
Secondly, for various reasons, other application methods when using the PS 
could be more advantageous (Austin, 2011; Rubin, 1979). For example, the PS can be 
estimated in each subgroup separately (Kreif et al., 2012; Radice et al., 2012), requiring 
a large study population to have sufficient power. If the sample size is large enough, a 
multivariable adjusted model including interaction terms for the subgroup effects can 
also be a valid alternative (Liem et al., 2010). In this study we applied the PS using 
covariate adjustment, as sample sizes in clinical practice can be small and this method 
uses the complete sample size. However, covariate adjustment inherently assumes a 
correctly specified outcome regression model (Rubin, 2004), whereas for matching this 
is not required. Inverse probability weighting on the PS is a third and efficient method to 
control for selection bias (Hirano et al., 2003). The latter 2 methods can indeed eliminate 
most systematic differences between treated and untreated subjects (Austin, 2009), but 
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matching for example can result in very small comparison groups (Spreeuwenberg et al., 
2010). To improve precision of the effect estimates, those methods can also be used in 
combination with regression analysis (Hirano & Imbens, 2001; Imbens, 2004). 
Thirdly, when using the PS, researchers should assess carefully which method is 
most appropriate for their specific research question. For example, when the treatment 
effect itself is more important, using the univariate PS and adjusting for extra covariates 
additionally reduces the bias of the treatment effect estimation (Rubin & Thomas, 2000; 
Stürmer et al., 2006). However, incorporating effect modification  reduces the direct 
interpretability of the main treatment effect (Liem et al., 2010; Sturmer et al., 2006). 
Furthermore, if the distributions of the effect modifying variables vary highly, the overall 
estimates may differ across PS quantiles (Lunt et al., 2009). Different adjustment methods 
can thus result in divergent results, which all may be correct, but strongly depends on 
the research question and the population in which the estimation is most suitable (Kurth 
et al., 2006; Liem et al., 2010).
Our study has several limitations. First, only a basic simulation study was designed. 
The characteristics of the simulated data were known in advance to the analyzer, 
which could have influenced the analysis and method chosen. Testing the methods 
using new simulated data that could be based on a real dataset, is recommended 
to further investigate the performance of the methods. Furthermore, the number of 
simulated datasets was rather small, which could have caused the small differences and 
inconsistencies in the simulation results, due to Monte Carlo error. Secondly, the overlap 
for the generalized PSs in the  case study appeared to be less than optimal (Figure 
2). This could have caused the difference in the estimated coefficients when the PS 
methods were compared. A distance score defined by Cochran and Rubin (1973) can be 
used to precisely test and define the overlap. A third limitation deals with the selection 
of variables into the PS. We left out the subgroup variable in the univariate PS, while 
Rubin and Thomas (2000) state that no prognostic variable should be left out. Although 
the results of our simulations and the case study only slightly changed when we added 
the subgroup variable to the univariate PS, we recommend investigating its influence 
in more detail. Fourth, although we controlled for observed pre-treatment variables, 
hidden bias due to unobserved confounders could not be controlled for in the case 
study. As we did not include hidden bias in the simulated datasets either, we do not 
know the effect of hidden bias in using the PSs in subgroup analysis. 
This study supports the idea that the generalized PS can be used in estimating 
the treatment effect when this is modified by a subgroup variable. As patient-tailored 
treatment becomes more and more important in outcomes research (Norcross & 
Wampold, 2011), this study contributes to the literature on how to handle effect 
estimation in non-randomized outcomes studies of patient subgroups using the PS. 
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Table I. Bias, standard error (SE) and mean squared error (MSE) of simulations– scenario 1* 
Sample 
size
Correlation 
covariates 
X1, X2, X3
Correlation 
Z - X1,
X2,X3
 
Variables in propensity score (PS) model
Univariate PS Generalized PS
X2, X3 X1, X2, X3 X2, X3, Z X1, X2, X3, Z X1, X2 X1, X2, Z X2 X2, Z X2, X3 X1, X2, X3 X1, X2 X2
N = 250
0
absent
Bias 0.0005 0.0015 0.0014 0.0018 0.0046 0.0051 0.0041 0.0055 -0.0022 -0.0035 -0.0066 -0.0088
SE 0.0071 0.0075 0.0079 0.0076 0.0076 0.0078 0.0072 0.0080 0.0057 0.0059 0.0065 0.0064
MSE 0.0523 0.0579 0.0642 0.0605 0.0600 0.0624 0.0541 0.0664 0.0329 0.0351 0.0428 0.0411
present
Bias 0.0033 0.0048 0.0059 0.0057 0.0046 0.0054 0.0021 0.0047 0.0027 0.0045 0.0009 0.0003
SE 0.0071 0.0074 0.0079 0.0075 0.0077 0.0078 0.0073 0.0081 0.0058 0.0061 0.0067 0.0065
MSE 0.0524 0.0561 0.0641 0.0583 0.0608 0.0630 0.0551 0.0674 0.0342 0.0367 0.0451 0.0424
0.3
absent
Bias -0.0041 -0.0032 -0.0019 -0.0024 0.0023 0.1683 0.0266 0.0287 -0.0063 0.0081 0.0062 0.0595
SE 0.0069 0.0074 0.0077 0.0077 0.0075 0.0069 0.0073 0.0080 0.0059 0.0061 0.0067 0.0065
MSE 0.0491 0.0562 0.0618 0.0608 0.0585 0.1322 0.0569 0.0675 0.0348 0.0375 0.0449 0.0472
present
Bias 0.0313 0.0491 -0.0186 0.0478 0.0477 0.0457 0.0765 0.0143 0.0007 -0.0029 0.0926 0.1599
SE 0.0071 0.0076 0.0080 0.0079 0.0077 0.0080 0.0074 0.0082 0.0060 0.0062 0.0066 0.0064
MSE 0.0556 0.0683 0.0687 0.0724 0.0682 0.0722 0.0673 0.0709 0.0356 0.0381 0.0578 0.0725
0.7
absent
Bias 0.0019 0.0038 0.0029 0.0042 0.0037 0.0043 0.0288 0.0297 0.0015 0.0051 0.0049 0.0579
SE 0.0068 0.0071 0.0076 0.0076 0.0073 0.0079 0.0072 0.0079 0.0060 0.0062 0.0065 0.0064
MSE 0.0481 0.0518 0.0593 0.0592 0.0560 0.0635 0.0561 0.0664 0.0365 0.0391 0.0422 0.0456
present
Bias 0.0319 0.0611 -0.0255 0.0589 0.0560 0.0520 0.1007 0.0088 0.0087 0.0055 0.1065 0.1999
SE 0.0078 0.0082 0.0091 0.0088 0.0080 0.0088 0.0077 0.0090 0.0069 0.0071 0.0073 0.0069
MSE 0.0657 0.0792 0.0926 0.0907 0.0741 0.0884 0.0805 0.0892 0.0476 0.0514 0.0719 0.0993
N = 500
0
absent
Bias 0.0015 0.0005 -0.0014 -0.0010 0.0001 -0.0014 -0.0004 -0.0034 0.0028 0.0017 0.0044 0.0019
SE 0.0050 0.0053 0.0056 0.0055 0.0055 0.0057 0.0052 0.0058 0.0040 0.0043 0.0047 0.0046
MSE 0.0261 0.0294 0.0330 0.0311 0.0312 0.0329 0.0278 0.0350 0.0162 0.0183 0.0218 0.0209
present
Bias 0.0006 0.0010 0.1738 0.0005 0.0036 0.0033 0.0036 0.0032 0.0050 -0.0070 -0.0060 -0.0062
SE 0.0053 0.0050 0.0047 0.0054 0.0053 0.0055 0.0052 0.0057 0.0040 0.0043 0.0048 0.0046
MSE 0.0292 0.0264 0.1095 0.0306 0.0297 0.0310 0.0277 0.0334 0.0163 0.0186 0.0227 0.0213
0.3
absent
Bias 0.0003 -0.0004 -0.0006 -0.0005 0.0008 0.0006 0.0277 0.0267 -0.0015 0.0011 0.0012 0.0515
SE 0.0049 0.0052 0.0055 0.0055 0.0053 0.0055 0.0051 0.0056 0.0042 0.0043 0.0047 0.0045
MSE 0.0245 0.0285 0.0318 0.0311 0.0285 0.0311 0.0285 0.0344 0.0174 0.0185 0.0217 0.0248
present
Bias 0.0370 0.0539 -0.0123 0.0526 0.0540 0.0525 0.0839 0.0233 0.0023 -0.0002 0.0961 0.1627
SE 0.0049 0.0053 0.0055 0.0055 0.0054 0.0056 0.0051 0.0057 0.0041 0.0043 0.0047 0.0045
MSE 0.0294 0.0381 0.0328 0.0394 0.0385 0.0400 0.0403 0.0350 0.0172 0.0186 0.0361 0.0519
0.7
absent
Bias 0.0002 0.0005 -0.0008 -0.0010 -0.0003 -0.0014 0.0270 0.0256 0.0048 0.0041 0.0043 0.0558
SE 0.0051 0.0049 0.0055 0.0055 0.0050 0.0054 0.0049 0.0055 0.0043 0.0044 0.0046 0.0045
MSE 0.0270 0.0248 0.0313 0.0315 0.0254 0.0299 0.0268 0.0326 0.0183 0.0198 0.0215 0.0250
present
Bias 0.0264 0.0546 -0.0297 0.0548 0.0555 0.0550 0.1025 0.0137 0.0079 0.0082 0.1103 0.2053
SE 0.0055 0.0058 0.0065 0.0063 0.0056 0.0061 0.0054 0.0064 0.0048 0.0049 0.0052 0.0049
MSE 0.0331 0.0432 0.0489 0.0494 0.0396 0.0469 0.0493 0.0450 0.0238 0.0249 0.0455 0.0776
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Table I. Bias, standard error (SE) and mean squared error (MSE) of simulations– scenario 1* 
Sample 
size
Correlation 
covariates 
X1, X2, X3
Correlation 
Z - X1,
X2,X3
 
Variables in propensity score (PS) model
Univariate PS Generalized PS
X2, X3 X1, X2, X3 X2, X3, Z X1, X2, X3, Z X1, X2 X1, X2, Z X2 X2, Z X2, X3 X1, X2, X3 X1, X2 X2
N = 250
0
absent
Bias 0.0005 0.0015 0.0014 0.0018 0.0046 0.0051 0.0041 0.0055 -0.0022 -0.0035 -0.0066 -0.0088
SE 0.0071 0.0075 0.0079 0.0076 0.0076 0.0078 0.0072 0.0080 0.0057 0.0059 0.0065 0.0064
MSE 0.0523 0.0579 0.0642 0.0605 0.0600 0.0624 0.0541 0.0664 0.0329 0.0351 0.0428 0.0411
present
Bias 0.0033 0.0048 0.0059 0.0057 0.0046 0.0054 0.0021 0.0047 0.0027 0.0045 0.0009 0.0003
SE 0.0071 0.0074 0.0079 0.0075 0.0077 0.0078 0.0073 0.0081 0.0058 0.0061 0.0067 0.0065
MSE 0.0524 0.0561 0.0641 0.0583 0.0608 0.0630 0.0551 0.0674 0.0342 0.0367 0.0451 0.0424
0.3
absent
Bias -0.0041 -0.0032 -0.0019 -0.0024 0.0023 0.1683 0.0266 0.0287 -0.0063 0.0081 0.0062 0.0595
SE 0.0069 0.0074 0.0077 0.0077 0.0075 0.0069 0.0073 0.0080 0.0059 0.0061 0.0067 0.0065
MSE 0.0491 0.0562 0.0618 0.0608 0.0585 0.1322 0.0569 0.0675 0.0348 0.0375 0.0449 0.0472
present
Bias 0.0313 0.0491 -0.0186 0.0478 0.0477 0.0457 0.0765 0.0143 0.0007 -0.0029 0.0926 0.1599
SE 0.0071 0.0076 0.0080 0.0079 0.0077 0.0080 0.0074 0.0082 0.0060 0.0062 0.0066 0.0064
MSE 0.0556 0.0683 0.0687 0.0724 0.0682 0.0722 0.0673 0.0709 0.0356 0.0381 0.0578 0.0725
0.7
absent
Bias 0.0019 0.0038 0.0029 0.0042 0.0037 0.0043 0.0288 0.0297 0.0015 0.0051 0.0049 0.0579
SE 0.0068 0.0071 0.0076 0.0076 0.0073 0.0079 0.0072 0.0079 0.0060 0.0062 0.0065 0.0064
MSE 0.0481 0.0518 0.0593 0.0592 0.0560 0.0635 0.0561 0.0664 0.0365 0.0391 0.0422 0.0456
present
Bias 0.0319 0.0611 -0.0255 0.0589 0.0560 0.0520 0.1007 0.0088 0.0087 0.0055 0.1065 0.1999
SE 0.0078 0.0082 0.0091 0.0088 0.0080 0.0088 0.0077 0.0090 0.0069 0.0071 0.0073 0.0069
MSE 0.0657 0.0792 0.0926 0.0907 0.0741 0.0884 0.0805 0.0892 0.0476 0.0514 0.0719 0.0993
N = 500
0
absent
Bias 0.0015 0.0005 -0.0014 -0.0010 0.0001 -0.0014 -0.0004 -0.0034 0.0028 0.0017 0.0044 0.0019
SE 0.0050 0.0053 0.0056 0.0055 0.0055 0.0057 0.0052 0.0058 0.0040 0.0043 0.0047 0.0046
MSE 0.0261 0.0294 0.0330 0.0311 0.0312 0.0329 0.0278 0.0350 0.0162 0.0183 0.0218 0.0209
present
Bias 0.0006 0.0010 0.1738 0.0005 0.0036 0.0033 0.0036 0.0032 0.0050 -0.0070 -0.0060 -0.0062
SE 0.0053 0.0050 0.0047 0.0054 0.0053 0.0055 0.0052 0.0057 0.0040 0.0043 0.0048 0.0046
MSE 0.0292 0.0264 0.1095 0.0306 0.0297 0.0310 0.0277 0.0334 0.0163 0.0186 0.0227 0.0213
0.3
absent
Bias 0.0003 -0.0004 -0.0006 -0.0005 0.0008 0.0006 0.0277 0.0267 -0.0015 0.0011 0.0012 0.0515
SE 0.0049 0.0052 0.0055 0.0055 0.0053 0.0055 0.0051 0.0056 0.0042 0.0043 0.0047 0.0045
MSE 0.0245 0.0285 0.0318 0.0311 0.0285 0.0311 0.0285 0.0344 0.0174 0.0185 0.0217 0.0248
present
Bias 0.0370 0.0539 -0.0123 0.0526 0.0540 0.0525 0.0839 0.0233 0.0023 -0.0002 0.0961 0.1627
SE 0.0049 0.0053 0.0055 0.0055 0.0054 0.0056 0.0051 0.0057 0.0041 0.0043 0.0047 0.0045
MSE 0.0294 0.0381 0.0328 0.0394 0.0385 0.0400 0.0403 0.0350 0.0172 0.0186 0.0361 0.0519
0.7
absent
Bias 0.0002 0.0005 -0.0008 -0.0010 -0.0003 -0.0014 0.0270 0.0256 0.0048 0.0041 0.0043 0.0558
SE 0.0051 0.0049 0.0055 0.0055 0.0050 0.0054 0.0049 0.0055 0.0043 0.0044 0.0046 0.0045
MSE 0.0270 0.0248 0.0313 0.0315 0.0254 0.0299 0.0268 0.0326 0.0183 0.0198 0.0215 0.0250
present
Bias 0.0264 0.0546 -0.0297 0.0548 0.0555 0.0550 0.1025 0.0137 0.0079 0.0082 0.1103 0.2053
SE 0.0055 0.0058 0.0065 0.0063 0.0056 0.0061 0.0054 0.0064 0.0048 0.0049 0.0052 0.0049
MSE 0.0331 0.0432 0.0489 0.0494 0.0396 0.0469 0.0493 0.0450 0.0238 0.0249 0.0455 0.0776
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Sample 
size
Correlation 
covariates 
X1, X2, X3
Correlation 
Z - X1,
X2,X3
 
Variables in propensity score (PS) model
Univariate PS Generalized PS
X2, X3 X1, X2, X3 X2, X3, Z X1, X2, X3, Z X1, X2 X1, X2, Z X2 X2, Z X2, X3 X1, X2, X3 X1, X2 X2
N = 1000
0
absent
Bias -0.0003 -0.0002 0.0009 0.0005 0.0016 0.0023 0.0010 0.0022 -0.0011 0.0021 0.0026 0.0014
SE 0.0035 0.0038 0.0039 0.0038 0.0038 0.0039 0.0036 0.0040 0.0028 0.0030 0.0033 0.0032
MSE 0.0132 0.0148 0.0160 0.0154 0.0149 0.0155 0.0136 0.0164 0.0081 0.0090 0.0110 0.0105
present
Bias 0.0009 0.0003 0.0007 0.0000 0.0037 0.0034 0.0028 0.0024 0.0032 0.0012 0.0015 0.0013
SE 0.0035 0.0037 0.0039 0.0038 0.0038 0.0039 0.0036 0.0040 0.0029 0.0028 0.0031 0.0031
MSE 0.0130 0.0146 0.0160 0.0152 0.0154 0.0161 0.0138 0.0168 0.0085 0.0081 0.0099 0.0094
0.3
absent
Bias 0.0001 0.0008 -0.0011 0.0000 -0.0033 -0.0042 0.0226 0.0216 -0.0015 0.0023 0.0018 0.0522
SE 0.0035 0.0037 0.0039 0.0038 0.0038 0.0039 0.0036 0.0040 0.0030 0.0030 0.0033 0.0032
MSE 0.0124 0.0141 0.0158 0.0153 0.0145 0.0157 0.0156 0.0184 0.0087 0.0090 0.0108 0.0144
present
Bias 0.0345 0.0502 -0.0149 0.0498 0.0501 0.0496 0.0814 0.0216 0.0019 -0.0050 0.0878 0.1543
SE 0.0034 0.0037 0.0040 0.0039 0.0039 0.0041 0.0037 0.0042 0.0029 0.0030 0.0033 0.0032
MSE 0.0162 0.0214 0.0174 0.0227 0.0232 0.0245 0.0262 0.0195 0.0084 0.0093 0.0235 0.0394
0.7
absent
Bias 0.0012 0.0012 0.0027 0.1706 0.0003 0.0018 0.0277 0.0292 0.0030 0.0039 0.0032 0.0563
SE 0.0034 0.0036 0.0039 0.0034 0.0035 0.0038 0.0035 0.0038 0.0030 0.0031 0.0032 0.0032
MSE 0.0121 0.0131 0.0153 0.0964 0.0123 0.0145 0.0146 0.0174 0.0093 0.0095 0.0103 0.0149
present
Bias 0.0304 0.0578 -0.0267 0.0580 0.0521 0.0522 0.1013 0.0129 0.0090 0.0052 0.1087 0.2039
SE 0.0039 0.0041 0.0046 0.0045 0.0040 0.0044 0.0038 0.0045 0.0034 0.0035 0.0036 0.0034
MSE 0.0174 0.0256 0.0270 0.0290 0.0237 0.0277 0.0354 0.0238 0.0116 0.0122 0.0312 0.0643
*Results in bold indicate bias was closest to zero, results in italic indicate MSE was closest to zero
| Chapter 4 Subgroup analysis using the propensity score |
4
| 82 83 |
Sample 
size
Correlation 
covariates 
X1, X2, X3
Correlation 
Z - X1,
X2,X3
 
Variables in propensity score (PS) model
Univariate PS Generalized PS
X2, X3 X1, X2, X3 X2, X3, Z X1, X2, X3, Z X1, X2 X1, X2, Z X2 X2, Z X2, X3 X1, X2, X3 X1, X2 X2
N = 1000
0
absent
Bias -0.0003 -0.0002 0.0009 0.0005 0.0016 0.0023 0.0010 0.0022 -0.0011 0.0021 0.0026 0.0014
SE 0.0035 0.0038 0.0039 0.0038 0.0038 0.0039 0.0036 0.0040 0.0028 0.0030 0.0033 0.0032
MSE 0.0132 0.0148 0.0160 0.0154 0.0149 0.0155 0.0136 0.0164 0.0081 0.0090 0.0110 0.0105
present
Bias 0.0009 0.0003 0.0007 0.0000 0.0037 0.0034 0.0028 0.0024 0.0032 0.0012 0.0015 0.0013
SE 0.0035 0.0037 0.0039 0.0038 0.0038 0.0039 0.0036 0.0040 0.0029 0.0028 0.0031 0.0031
MSE 0.0130 0.0146 0.0160 0.0152 0.0154 0.0161 0.0138 0.0168 0.0085 0.0081 0.0099 0.0094
0.3
absent
Bias 0.0001 0.0008 -0.0011 0.0000 -0.0033 -0.0042 0.0226 0.0216 -0.0015 0.0023 0.0018 0.0522
SE 0.0035 0.0037 0.0039 0.0038 0.0038 0.0039 0.0036 0.0040 0.0030 0.0030 0.0033 0.0032
MSE 0.0124 0.0141 0.0158 0.0153 0.0145 0.0157 0.0156 0.0184 0.0087 0.0090 0.0108 0.0144
present
Bias 0.0345 0.0502 -0.0149 0.0498 0.0501 0.0496 0.0814 0.0216 0.0019 -0.0050 0.0878 0.1543
SE 0.0034 0.0037 0.0040 0.0039 0.0039 0.0041 0.0037 0.0042 0.0029 0.0030 0.0033 0.0032
MSE 0.0162 0.0214 0.0174 0.0227 0.0232 0.0245 0.0262 0.0195 0.0084 0.0093 0.0235 0.0394
0.7
absent
Bias 0.0012 0.0012 0.0027 0.1706 0.0003 0.0018 0.0277 0.0292 0.0030 0.0039 0.0032 0.0563
SE 0.0034 0.0036 0.0039 0.0034 0.0035 0.0038 0.0035 0.0038 0.0030 0.0031 0.0032 0.0032
MSE 0.0121 0.0131 0.0153 0.0964 0.0123 0.0145 0.0146 0.0174 0.0093 0.0095 0.0103 0.0149
present
Bias 0.0304 0.0578 -0.0267 0.0580 0.0521 0.0522 0.1013 0.0129 0.0090 0.0052 0.1087 0.2039
SE 0.0039 0.0041 0.0046 0.0045 0.0040 0.0044 0.0038 0.0045 0.0034 0.0035 0.0036 0.0034
MSE 0.0174 0.0256 0.0270 0.0290 0.0237 0.0277 0.0354 0.0238 0.0116 0.0122 0.0312 0.0643
*Results in bold indicate bias was closest to zero, results in italic indicate MSE was closest to zero
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Table II. Bias, standard error (SE) and mean squared error (MSE) of simulations – scenario 2*
Sample 
size
Correlation 
covariates 
X1,X2,X3
Correlation 
Z - X1,
X2,X3
 
Variables in propensity score (PS) model
Univariate PS Generalized PS
X2, X3 X1, X2, X3 X2, X3, Z X1, X2, X3, Z X1, X2 X1, X2, Z X2 X2, Z X2, X3 X1, X2, X3 X1, X2 X2
N = 250
0
absent
Bias 0.0017 0.0032 -0.0964 -0.0438 0.0021 -0.0466 0.0009 -0.1033 0.0046 0.0067 0.0041 0.0030
SE 0.0072 0.0074 0.0082 0.0077 0.0076 0.0078 0.0073 0.0083 0.0057 0.0059 0.0066 0.0064
MSE 0.0537 0.0575 0.0994 0.0678 0.0591 0.0698 0.0545 0.1030 0.0329 0.0344 0.0436 0.0414
present
Bias -0.0038 -0.0051 -0.1062 -0.0555 -0.0041 -0.0548 -0.0023 -0.1084 -0.0084 -0.0093 -0.0119 -0.0100
SE 0.0074 0.0077 0.0084 0.0080 0.0079 0.0081 0.0076 0.0085 0.0059 0.0060 0.0067 0.0065
MSE 0.0576 0.0622 0.1116 0.0770 0.0643 0.0787 0.0595 0.1152 0.0348 0.0362 0.0445 0.0430
0.3
absent
Bias -0.0025 -0.0032 -0.1120 -0.0736 -0.0039 -0.0760 0.0208 -0.0798 -0.0033 -0.0024 -0.0073 0.0389
SE 0.0071 0.0076 0.0082 0.0081 0.0078 0.0082 0.0074 0.0084 0.0059 0.0061 0.0068 0.0065
MSE 0.0525 0.0604 0.1117 0.0850 0.0618 0.0876 0.0589 0.1106 0.0343 0.0374 0.0458 0.0453
present
Bias 0.0299 0.0446 -0.1255 -0.0163 0.0528 -0.0185 0.0809 -0.0847 0.0049 0.0058 0.1016 0.1618
SE 0.0074 0.0079 0.0089 0.0085 0.0080 0.0086 0.0078 0.0089 0.0061 0.0063 0.0069 0.0066
MSE 0.0605 0.0717 0.1382 0.0763 0.0745 0.0778 0.0739 0.1252 0.0375 0.0404 0.0627 0.0750
0.7
absent
Bias 0.0037 0.0031 -0.0927 -0.0791 0.0041 -0.0796 0.0295 -0.0623 0.0117 0.0126 0.0132 0.0584
SE 0.0070 0.0074 0.0080 0.0080 0.0074 0.0081 0.0073 0.0082 0.0061 0.0062 0.0065 0.0064
MSE 0.0512 0.0558 0.0944 0.0872 0.0562 0.0883 0.0577 0.0977 0.0373 0.0388 0.0428 0.0465
present
Bias 0.0285 0.0540 -0.1354 -0.0226 0.0622 -0.0303 0.1043 -0.0968 0.0134 0.0133 0.1244 0.2120
SE 0.0080 0.0084 0.0100 0.0095 0.0083 0.0094 0.0081 0.0101 0.0069 0.0072 0.0074 0.0070
MSE 0.0684 0.0809 0.1901 0.1042 0.0798 0.1045 0.0865 0.1732 0.0490 0.0531 0.0765 0.1042
N = 500
0
absent
Bias -0.0006 -0.0001 -0.0998 -0.0482 -0.0001 -0.0490 -0.0007 -0.1024 0.0015 0.0035 0.0031 0.0008
SE 0.0053 0.0056 0.0060 0.0058 0.0057 0.0059 0.0053 0.0060 0.0042 0.0043 0.0047 0.0046
MSE 0.0289 0.0330 0.0682 0.0427 0.0335 0.0433 0.0294 0.0696 0.0177 0.0186 0.0220 0.0210
present
Bias -0.0008 -0.0014 -0.1006 -0.0497 -0.0012 -0.0497 -0.0003 -0.1015 0.0017 0.0008 0.0007 0.0014
SE 0.0051 0.0053 0.0058 0.0055 0.0054 0.0055 0.0051 0.0058 0.0040 0.0041 0.0046 0.0044
MSE 0.0269 0.0295 0.0660 0.0383 0.0302 0.0390 0.0275 0.0666 0.0163 0.0171 0.0208 0.0199
0.3
absent
Bias 0.0001 -0.0001 -0.1091 -0.0713 0.0000 -0.0719 0.0240 -0.0749 0.0019 0.0024 0.0026 0.0469
SE 0.0049 0.0052 0.0056 0.0055 0.0053 0.0056 0.0051 0.0058 0.0041 0.0043 0.0046 0.0046
MSE 0.0245 0.0279 0.0702 0.0467 0.0287 0.0478 0.0287 0.0675 0.0172 0.0183 0.0214 0.0245
present
Bias 0.0297 0.0444 -0.1238 -0.0168 0.0509 -0.0198 0.0799 -0.0814 0.0007 0.0006 0.0962 0.1582
SE 0.0052 0.0056 0.0062 0.0060 0.0056 0.0060 0.0054 0.0062 0.0043 0.0044 0.0049 0.0047
MSE 0.0317 0.0394 0.0943 0.0390 0.0404 0.0392 0.0413 0.0784 0.0183 0.0196 0.0376 0.0517
0.7
absent
Bias 0.0013 0.0015 -0.0976 -0.0838 0.0019 -0.0841 0.0268 -0.0668 0.0089 0.0113 0.0093 0.0528
SE 0.0050 0.0052 0.0056 0.0057 0.0053 0.0057 0.0052 0.0057 0.0043 0.0044 0.0046 0.0045
MSE 0.0259 0.0283 0.0634 0.0560 0.0287 0.0565 0.0303 0.0652 0.0187 0.0194 0.0209 0.0249
present
Bias 0.0248 0.0488 -0.1445 -0.0339 0.0591 -0.0377 0.1033 -0.0979 0.0077 0.0073 0.1139 0.2033
SE 0.0058 0.0060 0.0072 0.0068 0.0059 0.0068 0.0058 0.0072 0.0050 0.0051 0.0052 0.0050
MSE 0.0370 0.0443 0.1483 0.0633 0.0445 0.0639 0.0528 0.1207 0.0254 0.0268 0.0471 0.0777
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Table II. Bias, standard error (SE) and mean squared error (MSE) of simulations – scenario 2*
Sample 
size
Correlation 
covariates 
X1,X2,X3
Correlation 
Z - X1,
X2,X3
 
Variables in propensity score (PS) model
Univariate PS Generalized PS
X2, X3 X1, X2, X3 X2, X3, Z X1, X2, X3, Z X1, X2 X1, X2, Z X2 X2, Z X2, X3 X1, X2, X3 X1, X2 X2
N = 250
0
absent
Bias 0.0017 0.0032 -0.0964 -0.0438 0.0021 -0.0466 0.0009 -0.1033 0.0046 0.0067 0.0041 0.0030
SE 0.0072 0.0074 0.0082 0.0077 0.0076 0.0078 0.0073 0.0083 0.0057 0.0059 0.0066 0.0064
MSE 0.0537 0.0575 0.0994 0.0678 0.0591 0.0698 0.0545 0.1030 0.0329 0.0344 0.0436 0.0414
present
Bias -0.0038 -0.0051 -0.1062 -0.0555 -0.0041 -0.0548 -0.0023 -0.1084 -0.0084 -0.0093 -0.0119 -0.0100
SE 0.0074 0.0077 0.0084 0.0080 0.0079 0.0081 0.0076 0.0085 0.0059 0.0060 0.0067 0.0065
MSE 0.0576 0.0622 0.1116 0.0770 0.0643 0.0787 0.0595 0.1152 0.0348 0.0362 0.0445 0.0430
0.3
absent
Bias -0.0025 -0.0032 -0.1120 -0.0736 -0.0039 -0.0760 0.0208 -0.0798 -0.0033 -0.0024 -0.0073 0.0389
SE 0.0071 0.0076 0.0082 0.0081 0.0078 0.0082 0.0074 0.0084 0.0059 0.0061 0.0068 0.0065
MSE 0.0525 0.0604 0.1117 0.0850 0.0618 0.0876 0.0589 0.1106 0.0343 0.0374 0.0458 0.0453
present
Bias 0.0299 0.0446 -0.1255 -0.0163 0.0528 -0.0185 0.0809 -0.0847 0.0049 0.0058 0.1016 0.1618
SE 0.0074 0.0079 0.0089 0.0085 0.0080 0.0086 0.0078 0.0089 0.0061 0.0063 0.0069 0.0066
MSE 0.0605 0.0717 0.1382 0.0763 0.0745 0.0778 0.0739 0.1252 0.0375 0.0404 0.0627 0.0750
0.7
absent
Bias 0.0037 0.0031 -0.0927 -0.0791 0.0041 -0.0796 0.0295 -0.0623 0.0117 0.0126 0.0132 0.0584
SE 0.0070 0.0074 0.0080 0.0080 0.0074 0.0081 0.0073 0.0082 0.0061 0.0062 0.0065 0.0064
MSE 0.0512 0.0558 0.0944 0.0872 0.0562 0.0883 0.0577 0.0977 0.0373 0.0388 0.0428 0.0465
present
Bias 0.0285 0.0540 -0.1354 -0.0226 0.0622 -0.0303 0.1043 -0.0968 0.0134 0.0133 0.1244 0.2120
SE 0.0080 0.0084 0.0100 0.0095 0.0083 0.0094 0.0081 0.0101 0.0069 0.0072 0.0074 0.0070
MSE 0.0684 0.0809 0.1901 0.1042 0.0798 0.1045 0.0865 0.1732 0.0490 0.0531 0.0765 0.1042
N = 500
0
absent
Bias -0.0006 -0.0001 -0.0998 -0.0482 -0.0001 -0.0490 -0.0007 -0.1024 0.0015 0.0035 0.0031 0.0008
SE 0.0053 0.0056 0.0060 0.0058 0.0057 0.0059 0.0053 0.0060 0.0042 0.0043 0.0047 0.0046
MSE 0.0289 0.0330 0.0682 0.0427 0.0335 0.0433 0.0294 0.0696 0.0177 0.0186 0.0220 0.0210
present
Bias -0.0008 -0.0014 -0.1006 -0.0497 -0.0012 -0.0497 -0.0003 -0.1015 0.0017 0.0008 0.0007 0.0014
SE 0.0051 0.0053 0.0058 0.0055 0.0054 0.0055 0.0051 0.0058 0.0040 0.0041 0.0046 0.0044
MSE 0.0269 0.0295 0.0660 0.0383 0.0302 0.0390 0.0275 0.0666 0.0163 0.0171 0.0208 0.0199
0.3
absent
Bias 0.0001 -0.0001 -0.1091 -0.0713 0.0000 -0.0719 0.0240 -0.0749 0.0019 0.0024 0.0026 0.0469
SE 0.0049 0.0052 0.0056 0.0055 0.0053 0.0056 0.0051 0.0058 0.0041 0.0043 0.0046 0.0046
MSE 0.0245 0.0279 0.0702 0.0467 0.0287 0.0478 0.0287 0.0675 0.0172 0.0183 0.0214 0.0245
present
Bias 0.0297 0.0444 -0.1238 -0.0168 0.0509 -0.0198 0.0799 -0.0814 0.0007 0.0006 0.0962 0.1582
SE 0.0052 0.0056 0.0062 0.0060 0.0056 0.0060 0.0054 0.0062 0.0043 0.0044 0.0049 0.0047
MSE 0.0317 0.0394 0.0943 0.0390 0.0404 0.0392 0.0413 0.0784 0.0183 0.0196 0.0376 0.0517
0.7
absent
Bias 0.0013 0.0015 -0.0976 -0.0838 0.0019 -0.0841 0.0268 -0.0668 0.0089 0.0113 0.0093 0.0528
SE 0.0050 0.0052 0.0056 0.0057 0.0053 0.0057 0.0052 0.0057 0.0043 0.0044 0.0046 0.0045
MSE 0.0259 0.0283 0.0634 0.0560 0.0287 0.0565 0.0303 0.0652 0.0187 0.0194 0.0209 0.0249
present
Bias 0.0248 0.0488 -0.1445 -0.0339 0.0591 -0.0377 0.1033 -0.0979 0.0077 0.0073 0.1139 0.2033
SE 0.0058 0.0060 0.0072 0.0068 0.0059 0.0068 0.0058 0.0072 0.0050 0.0051 0.0052 0.0050
MSE 0.0370 0.0443 0.1483 0.0633 0.0445 0.0639 0.0528 0.1207 0.0254 0.0268 0.0471 0.0777
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Sample 
size
Correlation 
covariates 
X1,X2,X3
Correlation 
Z - X1,
X2,X3
 
Variables in propensity score (PS) model
Univariate PS Generalized PS
X2, X3 X1, X2, X3 X2, X3, Z X1, X2, X3, Z X1, X2 X1, X2, Z X2 X2, Z X2, X3 X1, X2, X3 X1, X2 X2
N = 1000
0
absent
Bias 0.0009 0.0013 -0.0963 -0.0461 0.0014 -0.0463 0.0011 -0.0972 0.0030 0.0046 0.0036 0.0020
SE 0.0035 0.0037 0.0040 0.0038 0.0038 0.0039 0.0036 0.0040 0.0029 0.0030 0.0032 0.0032
MSE 0.0128 0.0145 0.0453 0.0219 0.0149 0.0224 0.0133 0.0463 0.0083 0.0089 0.0105 0.0101
present
Bias -0.0011 -0.0008 -0.1020 -0.0499 -0.0013 -0.0508 -0.0017 -0.1042 0.0005 0.0019 -0.0012 -0.0031
SE 0.0037 0.0039 0.0042 0.0040 0.0040 0.0041 0.0038 0.0042 0.0030 0.0031 0.0034 0.0033
MSE 0.0145 0.0161 0.0502 0.0249 0.0166 0.0254 0.0148 0.0511 0.0088 0.0093 0.0114 0.0107
0.3
absent
Bias 0.0002 -0.0001 -0.1074 -0.0695 -0.0003 -0.0702 0.0239 -0.0730 0.0032 0.0038 0.0030 0.0488
SE 0.0035 0.0037 0.0040 0.0039 0.0038 0.0040 0.0037 0.0040 0.0029 0.0030 0.0033 0.0032
MSE 0.0127 0.0146 0.0523 0.0308 0.0150 0.0315 0.0160 0.0491 0.0087 0.0092 0.0108 0.0141
present
Bias 0.0296 0.0437 -0.1210 -0.0167 0.0507 -0.0184 0.0798 -0.0771 -0.0005 -0.0006 0.0955 0.1566
SE 0.0037 0.0039 0.0044 0.0042 0.0039 0.0042 0.0038 0.0044 0.0030 0.0031 0.0034 0.0033
MSE 0.0173 0.0220 0.0713 0.0203 0.0230 0.0205 0.0260 0.0555 0.0090 0.0098 0.0256 0.0404
0.7
absent
Bias 0.0000 0.0004 -0.1002 -0.0862 0.0003 -0.0867 0.0254 -0.0690 0.0047 0.0066 0.0061 0.0516
SE 0.0034 0.0035 0.0038 0.0038 0.0036 0.0038 0.0036 0.0039 0.0030 0.0031 0.0032 0.0031
MSE 0.0121 0.0129 0.0468 0.0384 0.0131 0.0387 0.0153 0.0470 0.0090 0.0094 0.0102 0.0141
present
Bias 0.0239 0.0462 -0.1445 -0.0375 0.0571 -0.0394 0.1025 -0.0960 0.0112 0.0128 0.1174 0.2056
SE 0.0040 0.0043 0.0052 0.0049 0.0043 0.0049 0.0041 0.0052 0.0035 0.0036 0.0038 0.0036
MSE 0.0189 0.0247 0.1193 0.0395 0.0260 0.0399 0.0356 0.0893 0.0124 0.0134 0.0342 0.0651
*Results in bold indicate bias was closest to zero, results in italic indicate MSE was closest to zero
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Sample 
size
Correlation 
covariates 
X1,X2,X3
Correlation 
Z - X1,
X2,X3
 
Variables in propensity score (PS) model
Univariate PS Generalized PS
X2, X3 X1, X2, X3 X2, X3, Z X1, X2, X3, Z X1, X2 X1, X2, Z X2 X2, Z X2, X3 X1, X2, X3 X1, X2 X2
N = 1000
0
absent
Bias 0.0009 0.0013 -0.0963 -0.0461 0.0014 -0.0463 0.0011 -0.0972 0.0030 0.0046 0.0036 0.0020
SE 0.0035 0.0037 0.0040 0.0038 0.0038 0.0039 0.0036 0.0040 0.0029 0.0030 0.0032 0.0032
MSE 0.0128 0.0145 0.0453 0.0219 0.0149 0.0224 0.0133 0.0463 0.0083 0.0089 0.0105 0.0101
present
Bias -0.0011 -0.0008 -0.1020 -0.0499 -0.0013 -0.0508 -0.0017 -0.1042 0.0005 0.0019 -0.0012 -0.0031
SE 0.0037 0.0039 0.0042 0.0040 0.0040 0.0041 0.0038 0.0042 0.0030 0.0031 0.0034 0.0033
MSE 0.0145 0.0161 0.0502 0.0249 0.0166 0.0254 0.0148 0.0511 0.0088 0.0093 0.0114 0.0107
0.3
absent
Bias 0.0002 -0.0001 -0.1074 -0.0695 -0.0003 -0.0702 0.0239 -0.0730 0.0032 0.0038 0.0030 0.0488
SE 0.0035 0.0037 0.0040 0.0039 0.0038 0.0040 0.0037 0.0040 0.0029 0.0030 0.0033 0.0032
MSE 0.0127 0.0146 0.0523 0.0308 0.0150 0.0315 0.0160 0.0491 0.0087 0.0092 0.0108 0.0141
present
Bias 0.0296 0.0437 -0.1210 -0.0167 0.0507 -0.0184 0.0798 -0.0771 -0.0005 -0.0006 0.0955 0.1566
SE 0.0037 0.0039 0.0044 0.0042 0.0039 0.0042 0.0038 0.0044 0.0030 0.0031 0.0034 0.0033
MSE 0.0173 0.0220 0.0713 0.0203 0.0230 0.0205 0.0260 0.0555 0.0090 0.0098 0.0256 0.0404
0.7
absent
Bias 0.0000 0.0004 -0.1002 -0.0862 0.0003 -0.0867 0.0254 -0.0690 0.0047 0.0066 0.0061 0.0516
SE 0.0034 0.0035 0.0038 0.0038 0.0036 0.0038 0.0036 0.0039 0.0030 0.0031 0.0032 0.0031
MSE 0.0121 0.0129 0.0468 0.0384 0.0131 0.0387 0.0153 0.0470 0.0090 0.0094 0.0102 0.0141
present
Bias 0.0239 0.0462 -0.1445 -0.0375 0.0571 -0.0394 0.1025 -0.0960 0.0112 0.0128 0.1174 0.2056
SE 0.0040 0.0043 0.0052 0.0049 0.0043 0.0049 0.0041 0.0052 0.0035 0.0036 0.0038 0.0036
MSE 0.0189 0.0247 0.1193 0.0395 0.0260 0.0399 0.0356 0.0893 0.0124 0.0134 0.0342 0.0651
*Results in bold indicate bias was closest to zero, results in italic indicate MSE was closest to zero
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Abstract 
Objective: To compare the effectiveness of Multisystemic Therapy (MST) and Functional 
Family Therapy (FFT) using a quasi-experimental design in the Netherlands. 
Method: Between October, 2009 and June, 2014, outcome data were collected from 
697 adolescents assigned to either MST or FFT (422 MST; 275 FFT). Data were gathered 
during Routine Outcome Monitoring. The primary outcome was externalizing problem 
behavior (Child Behavior Checklist and Youth Self Report). Secondary outcomes were the 
proportion of adolescents living at home, engaged in school or work, and who lacked 
police contact during treatment. Because of the non-random assignment, a propensity 
score method was used to control for observed pre-treatment differences. Because the 
risk-need-responsivity (RNR) model guided treatment assignment, effectiveness was 
also estimated in youth with and without a court order as an indicator of their risk level. 
Results: In the study sample, no difference was found with regard to externalizing 
problems. For adolescents without a court order, effects on externalizing problems were 
larger from MST. Because many more adolescents with a court order were assigned to 
MST compared to FFT, the propensity score method could not balance the treatment 
groups in this subsample. 
Conclusions: In accordance with previous results, few differences between MST and 
FFT can be found in the Netherlands. Though treatment assignment was based on the 
RNR model, results in the group without a court order were not in accordance with 
this model, while higher-risk adolescents with a court order were indeed more often 
assigned to the more intensive treatment, namely MST.
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Introduction
Multisystemic Therapy (MST) and Functional Family Therapy (FFT) both originated in 
the US. Their proven effectiveness in reducing adolescents’ antisocial behavior and 
delinquency has led to the worldwide dissemination of these interventions. Both MST 
and FFT are aimed at reducing the behavioral problems of 12–18 year old adolescents by 
intervening in the youth’s family and environmental system. Functional Family Therapy 
has an integrated theoretical base in which behavioral techniques, system perspectives, 
and cognitive theory are combined while remaining informed by intrapsychic 
perspectives (Breuk et al., 2006; Sexton & Alexander, 2003). Antisocial behavior is 
thought to be mediated and embedded in a complex sequence of relations between 
the adolescent and his or her family members (Sexton & Alexander, 2003). Therefore, 
FFT is specifically aimed at improving family communication and supportiveness while 
decreasing negativity and dysfunctional behavioral patterns (Blueprints for healthy youth 
development, 2015). The therapy mainly consists of direct contact with family members, 
but may be coupled with support system services, such as school or work. Research has 
shown that FFT is effective in reducing (delinquent) behavioral problems, recidivism, and 
substance abuse, and that it guides family members in improving their family situation 
(Alexander & Sexton, 2002; Sexton & Turner, 2010; Sexton & Alexander, 2000)). 
Caregivers are also seen as the most important link in the treatment process of 
MST, but MST also actively involves all other systems surrounding the youth, such as 
friends, schools, and neighborhoods (Henggeler, Schoenwald, Borduin, Rowland, 
& Cunningham, 2009). This approach is founded in the social-ecological theory of 
Bronfenbrenner (Bronfenbrenner, 1979), in which it is thought that antisocial behavior 
is multi-determined by the different social systems in which an individual acts. By 
intervening in and with these social systems, risk factors are reduced and a youth’s social 
environment is changed such that it stimulates prosocial activities instead of antisocial 
behavior (Henggeler et al., 2009). Multisystemic Therapy is more intensive than FFT 
because a therapist visits the family at home and is available to the family round-the-
clock. Research has shown that MST effectively reduces behavioral problems and 
delinquency, recidivism, substance abuse, out-of-home placement, family problems, 
and involvement with deviant peers (Henggeler, 2011; van der Stouwe, Asscher, Stams, 
Deković, & van der Laan, 2014).  
The effectiveness of both MST and FFT is well-established compared to regular 
treatment, such as individual treatment or family-based interventions, such as parenting 
counseling (Asscher, Dekovic, Manders, van der Laan, & Prins, 2013; Sundell et al., 2008). 
Multisystemic Therapy and FFT clearly show overlap in their target populations and 
treatment goals (e.g., Chorpita et al., 2011; Henggeler, 2011; Sexton & Turner, 2010). 
However, little is known about their relative effectiveness (i.e., whether one intervention 
outperforms the other). A recent study by Baglivio and colleagues (2014) compared 
the effectiveness of MST and FFT in juvenile practice in the US. In this study, youth 
receiving MST or FFT had been referred by probation officers from the juvenile justice 
department. Results showed little significant difference in the effectiveness of the two 
interventions. However, low-risk youth receiving FFT committed fewer offenses during 
treatment than low-risk youth receiving MST. 
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Because referral practices and treatment populations differ between countries 
(Asscher et al., 2013; Sundell et al., 2008), the relative effectiveness of MST and FFT 
is unknown in other countries. In the Netherlands, youth are referred to MST or FFT 
by various referral agencies, including the Child Protection Council, juvenile judges, 
local referral institutions, and primary health care providers. To allocate adolescents 
and their families to either one of the treatments, a well-known model, the Risk-Need-
Responsivity (RNR) model, is often used. Following this model, the intensity of the 
treatment is matched to risks and characteristics of the adolescent. The higher the risk 
of delinquent behavior, the more intensive treatment should be (Andrews & Bonta, 
2010; Andrews, Bonta, & Wormith, 2006). The model implies that adolescents should 
be assigned to FFT unless there are indications that MST would be more suitable, 
such as serious delinquent behavior, a high risk that the family cannot provide a safe 
environment, and an increased risk of recidivism (Oudhof, Ten Berge, & Berger, 2009). 
In practice, this assignment procedure is followed by clinicians, assigning youth to either 
FFT or MST. A previous Dutch study comparing both treatment populations found 
that more youth receiving MST had a court order than youth receiving FFT, and that 
youth receiving MST had more risk factors than those receiving FFT (Hendriks, Lange, 
Boonstoppel-Boender, & van der Rijken, 2014). This finding is in accordance with the 
results of a Swedish study which demonstrated that youth receiving MST had more 
behavioral problems than youth receiving FFT (Gustle, Hansson, Sundell, Lundh, & 
Lofhölm, 2006). However, although both European studies showed that the most at 
risk youth received the most intensive treatment (i.e., MST), the model leaves room for 
interpretation and may be subject to chance. In fact, the target populations of MST and 
FFT show substantial overlap (Hendriks et al., 2014). Therefore, it appears that criteria 
used to allocate adolescents and their families to either one of the treatments are not 
fully mutually exclusive. Because these studies only looked into treatment populations 
and did not consider treatment effects, it remains unknown which intervention is the 
most effective for these overlapping target populations.  
Therefore, the current study aimed to investigate the relative effectiveness of MST 
and FFT in the Netherlands. Because interventions are compared in their everyday 
practice settings, a quasi-experimental design was used, meaning that youth were not 
randomly allocated to one of the interventions. Without controlling for pre-treatment 
differences, a difference in outcomes is either caused by the intervention itself, or by 
pre-treatment characteristics of adolescents and their families. Therefore, a propensity 
score (PS) was estimated and used to control for this ‘allocation bias’. Using the PS, 
the treatment arms can be balanced from a large set of observed, pre-treatment 
characteristics (Austin, 2011; Rosenbaum & Rubin, 1983; Rubin, 2001). When all important 
covariates are measured, applying the PS to achieve the balance of the treatment 
arms enables controlling for allocation bias and may even yield results equivalent to 
randomized studies (Austin, 2011; Shadish, 2013; West et al., 2014). If randomization is 
not feasible in clinical practice, the use of a PS is a valid solution (Shadish, 2013; West et 
al., 2014). It should, however, be noted that, in contrast to randomized studies, a PS can 
only control for overt bias (i.e., bias due to observed pre-treatment differences) and not 
for hidden bias (i.e., bias due to unmeasured or unobserved differences) (Rosenbaum, 
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1991). Furthermore, for each adolescent, there must be a chance of being in either 
treatment group (Shadish, 2013). 
The use of a PS in psychological research has increased in recent years (e.g., 
Austin, 2011; Green & Stuart, 2014; Thoemmes & Kim, 2011; West et al., 2014). The 
current study used these tutorials and literature as a starting point in comparing MST 
and FFT. Because previous research has shown that youth receiving MST were more at 
risk than youth receiving FFT (Gustle et al., 2006; Hendriks et al., 2014), and because 
the only study to directly compare the effectiveness of FFT and MST thus far takes 
risk level into account as well (Baglivio et al., 2014), the current study compared the 
treatment effects not only for the whole sample, but also in two subsamples of youth: 
with and without a court order. Having a court order can be interpreted as a risk factor 
and indicate the risk level of an adolescent before treatment. Based on this model, FFT 
could be sufficiently effective in the group of adolescents without a court order since 
FFT is expected to be less intensive. Multisystemic Therapy, on the other hand, could be 
more effective in adolescents with a court order. Since MST and FFT are both aimed at 
reducing behavioral problems, the primary outcome measure was externalizing problem 
behavior. Secondary outcomes were the proportion of youth living at home (i.e., the 
adolescent had not been placed out of home), engaged in school or work at the end of 
treatment, and without new police contact during the treatment period. 
With a growing body of research examining evidence-based treatment, and given 
today’s stringent health care budgets, it seems only logical to allocate youth to a more 
intensive and likely more expensive treatment only when there is no effective alternative. 
By comparing evidence-based interventions, budget allocation and the assignment of 
youth to proper interventions can be optimized.
Methods
Participants and Procedure
As part of the treatment procedure, adolescents and their families filled in questionnaires 
for Routine Outcome Monitoring (ROM) at the beginning of and after completing 
treatment. Routine Outcome Monitoring is a measurement system to routinely collect 
data on the outcome of treatment, evaluate individual treatment progress, and provide 
transparency regarding the effectiveness of treatment (Buwalda, Nugter, Swinkels, & 
Mulder, 2011). Within ROM, adolescents and their families provide consent concerning 
the collection of data and its use for quality control and research. The Medical Ethical 
Committee of the Erasmus Medical Centre approved this study (METC-2015-124).
Between October, 2009 and June, 2014, 1,714 adolescents and their families began 
either FFT (N=640) or MST (N=1074) at De Viersprong, institute for personality disorders 
and behavioral problems in the Netherlands. After finishing treatment, 697 (40.7%) 
participants completed the primary outcome measure on the Child Behavior Checklist 
(CBCL) (275 [43%] adolescents who had received FFT and 422 [39.3%] adolescents who 
had received MST). Such a low percentage of completed questionnaires after treatment 
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is not uncommon within ROM because data is not gathered for specific research 
purposes (Stichting Benchmark GGZ (SBG), 2016). To reduce uncertainty in the statistical 
analyses and results, these 697 families formed the study sample for the statistical 
analyses. Adolescents who had received FFT and completed the primary outcome 
measure differed significantly from those who did not with regard to their country of 
birth, living situation, and whether or not they had a court order before treatment (see 
Table I in Supplemental Material). Adolescents who received MST and completed the 
assessment after finishing treatment differed from those who did not with regard to their 
country of birth, living situation, engagement in school or work, whether or not they had 
a court order before treatment, as well as the country of birth, level of education, and 
employment status of their primary caregiver, and whether or not this primary caregiver 
had a partner (see Table II in Supplemental Material). 
In addition to the study sample of 697 adolescents, the effectiveness of the 
treatments was compared between the two subsamples of youth with and without a 
court order. Of the 422 adolescents who received MST, 246 had a court order and 168 
did not (for 10 adolescents [2 FFT; 8 MST], the judicial status was unknown). For FFT, 71 
adolescents had a court order, while 202 did not.
Because the assignment procedure following the RNR model implies that 
adolescents should be assigned to FFT unless there are indicators that MST would be 
more suitable (Oudhof et al., 2009), FFT was considered the reference treatment and 
MST the ‘new’ treatment. Both interventions are continuously monitored on their fidelity 
and implementation research has shown that both MST and FFT are provided with 
fidelity in the Netherlands (Manders, Deković, Asscher, van der Laan, & Prins, 2011; van 
der Rijken, 2015).
Instruments
Baseline measurements
To correct for initial differences between treatment groups, an extensive set of 
questionnaires were completed at the beginning of treatment. The therapist recorded 
several demographics of the adolescents and their primary caregiver. Age, gender, 
country of birth, living situation, level of education, previous treatment, engagement 
in school or work, previous court orders, police contacts, and the relation with their 
father, mother, siblings, and peers were reported for each adolescent. Furthermore, 
the country of birth, level of education, employment status, and presence of a partner 
were reported for the primary caregiver (Praktikon/MST-NL, 2012). Table 1 shows all 
demographic characteristics at baseline separately for both treatment groups.
Furthermore, parents completed the CBCL (Achenbach & Rescorla, 2001; Dutch 
version by Verhulst & van der Ende, 2001a) and the youths themselves completed the 
Youth Self Report (YSR) (Achenbach & Rescorla, 2001; Dutch version by Verhulst & van 
der Ende, 2001b). A youth’s internalizing problem behavior, externalizing problem 
behavior, and the total score of the problem behavior were used for analyses. On both 
questionnaires, items were completed on a 3-point scale (ranging from 0 = never to 2 
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= often). T-scores were computed and used for analyses. A higher T-score indicates that 
an adolescent has more problems. Both CBCL and YSR scales were used to measure 
problem behavior from different perspectives. The Cronbach’s alpha coefficients of the 
study sample for internalizing, externalizing, and total problem behavior measured with 
the CBCL were .88, .93, and .96 respectively. For the YSR these coefficients were .92, 
.90, and .95 respectively. The Cronbach’s alpha coefficients found in the study sample 
were similar to those reported in the CBCL and YSR manual (i.e., CBCL:.90, .94, and .97, 
YSR: .90, .90, and .95) (Achenbach & Rescorla, 2001). 
Finally, until September, 2012, parenting stress was measured with the ‘Nijmeegse 
Ouderlijke Stress Index’ (NOSI-R) (De Brock, Vermulst, Gerris, Veerman, & Abidin, 2004) 
in which the primary caregiver completes 42 items on a 4-point scale (ranging from 1 = 
fully disagree to 4 = fully agree). These items are used to estimate a score for parenting 
stress wherein a higher score indicates more stress. The reliability coefficient was .95. 
From October, 2012 onwards, the ‘Opvoedingsbelasting Vragenlijst’ (OBVL) (Vermulst, 
Kroes, De Meyer, Nguyen, & Veerman, 2012) was used to measure parenting stress. For 
this measure, the primary caregiver completes 34 items on a 4-point scale (ranging from 
1 = not true, to 4 = true). The scores of all items are summed for a total score regarding 
parenting stress. The alpha coefficient for this measure was .94. Because parenting 
stress was measured with two different questionnaires, the deviance score of the scales 
was used to express the level of parenting stress for both questionnaires in one score 
concerning parenting stress. This was estimated by subtracting the normscore from the 
score of the adolescent and dividing this by the standard deviation of the norm group. 
Treatment variables, such as length of treatment and dosage of treatment, were not 
controlled for in the propensity score since these treatment characteristics are part of the 
treatment itself and the treatment is adapted to the specific situation of the adolescent 
and his or her family. 
Outcome measures
Because both FFT and MST are primarily aimed at reducing externalizing problem 
behavior, this was defined as the primary outcome measure and was measured with the 
CBCL and with the YSR (Achenbach & Rescorla, 2001). The primary caregiver reported 
the externalizing problems of the adolescent with the CBCL, while the youth reported 
this behavior with the YSR. Both measures were completed at the start of and the end 
of treatment by completing 35 items on a 3-point scale (ranging from 0 = never to 2 = 
often). T-scores were computed and used for the analyses. A higher T-score indicates 
that an adolescent has more problems. The alpha reliability coefficient for the current 
sample at the end of the treatment with the CBCL is .94. For externalizing problems with 
the YSR, it is .88. 
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Table 1. Baseline differences between adolescents assigned to FFT and MST and standardized bias in 
full sample (N=697)
Variable   FFT (N = 275)  MST (N = 422)  Test statistic Standardized bias 
Continuous variables Mean SD N Mean SD N T-test
Before PS 
application
After PS 
application
Age  15.9 1.59 275 15.67 1.35 422 1.96 0.17 0.12
CBCL Internalizing problems 62.51 9.26 263 61.04 9.68 409 1.95 0.15 0.01
 Primary outcome Externalizing problems 67.08 9.57 263 68.29 10.06 409 -1.56 0.12 0.07
 Total behavioral problems † 66.04 8.61 263 65.32 9.76 409 1.00 0.07 0.01
YSR Internalizing problems 54.79 11.31 246 50.78 11.5 356 4.24*** 0.35 0.11
 Externalizing problems 59.27 9.73 246 57.54 10.87 356 2.04* 0.16 0.04
 Total behavioral problems 57.35 9.78 246 53.59 11.02 356 4.40*** 0.34 0.07
Parenting stress  1.97 1.78 258 2.06 2.07 397 -0.61 0.05 0.06
Categorical variables %  N %  N
Chi-Square 
statistic
Before PS 
application
After PS 
application
Gender Male 53.6 141 67.2 275 12.60*** 0.29 0.23
 Female 46.4 122 32.8 134  0.29 0.23
Country of birth Netherlands 95.8 253 83.4 341 24.04*** 0.19 0.06
 Western country 1.1 3 4.6 19  0.05 0.04
 Non-Western country 3.0 8 12.0 49  0.13 0.02
Living situation adolescent Together with one parent 36.1 97 42.9 179 6.93* 0.12 0.06
 Together with multiple parents 60.6 163 51.1 213  0.16 0.04
 Other 3.3 9 6.0 25  0.05 0.02
Living situation adolescent Lived not at home 0.8 2 2.9 12 3.64 0.13 0.01
Secondary outcome Lived at home 99.2 260 97.1 400  0.13 0.01
Level of education None 7.1 19 13.7 56 32.55*** 0.08 0.03
 Primary education 3.7 10 2.7 11  0.01 0.01
 Lower secondary education 54.5 146 66.8 274  0.15 0.11
 Higher secondary education 34.7 93 16.8 69  0.21 0.07
Previous treatment Absent 9.8 26 5.5 23 4.46* 0.19 0.01
 Present 90.2 240 94.5 395  0.19 0.01
Engagement in school or work Absent 14.5 37 22.6 91 6.61** 0.19 0.16
Secondary outcome Present 85.5 219 77.4 312  0.19 0.16
Court order No 74.0 202 40.6 168 75.91*** 0.41 0.05
 Civil 10.6 29 30.9 128  0.25 0.18
 Criminal 15.4 42 28.5 118  0.16 0.13
Police contacts during treatment Absent 66.9 176 50.8 198 16.74*** 0.32 0.01
Secondary outcome Present 33.1 87 49.2 192  0.32 0.01
Relation father Absent 6.8 17 9.2 37 1.22 0.09 0.15
 Present 93.2 234 90.8 364  0.09 0.15
Relation mother Absent 0.4 1 0.7 3 0.30 0.04 0.06
 Present 99.6 249 99.3 402  0.04 0.06
Relation siblings Absent 7.6 18 6.0 23 0.64 0.07 0.02
 Present 92.4 218 94.0 361  0.07 0.02
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Variable   FFT (N = 275)  MST (N = 422)  Test statistic Standardized bias 
Categorical variables %  N %  N
Chi-Square 
statistic
Before PS 
application
After PS 
application
Relation peers Absent 0.0 0 1.3 5 3.15 0.11 0.00
 Present 100.0 249 98.7 393  0.11 0.00
Country of birth primary caregiver the Netherlands 88.5 232 79.3 325 11.28** 0.13 0.02
 Western country 4.2 11 4.9 20  0.01 0.02
 Non-Western country 7.3 19 15.9 65  0.12 0.01
Level of education primary caregiver None 1.2 3 3.0 12 8.17 0.02 0.05
 Primary education 4.1 10 8.0 32  0.04 0.00
 Lower secondary education 27.9 68 31.3 126  0.04 0.01
 Higher secondary education 45.5 111 39.1 157  0.07 0.04
 Higher education 21.3 52 18.7 75  0.03 0.02
Employment primary caregiver Employed 71.8 186 61.9 253 6.98** 0.21 0.17
 Unemployed 28.2 73 38.1 156  0.21 0.17
Partner primary caregiver Absent 21.7 55 23.9 94 0.41 0.05 0.01
 Present 78.3 198 76.1 299  0.05 0.01
* p < .05, ** p < .01, *** p < .001
† Not selected for PS estimation.
NOTE:
Values depict the mean values and standard deviations. Except for age and parenting stress all other 
scores are standardized T-scores, having a mean of 50 and a standard deviation of 10. For NOSI-R and 
parenting stress, normed z-scores are displayed. 
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Three secondary outcome measures were assessed at the end of the treatment: 1) 
whether or not the youth was living at home (i.e., the adolescent had not been placed 
out of home); 2) whether or not the adolescent was engaged in school or work for at 
least 20 hrs/week at the end of the treatment; and 3) whether or not the adolescent had 
new police contact due to inappropriate or illegal behavior during the treatment period. 
The therapist registered these treatment outcomes after treatment and in consultation 
with the primary caregiver. These three outcomes have been operationalized and 
standardized by MST Services to ensure that these outcomes are scored identically by 
all therapists (Institute, 2016). This scoring procedure was also followed by FFT.  The 
quality assurance systems of both treatments ensure that their ultimate outcomes are 
monitored by the therapist,  the team supervisor, and the team consultant. 
Statistical analysis
Development of the propensity score
The PS is defined as the conditional probability of assignment to an intervention given 
a set of observed, pre-treatment variables (Rosenbaum & Rubin, 1983). Moreover, the 
PS is a balancing score which can be used to achieve a balanced distribution for the 
observed covariates of the treated and control group (Austin, 2011; Rubin, 2001). The 
PS was estimated in a univariate logistic regression function for the intervention groups. 
Here, MST is considered the treated group (coded as 1), and FFT the comparison group 
(coded as 0). This is because, according to the RNR model, adolescents should be 
assigned to FFT unless there are serious indications to assign an adolescent to MST 
(Oudhof et al., 2009).
The observed pre-treatment variables of adolescents are the independent variables 
added to the model (Austin, 2011; D'Agostino R.B., 1998; Thoemmes & Kim, 2011). 
These variables, the potential confounders, were selected for the PS model based on 
clinical knowledge and their expected relation to at least the outcome, and possibly to 
the treatment itself (Ali et al., 2015; Austin, 2011; Brookhart et al., 2006; Stuart, 2010). 
Variables solely related to treatment assignment or influenced by treatment should not 
be included in a PS model (Ali et al., 2015; Austin, 2011; Brookhart et al., 2006).  
Weighting by the propensity score
The PS was applied by weighting groups by the odds of their estimated PS score (Stuart, 
2010). Weighting by their odds was preferred because there were more treated MST 
cases than control FFT cases and the interest lies in the average treatment effect in the 
treated (ATT) rather than the average treatment effect (ATE) (Stuart, 2010). The ATT is the 
average effect that would be found if all adolescents treated with MST had been treated 
with FFT. The ATE, however, estimates the average effect if all adolescents (MST and 
FFT) had received MST compared to all of them received FFT (Harder, Stuart, & Anthony, 
2010). In other words, because the ATT is estimated, treatment effects for adolescents 
who received MST are compared with treatment effects that would have been found 
had they received FFT (Harder et al., 2010; Stuart, 2010). The MST group was therefore 
weighted with 1, while the FFT group was weighted with the odds of the PS, that is, the 
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PS score divided by one subtracted by the PS score (Harder et al., 2010). The PS scores 
that showed no overlap in the treatment groups were removed. The treatment effect 
was then estimated in the sample containing overlap with the estimated PSs. Though 
this restricts the generalizab7ility of the results to cases for which overlap is present, 
removing cases without overlap allows for more precisely balancing the treatment arms 
(Harder et al., 2010).  
Missing indicator approach
The baseline covariates in the dataset of 697 adolescents who completed either FFT or 
MST had missing values. To manage these missing values, a missing indicator approach 
was used while estimating the PS (Cham & West, 2016; D’Agostino, Lang, Walkup, 
Morgan, & Karter, 2001; Harder et al., 2010; Rosenbaum & Rubin, 1984; West et al., 
2014). This method can be theoretically justified and works well to balance observed 
and missing value patterns across treatment groups without removing cases from the 
analysis (Cham & West, 2016; Harder et al., 2010; Rosenbaum & Rubin, 1984). In applying 
this method, the covariate and a missing indicator for this covariate were included in 
the PS estimation, coded 1 if there was a missing value for the covariate and 0 if not 
(D’Agostino et al., 2001; Haviland, Nagin, & Rosenbaum, 2007; Rosenbaum, 2010). The 
missing values of the covariates included in the PS were replaced with an arbitrary value 
in the range of the values of the covariate itself (Haviland et al., 2007; Rosenbaum, 2010). 
Using a missing indicator and the covariate with substitution of missing values in the PS 
estimation enables the use of all cases and balances observed values in the covariates, 
as well as the missing patterns of these covariates. After PS estimation, balance was 
assessed for the missing indicators and covariates without missing value substitution. In 
estimating treatment effects, the missing value substitution was also removed. Thus, this 
substitution does not affect the evaluated balance, nor does it affect the treatment effect 
estimation. Furthermore, missing indicators were not taken into account in estimating 
treatment effects (Haviland et al., 2007; Rosenbaum, 2010).
Balance assessment
An important step in applying the PS is to assess the balance of the observed covariates 
between the two treatment arms instead of assessing the parameter estimates of the 
PS model itself (Stuart, 2010). Balance was evaluated for the covariate without missing 
value substitution and for the missing indicators of the covariates (Harder et al., 2010; 
Haviland et al., 2007). Balance is achieved when the distribution of the baseline covariates 
is similar for the two interventions. Balance was assessed with the standardized bias 
which is independent of the sample size of the study. It was calculated by dividing the 
difference of the means of the covariates between the treated (MST) and comparison 
(FFT) group by the standard deviation of the treated group (Ali et al., 2015; Austin, 
2009; Austin, 2011; Harder et al., 2010; Stuart, 2010; West et al., 2014). As such, the 
difference in means was divided by the standard deviation of the MST group (Harder et 
al., 2010; McCaffrey et al., 2013). For the categorical covariates, the standardized bias 
was estimated per level. For instance, if the covariate had three levels, the standardized 
bias was calculated for all three (Harder et al., 2010). 
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The standardized bias was assessed before and after applying the PS to determine 
whether balance was achieved. The balance of the baseline covariates and missing 
indicators was assessed in the weighted sample. As a rule of thumb, it was assumed that 
balance was achieved when the standardized bias was less than .25 (Harder et al., 2010; 
Ho, Imai, King, & Stuart, 2007; West et al., 2014). The standardized bias of all covariates 
was carefully evaluated in addition to the balance of important, prognostic covariates 
(Ho et al., 2007). 
In addition to the standardized bias, the variance ratio and the five-number-summary 
of the continuous covariates were assessed to determine whether these distributions were 
similar in higher order moments (Austin, 2009). The distributions of the estimated variances 
are assumed to follow an F-distribution (Austin, 2009). The 2.5th and 97.5th percentiles can 
serve as a guide as to which variance ratios are tested to be equal between the treatment 
groups (Austin, 2009). The five-number summaries should also be used as a qualitative 
assessment because there is no method to test the similarity of these summaries between 
treatment groups (Austin, 2009).
Analysis of treatment effect
Regression analysis was used to estimate treatment effect estimates in the weighted 
sample. The treatment effect on the primary outcome measure — externalizing problem 
behavior measured with the CBCL — was estimated with an OLS regression on the outcome 
and the treatment indicator as an independent variable. The effect of interventions on the 
secondary outcome measures—living at home, being in school or having a job, new contact 
with the police—was analyzed with logistic regression analyses. The results were used to 
calculate average risk differences and risk ratios, as these measures are collapsible among 
subgroups. Odds ratios are not collapsible, meaning they are not comparable when they 
result from analyses with different sets of covariates or over different subgroups (Goossens, 
Redekop, & van Gils, 2015). These measures were estimated using ordinary cross tabs of the 
outcomes and treatment indicators in the weighted sample. For example, for the outcome 
‘living at home after treatment’, the risk ratio was estimated as the probability of living at 
home after MST divided by the probability of living at home after FFT. The risk difference 
is the difference between these probabilities, estimated as the probability of living at home 
after MST minus the probability of living at home after FFT. For ‘engaged in school or 
work’ and ‘new police contacts’, the probability of being engaged in school or work and of 
having had police contact during treatment were looked at. The 95% confidence intervals 
of the final treatment effects were estimated using simple bootstrapping, as advised by 
Austin and Small (2014). In total, 5,000 bootstrap samples were drawn from the weighted 
sample and in each bootstrapped sample, treatment effects were estimated as described. 
A nonparametric percentile-based approach was used to define the 95% interval (Austin & 
Small, 2014). 
Regression analyses were done with and without adjustment for the covariates used 
to calculate the PS. Analyses with the treatment indicator as the only covariate in the study 
sample (N=697) were followed by analyses in the complete case sample (N=361; 132 FFT 
and 229 MST)—with and without all covariates—to overcome possible misspecification 
of this model and to assess whether results were robust (Harder et al., 2010; Rubin & 
Thomas, 2000). A case was determined ‘complete’ when all baseline data were available 
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and there were no missing values for the baseline variables. 1 When adding covariates to 
the regression analyses in the complete case sample, backward selection of the covariates 
on the treatment effect was used to find a parsimonious model for the outcome. For the 
secondary outcomes, it was not possible to also control for covariates, as the number of 
events needed per covariate in a logistic regression was not met (Peduzzi, Concato, Kemper, 
Holford, & Feinstein, 1996). Therefore, treatment effects on the secondary outcomes in the 
complete case sample were estimated without controlling for additional covariates.  
Subgroup effects
Finally, within the study sample, analyses were repeated for the subsamples of youth 
who had a court order (246 adolescents assigned to MST; 71 FFT) and youth who did not 
have a court order (168 MST; 202 FFT). Within the complete case sample, analyses were 
also repeated for the subsamples of youth with (125 MST; 26 FFT) and without (104 MST; 
106 FFT) a court order. Here, the PS within each subsample was estimated separately, 
as recommended by Green and Stuart (2014). Within each subsample, again the balance 
between the treatment arms was assessed and then the PS was applied by weighting 
groups by the odds of the estimated PS score (Green & Stuart, 2014). 
The analyses were performed with IBM SPSS for Windows, version 22 (IBM Corp, 2013) 
and Microsoft Excel (2013). The 95% confidence intervals were bootstrapped in Stata 12 
(StataCorp, 2011). 
Results
This section first describes the sample characteristics, then the balance in the covariates, 
and finally the treatment effect for respectively all adolescents in the study sample (N = 
697), the subsample of adolescents without a court order (N = 370), and the subsample of 
adolescents with a court order (N = 317). Within each sample, the results of the complete 
cases analyses are also described. 
Study sample: All adolescents
Within the study sample of 697 adolescents, 422 completed MST and 275 completed 
FFT. Of the adolescents who completed MST, 67.2% were male and 83.4% were born 
in the Netherlands. For FFT, 53.6% of the adolescents were male and 95.8% were born 
in the Netherlands (see Table 1 for an extensive comparison of the treatment arms). 
Comparing the treatment groups on baseline characteristics showed substantial differences 
in internalizing, externalizing, and total behavioral problems reported by adolescents. 
Furthermore, treatment groups differed in gender, country of birth, the adolescent’s living 
situation, level of education, previous treatment, engagement in school or work, previous 
court order, previous police contact, and country of birth and employment status of the 
primary caregiver (Table 1). 
1 Because the complete case sample had no missing values on any of the covariates, no missing 
indicators were needed in estimating the PS and assessing balance of the covariates between the 
treatment arms
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Balance assessment
Before the PS application, balance was assessed in all measured baseline characteristics. 
Table 1 represents the standardized biases. The largest imbalances were found for 
internalizing problems reported on the YSR (mean T-score: 54.79 for FFT and 50.78 for 
MST), total behavioral problems measured with the YSR (mean T-score: 57.35 for FFT 
and 53.59 for MST), gender (53.6% male for FFT and 67.2% male for MST), previous 
court order (26% had a court order for FFT and 59.4% had a court order for MST), and 
having police contact before treatment (33.1% had police contact for FFT and 49.2% 
had police contact for MST) (Table 1). The standardized bias of these baseline variables 
was higher than the accepted .25 (Table 1). 
After weighting, balance for all of the covariates was found when the PS model 
contained all covariates except for the total score of behavioral problems measured by 
the CBCL (Table 1). Balance was inspected in the sample with overlapping PS scores. As 
a result, 8 MST and 12 FFT cases were removed from the resulting sample. As Table 1 
shows, values for the standardized bias after PS application are all lower than .25. The 
values of the standardized bias for the missing indicator variables were also lower than 
.25 (Table III in Supplemental Material shows standardized bias for missing indicators 
before and after applying the PS). 
Table 2 shows the variance ratio and five-number summaries of the continuous 
variables as additional measures for inspecting balance. In the weighted sample, the 
2.5th and 97.5th percentiles are .78 and 1.22. The estimated variance ratios are within 
these boundaries, and thus equality between treatment groups using this measure can 
be assumed. Moreover, the five-number summaries are also roughly equal in the PS 
weighted sample (Table 2).   
In the complete case sample of 361 adolescents and their families, balance 
was achieved when the variables of age, internalizing and externalizing problems 
measured with the CBCL, parenting stress, gender, country of birth, previous treatment, 
engagement in school or work, court order, police contacts, and employment status 
of the primary caregiver were included in the PS estimation. Because balance was 
inspected in the sample with overlapping PS scores, 49 MST and 3 FFT cases were 
removed from this sample.
Analysis of treatment effect
After assessing the balance, the effectiveness of MST and FFT was compared in the 
outcome model. Table 3 shows no difference in externalizing problem behavior (CBCL: 
0.14; 95% CI -3.23 – 3.49, YSR: -0.29; 95% CI -2.45 – 1.90), with a small effect size of 
d = 0.01 and d = 0.03, respectively. The risk ratios (RR) and risk differences (RD) of the 
secondary outcomes showed no differences between MST and FFT for the proportion 
of youth living at home and having had police contact (Table 3). However, a significantly 
higher proportion of adolescents who had completed MST were engaged in school or 
work after treatment compared with FFT (RR 1.27; 95% CI 1.06 – 1.57, RD 19.2%; 95% 
CI 5.2% - 32.9%) (Table 3). 
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Table 2. Variance ratio and 5-number summary of continuous covariates after PS application in full 
sample (N = 697)
   
Variance 
ratio‡
Minimum
25th 
percentile
Median 75th 
percentile
Maximum
Age   FFT 0.79 12.10 14.76 15.95 16.79 20.39
    MST 11.07 14.80 15.83 16.72 18.34
CBCL
Internalizing 
problems
FFT 0.96 33.00 55.00 61.00 68.00 88.00
    MST 33.00 55.00 62.00 69.00 82.00
 
Externalizing 
problems
FFT 0.92 34.00 61.00 70.00 74.00 92.00
    MST 34.00 63.00 69.00 75.00 88.00
 
Total behavioral 
problems
FFT 0.87 24.00 60.00 68.28 71.00 85.00
    MST 27.00 60.00 67.00 72.00 83.00
YSR
Internalizing 
problems
FFT 0.97 30.00 44.00 54.00 61.00 83.00
    MST 27.00 44.00 50.00 58.00 85.00
 
Externalizing 
problems
FFT 1.02 29.00 52.00 59.00 66.00 80.00
    MST 29.00 51.00 58.00 66.00 93.00
 
Total behavioral 
problems
FFT 1.06 28.00 47.00 56.00 62.00 77.00
    MST 26.00 46.00 54.00 62.00 82.00
Parenting stress  FFT 1.21 -1.40 0.61 1.98 3.34 7.78
    MST -1.52 0.45 1.92 3.42 8.95
‡ In the weighted sample the 2.5th and 97.5th percentiles of the F-distribution are 0.78 and 1.22 
respectively. 
Repeating the analyses in the complete case sample of 361 adolescents and their 
families also showed no difference in externalizing problem behavior (CBCL: -0.16; 
95% CI -4.32 – 4.14, YSR: -0.56; 95% CI -3.79 – 2.68), with, again, a small effect size 
of d = 0.01 and d = 0.05, respectively. While there was no difference in this sample 
between the treatment groups concerning the proportion of youth living at home and 
the proportion of youth engaged in school or work after treatment, it was significantly 
more likely that adolescents assigned to MST had had police contact during treatment 
than those assigned to FFT (RR 2.40; 95% CI 1.26 – 5.94, RD 15.3 %; 95% CI 4.7% - 
24.5%) (Table 3).  
After this, covariates selected for the PS in the outcome regression model were 
added in the complete case sample to overcome possible misspecifications of the 
model. All covariates were selected except for level of education of the adolescent, level 
of education and employment of the primary caregiver, and internalizing behavioral 
problems reported by adolescents in a parsimonious model on the outcome. This model 
can be interpreted as an additional check on the results found earlier. Again, it showed 
no difference between the effect of MST and FFT on externalizing problem behavior 
(CBCL: -0.56; 95% CI -3.06 – 1.49, YSR: 0.35; 95% CI -1.58 – 2.31) (Table 3). 
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Table 3. Comparing MST with FFT average treatment effects of the treated
 All adolescents
 Study sample (N=697)            Study sample (N=697) Complete cases (N = 361)
  B 95% CI   B 95% CI B adjusted 95% CI
Externalizing problem behavior CBCL 0.14  -3.23 - 3.49   -0.16  -4.32 - 4.14 -0.56  -3.06 - 1.49
Externalizing problem behavior YSR -0.29   -2.45 - 1.90 -0.56  -3.79 - 2.68 0.35  -1.58 - 2.31
         
 RR 95% CI RD 95% CI RR 95% CI RD 95% CI
Police contact during treatment 1.61  0.98 - 3.08 0.10  -0.01 - 0.19 2.41**  1.26 - 5.94 0.15*  0.05 - 0.25
Living at home after treatment 0.98  0.96 - 1.01 -0.02  -0.04 - 0.01 0.98  0.95 - 1.01 -0.02  -0.06 - 0.01
Engaged in school or work after treatment 1.27**  1.06 - 1.57 0.19*  0.05 - 0.33 1.09  0.96 - 1.29 0.08  -0.03 - 0.21
 Youth without a court order
 Study sample (N=370) Study sample (N=370) Complete cases (N = 210)
 B 95% CI   B 95% CI B adjusted 95% CI
Externalizing problem behavior CBCL -3.24*  -5.97 - -0.39   -4.55*  -8.30 - -0.41 -3.21*  -5.89 - -0.76
Externalizing problem behavior YSR -3.33*  -5.81 - -0.86 -3.21*  -6.03 - -0.14 -1.55  -4.26 - 0.99
         
 RR 95% CI RD 95% CI RR 95% CI RD 95% CI
Police contact during treatment 1.20  0.72 - 2.77 0.05  -0.10 - 0.20 0.90  0.50 - 2.53 -0.03  -0.24 - 0.19
Living at home after treatment 0.97  0.94 - 1.01 -0.03  -0.06 - 0.01 1.00  0.95 - 1.07 0.00  -0.05 - 0.06
Engaged in school or work after treatment 1.09  0.94 - 1.31 0.07  -0.05 - 0.21 1.14  0.92 - 1.54 0.11  -0.08 - 0.32
 Youth with a court order
 Study sample (N=317) Study sample (N=317) Complete cases (N = 151)
 B 95% CI   B 95% CI B adjusted 95% CI
Externalizing problem behavior CBCL
Balance not achieved ‖ Balance not achieved ‖ Balance not achieved ‖ 
Externalizing problem behavior YSR
        
 RR 95% CI RD 95% CI RR 95% CI RD 95% CI
Police contact during treatment
Balance not achieved ‖ 
 
Balance not achieved ‖ Balance not achieved ‖ Living at home after treatment
Engaged in school or work after treatment
* Confidence interval does not contain 0
** Confidence interval does not contain 1
‖ Balance was not achieved, therefore the differential effectiveness of FFT and MST could not be estimated
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Subsample: Youth without a court order
Of the 697 adolescents in the study sample, 370 (168 MST; 202 FFT) had no court order 
before beginning the intervention. Of adolescents who had completed MST, 61.5% 
were male and 90.3% born in the Netherlands. For FFT, 52.3% of the adolescents were 
male and 97.4% born in the Netherlands (for an extensive comparison of the treatment 
arms, see Table IV in Supplemental Material). Comparing the treatment groups within 
this subsample on baseline characteristics showed significant differences in age, 
externalizing and total behavioral problems measured with the CBCL, parenting stress, 
country of birth, level of education, previous treatment, engagement in school or work, 
and previous police contact (Table IV in Supplemental Material). 
Balance assessment
Before the PS application, the largest imbalances—standardized bias higher than 
the accepted .25—were found for age, externalizing problems on the CBCL, level of 
education, previous treatment, and having had police contact before treatment (Table IV 
in Supplemental Material). After PS application, balance was found when all covariates 
except for the total score of behavioral problems measured by the CBCL were selected 
for the PS estimation. Before inspecting balance, 11 MST and 29 FFT cases were 
removed for which there was no overlap on the PS scores. Except for the standardized 
bias of the level of education of the adolescent, values of the standardized bias after 
PS application were lower than .25 (Table IV in Supplemental Material). Values for the 
standardized bias for the missing indicator variables were also lower than .25 (Table V 
in Supplemental Material). The variance ratios of the continuous variables, except for 
parenting stress, were within the boundaries defined by the 2.5th and 97.5th percentiles 
of the F-distribution in the weighted sample. Thus, except for parenting stress, balance 
can be assumed given these values (Table VI in Supplemental Material). The five-number 
summaries show roughly equally distributed continuous variables between the treatment 
groups (Table VI in Supplemental Material). 
In the complete case sample of 210 adolescents without court orders (104 MST; 106 
FFT), balance was achieved when the variables of age, internalizing and externalizing 
problems measured with the CBCL, parenting stress, gender, country of birth, previous 
treatment, engagement in school or work, court order, police contacts, and employment 
status of the primary caregiver were included in the PS estimation. Except for the level 
of education of the adolescent, all standardized bias values were lower than .25 after PS 
application. Because balance was inspected in the sample with overlapping PS scores, 
6 MST and 5 FFT cases were removed from this sample.
Analysis of treatment effect
In the subsample of adolescents without a court order, MST and FFT differed significantly 
in terms of externalizing problem behavior. Multisystemic Therapy resulted in lower 
scores on externalizing problem behavior than FFT (CBCL: -3.24; 95% CI -5.97 – -.39, 
YSR: -3.33; 95% CI -5.81 – -.86), with a medium effect size of d = 0.32 and d = 0.34, 
respectively. The differences (RR and RD) between MST and FFT on the three secondary 
outcomes were insignificant (Table 3). 
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Repeating the analyses within the complete case sample of 210 adolescents without 
a court order yielded the same results. Again, MST showed lower scores than FFT on 
externalizing problems (CBCL: -4.55; 95% CI -8.30 – -.41, YSR: -3.21; 95% CI -6.03 – 
-.14), with a medium effect size of d = 0.43 and d = 0.33, respectively. As before, no 
differences were found for the secondary outcomes within this sample. 
To overcome possible misspecifications in the outcome model for this subgroup in 
the complete case sample, all covariates were selected except for the level of education 
of the adolescent, level of education of the primary caregiver, previous treatment, 
engagement in school or work, relation with mother, internalizing behavioral problems 
measured with the CBCL and YSR, and total problem behavior measured with the CBCL 
in a parsimonious model on the outcome. Again, a significant difference between MST 
and FFT on externalizing problem behavior was found for the CBCL (-3.21; 95% CI -5.89 
– -.76), while no difference was found for the YSR (-1.55; 95% CI -4.26 – -.99) (Table 3). 
Subsample: Youth with a court order
In total, 317 (246 MST; 71 FFT) of the 697 adolescents in the study sample had a court 
order before starting treatment. Of the adolescents who had completed MST, 70.4% were 
male and 78.2% were born in the Netherlands, while for FFT, 56.1% of the adolescents 
were male and 91% were born in the Netherlands (for an extensive comparison of the 
treatment arms, see Table VII in Supplemental Material). Multisystemic Therapy and 
FFT showed significant differences in terms of age, externalizing behavioral problems 
measured with the CBCL, internalizing problems measured with the YSR, gender, relation 
with father, and employment status of the primary caregiver at the baseline (Table VII in 
Supplemental Material). 
Balance assessment
Before the PS application, the standardized bias was higher than the accepted .25 for 
age, externalizing problem behavior on the CBCL, internalizing problems on the YSR, 
gender, relation with father, and employment status of the primary caregiver (Table VII in 
Supplemental Material). After PS application, balance was not achieved using different 
PS estimations. Either there were some variables with a standardized bias higher than .25, 
or there were numerous variables with a standardized bias just below.25. Furthermore, 
if balance was assessed in the sample with overlapping scores on the PS, roughly 60–80 
MST cases had to be removed each time when testing various PS estimations. This 
indicates that the sample of adolescents assigned to MST could not be balanced to the 
sample of adolescents assigned to FFT (West et al., 2014).
In the complete case sample, 151 adolescents had a court order before treatment 
(125 MST; 26 FFT). Again, no balance was found between the treatment groups when 
testing and applying different PS estimations.
Analysis of treatment effect
Because there was not confidence in assuming balance was achieved in this subsample 
of youth with a court order, the effectiveness could not be estimated without ensuring 
the control of allocation bias. The same holds for the complete case sample of 151 
adolescents. 
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Discussion
Using the PS method to control for the non-random assignment of adolescents to 
either MST or FFT, this study compared these two interventions on their effectiveness 
in the Netherlands. In the study sample, target populations were balanced and no 
differences between the interventions were found regarding externalizing problem 
behavior. This result proved to be robust in the complete case sample. Some additional 
results were found, but these were not robust: adolescents assigned to MST were 
more often engaged in school or work after treatment. This treatment objective likely 
receives greater emphasis during MST than FFT. Moreover, in the complete case 
sample, adolescents who had received FFT had less police contact during treatment 
than adolescents who had received MST. Because the MST sample included a higher 
percentage of adolescents who had a court order before treatment, they were probably 
more likely to have additional police contact during treatment. 
In the present study, the average treatment effect of the treated was estimated 
and the finding suggests that adolescents who receive MST may display the same 
treatment effects if they would have received FFT. This treatment effect, however, is 
only applicable for adolescents and their sample characteristics for whom there were 
outcome measurements after treatment. Finding only a few robust differences when 
comparing the effectiveness of MST and FFT in the overall study sample is in accordance 
with previous findings by Baglivio and colleagues (2014). 
As the present study demonstrates that adolescents with a court order — interpreted 
as a possible risk factor following the RNR-model (Andrews et al., 2006; Laan, Slotboom, 
& Stams, 2010) — were more often assigned to MST (246 MST; 71 FFT), MST could also 
be expected to be more effective in this subsample. However, due to the incomparability 
of the FFT and MST subsamples of youth with a court order, the present study cannot 
confirm this. On the other hand, following the RNR model, FFT could be expected 
to be sufficiently effective in the subsample of adolescents without a court order, as 
these adolescents would be expected to have lower risks, and therefore, less intensive 
treatment would be adequate (Andrews et al., 2006; Laan et al., 2010). However, MST 
was more effective in reducing externalizing problems in the subsample without a court 
order. This may be explained by the fact that, although some risk factors were less 
present in the group without a court order, such as engagement in school or police 
contact (Table I and IV in Supplemental Material), this group nevertheless reported more 
problem behavior measured with the CBCL and the YSR (Tables I and IV in Supplemental 
Material). Another explanation may be that having or not having a court order only 
provides a rough indication of the risk level of an adolescent, while clinicians assign 
adolescents to either MST or FFT based on other risk factors as well. The RNR model 
thus leaves room for interpretation, or a single characteristic cannot fully represent the 
risk level of an adolescent. Even more, it could be possible that more intensive treatment 
in a less severe target population is always likely to be more effective, but the question 
remains as to whether it is appropriate and proportional treatment. For the secondary 
outcomes, however, no differences were found between the interventions, though these 
outcomes may be highly relevant to society. This should be taken into account when 
interpreting the overall effectiveness of the interventions in this subgroup. Furthermore, 
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future research could focus on the applicability and validity of a checklist based on 
the RNR model, for example, to support stepped care when applicable, and assigning 
adolescents directly to more intensive interventions when needed (Krugten et al., 2016). 
In addition to the effectiveness and assignment procedures of the interventions, 
and with  stringent health care budgets, the costs of an intervention should be taken 
into account. If costs of a more effective intervention are higher than the costs of its 
alternative, it can be worthwhile to compare the interventions and their cost-effectiveness. 
Earlier studies in the US and UK have shown MST to be cost-effective compared with 
alternatives like individual therapy (Cary, Butler, Baruch, Hickey, & Byford, 2013; Klietz, 
Borduin, & Schaeffer, 2010). The cost-benefit ratio of FFT compared to MST in the US 
has been shown to be in favor of FFT (Lee et al., 2012). In the Netherlands, Vermeulen 
and colleagues (2016) compared MST to treatment as usual, including FFT, and found 
MST to be more cost-effective. Thus, cost-effectiveness depends on the context of the 
study, e.g. sample or country. With regard to the current study, it would for example be 
beneficial to implement a cost-effectiveness analysis in the subsample of adolescents 
without a court order. In this subsample, MST was more effective at reducing externalizing 
problems than FFT. Although it is unknown what the precise costs of MST and FFT are 
in the Netherlands, it is expected that MST is more expensive due to the intensity of the 
intervention. Cost-effectiveness analysis could reveal whether additional costs for MST 
are worth the higher effects. Future research must focus on estimating the exact costs of 
MST and FFT in the Netherlands and estimating health services use of this population to 
indeed estimate the cost-effectiveness. Moreover, it is of additional interest to determine 
the cost-effectiveness of intervention options when following a stepped care procedure, 
i.e. should youth with a lower risk be assigned to MST directly, or should a less intensive 
option be the first choice.  
Comparing evidence-based interventions within overlapping target populations 
could eventually result in greater knowledge about which interventions work best for 
whom (Yirmiya, 2010). Therefore, it is important to examine treatment through client 
interactions and understand and study the assignment procedure based on the RNR 
model in greater detail. However, it is likely even more necessary—given the broad range 
of interventions currently available—to study practice elements or program elements of 
interventions to determine overlapping, effective elements (Chorpita & Daleiden, 2009; 
Evenboer, Huyghen, Tuinstra, Knorth, & Reijneveld, 2012; Lee et al., 2014). Furthermore, 
it would be of interest to compare the long-term effects of MST and FFT to find out 
whether their comparative effectiveness changes over time. 
This study also shows that using clinical practice data, like ROM data, is worthwhile 
for evaluating treatments. It increases both the external validity of the study and the 
clinical utility because data was gathered in regular clinical practice and sample selection 
bias is less present (Hodgson, Bushe, & Hunter, 2007). The current study shows that 
the PS method is a useful and important method for using these data (West et al., 
2014). It is, however, relevant to evaluate the chosen treatment outcomes in light of 
the selected dataset. The current study selected data from the Viersprong and not from 
other youth care institutions. Moreover, of the data selected, a sample was selected 
for which there was an outcome measure after treatment. The study sample — within 
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which the comparative effectiveness was studied — consisted of adolescents with 
overall less risk factors (i.e., less reported court orders, see Table I and II in Supplemental 
Material) compared to the group for which no data was available after treatment, which 
could in turn result in less differences between interventions because this group might 
have shown better results overall. And thus, though clinical practice data were used, 
the findings can only be generalized to the selected group of adolescents and the 
findings should be interpreted in light of this sample selection. On the one hand, this 
study sample is likely larger and has less sample selection bias compared to data from 
randomized clinical trials (RCTs). But using observational data still merits reflection on 
the generalizability of the findings and evaluation given the selections, regardless of the 
study design (Stuart, Cole, Bradshaw, & Leaf, 2011). Furthermore, partial replication of a 
previous study (Baglivio et al., 2014) supports prior evidence and shows that the results 
are robust across different clinical settings and study designs (Duncan, Engel, Claessens, 
& Dowsett, 2014). 
Despite the clinical relevance and use of this study, some limitations merit reflection. 
First, although a wide range of initial differences between adolescents in the treatment 
arms were controlled for, there could still be differences that were unmeasured and thus 
not controlled for. For example, the quality of life of the adolescent was not measured. 
This could have led to hidden biases in the presented results (Rosenbaum, 1991; Shadish, 
2013). Second, though a response rate of ~40% is common when using clinical practice 
data from ROM in the Netherlands and not gathered for specific research purposes, 
there were a number of families who did not complete the CBCL at the end of the 
treatment. When comparing adolescents who did and did not complete this primary 
outcome measure, there were differences within the MST and FFT group. As a result, 
the external validity of this study is not optimal because the effect of the treatments 
in the group with missing data could not be measured. Third, the interventions are 
monitored in a quality system, follow detailed protocols, and require therapists to have 
completed higher education in a relevant domain.  Differences between interventions, 
however, could be related to the duration of the treatment, the dosage and intensity 
of the interventions, and adherence of therapists to treatment protocol. Because the 
duration and intensity of treatment depend on the particular situation of an adolescent 
assigned to MST and FFT which could be related to specific background characteristics 
of the adolescent and the family, controlling for these factors would not fully represent 
the services as provided. Even more, it is yet unclear how the intensity of treatment can 
be defined. It could, for example, be related to the number of sessions, the amount 
of time, directly and indirectly, given to an adolescent and his or her family, and the 
length of treatment. Fourth, we had not data on adolescents assigned to treatment as 
usual or a control group consisting of adolescents not receiving treatment. However, 
when decision makers decided on the use of these interventions, it would have been 
helpful to include a reference treatment option. Fifth, though the chosen method was 
thoroughly considered, and all assumptions checked, and although results were robust 
over different samples (the study sample and the complete case sample), the choice 
of methods could influence the outcomes. There could, for example, be different 
estimation methods, e.g., matching with the PS or stratification using the PS, which 
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arrive even closer to the true effect (Cham & West, 2016; Harder et al., 2010). Even 
more, using different approaches can help reducing uncertainty surrounding outcomes. 
Finally, the subgroup was chosen to indicate risk level according to the RNR model, but 
other demographic characteristics (in combination) could have also been used, such as 
living situation or education level.
In conclusion, the current study found few differences in the relative effectiveness 
of MST and FFT. This paper also stresses the necessity of investigating effects within 
subgroups of adolescents, as conclusions can change in looking at specific subgroups. 
Though RCTs are considered to be most effective for evaluating treatment options, 
using clinical practice data is certainly a viable alternative when carefully applied. By 
thoroughly controlling for treatment selection, the approach even enhances external 
validity because sample selection is less present than in RCTs (Stuart et al., 2011). 
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Supplemental Material
Table I: Excluded versus included adolescents due to missing outcome measure after treatment (FFT)
Variable   Excluded (N = 365)  Included (N = 275)  Test statistic
Continuous variables  Mean SD N Mean SD N T-test
Age  15.95 1.65 365 15.9 1.59 275  0.70
CBCL Internalizing problems 62.5 10.45 268 62.51 9.26 263 -0.02
Primary outcome Externalizing problems 65.88 10.49 268 67.08 9.57 263 -1.37
 Total behavioral problems 65.17 9.93 268 66.04 8.61 263 -1.08
YSR Internalizing problems 53.54 10.78 228 54.79 11.31 246 -1.24
 Externalizing problems 58.01 10.28 228 59.27 9.73 246 -1.37
 Total behavioral problems 65.05 9.53 228 57.35 9.78 246 -1.46
Parenting stress  2 1.92 248 1.97 1.78 258  0.21
         
Categorical variables  %  N %  N
Chi-Square 
statistic
Gender Male 50.1  183 53.6  141 0.74
 Female 49.9  182 46.4  122  
Country of birth Netherlands 90.1  301 95.8  253 7.17*
 Western country 3.3  11 1.1  3  
 Non-Western country 6.6  22 3.0  8  
Living situation adolescent Together with one parent 45.0  154 36.1  97 9.20**
 Together with multiple parents 48.8  167 60.6  163  
 Other 6.1  21 3.3  9  
Living situation adolescent Lived not at home 2.1  7 0.8  2 1.76
Secondary outcome Lived at home 97.9  326 99.2  260  
Level of education None 9.2  30 7.1  19 1.77
 Primary education 4.0  13 3.7  10  
 Lower secondary education 52.5  171 54.5  146  
 Higher secondary education 34.0  111 34.7  93  
 Higher education 0.3  1 0.0  0  
Previous treatment Absent 10.4  35 9.8  26 0.06
Engagement in school or work Absent 20.3  64 14.5  37 3.34
Secondary outcome Present 79.7  251 85.5  219  
Court order No 67.0  229 74.0  202 7.76*
 Civil 18.7  64 10.6  29  
 Criminal 14.3  49 15.4  42  
Police contacts during treatment Absent 73.4  240 66.9  176 2.94
Secondary outcome Present 26.6  87 33.1  87  
Relation father Absent 10.2  33 6.8  17 2.04
 Present 89.8  292 93.2  234  
Relation mother Absent 1.2  4 0.4  1 1.07
 Present 98.8  330 99.6  249  
Relation siblings Absent 9.2  29 7.6  18 0.42
 Present 90.8  287 92.4  218  
Relation peers Absent 0.6  2 0.0  0 1.51
 Present 99.4  330 100.0  249  
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Variable   Excluded (N = 365)  Included (N = 275)  Test statistic
Categorical variables  %  N %  N
Chi-Square
 statistic
Country of birth primary caregiver the Netherlands 85.6  274 88.5  232 3.04
 Western country 3.1  10 4.2  11  
 Non-Western country 11.3  36 7.3  19  
Level of education primary caregiver None 3.8  11 1.2  3 5.47
 Primary education 5.2  15 4.1  10  
 Lower secondary education 31.4  90 27.9  68  
 Higher secondary education 41.5  119 45.5  111  
 Higher education 18.1  52 21.3  52  
Employment primary caregiver Employed 66.0  214 71.8  186 2.22
 Unemployed 34.0  110 28.2  73  
Partner primary caregiver Absent 25.3  80 21.7  55 0.99
 Present 74.7  236 78.3  198  
* p < .05, ** p < .01, *** p < .001
NOTE: Values depict the mean values and standard deviations. Except for age and parenting stress all 
other scores are standardized T-scores, having a mean of 50 and a standard deviation of 10. For NOSI-R 
and parenting stress, normed z-scores are displayed.
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Table II. Excluded versus included adolescents due to missing outcome measure after treatment (MST)
Variable   Excluded (N = 652)  Included (N = 422)  Test statistic
Continuous variables  Mean SD N Mean SD N T-test
Age  15.65 1.43 652 15.67 1.35 422 -0.22
CBCL Internalizing problems 61.42 9.71 485 61.04 9.68 409 0.58
Primary outcome Externalizing problems 68.09 10.13 485 68.29 10.06 409 -0.31
 Total behavioral problems 65.45 9.29 485 65.32 9.76 409 0.19
YSR Internalizing problems 51.58 11.19 431 50.78 11.5 356 0.99
 Externalizing problems 57.2 10.59 431 57.54 10.87 356 -0.45
 Total behavioral problems 53.4 10.91 431 53.59 11.02 356 -0.24
Parenting stress  2.09 2.01 425 2.06 2.07 397 0.21
         
Categorical variables  %  N %  N
Chi-Square 
statistic
Gender Male 68.9  447 67.2  275 0.31
 Female 31.1  202 32.8  134  
Country of birth Netherlands 73.7  468 83.4  341 20.32***
 Western country 3.3  21 4.6  19  
 Non-Western country 23.0  146 12.0  49  
Living situation adolescent Together with one parent 53.5  345 42.9  179 13.09***
 Together with multiple parents 43.1  278 51.1  213  
 Other 3.4  22 6.0  25  
Living situation adolescent Lived not at home 0.9  6 2.9  12 5.76*
Secondary outcome Lived at home 99.1  631 97.1  400  
Level of education None 14.8  93 13.7  56 2.07
 Primary education 3.8  24 2.7  11  
 Lower secondary education 64.3  404 66.8  274  
 Higher secondary education 16.9  106 16.8  69  
Previous treatment Absent 7.6  49 5.5  23 1.75
 Present 92.4  597 94.5  395  
Engagement in school or work Absent 31.2  193 22.6  91 8.99**
Secondary outcome Present 68.8  426 77.4  312  
Court order No 30.6  197 40.6  168 13.10**
 Civil 40.1  258 30.9  128  
 Criminal 29.2  188 28.5  118  
Police contacts during treatment Absent 46.3  285 50.8  198 1.87
Secondary outcome Present 53.7  330 49.2  192  
Relation father Absent 13.1  81 9.2  37 3.51
 Present 86.9  539 90.8  364  
Relation mother Absent 1.0  6 0.7  3 0.13
 Present 99.0  623 99.3  402  
Relation siblings Absent 7.4  45 6.0  23 0.74
 Present 92.6  563 94.0  361  
Relation peers Absent 1.1  7 1.3  5 0.04
 Present 98.9  615 98.7  393  
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Table II. Excluded versus included adolescents due to missing outcome measure after treatment (MST)
Variable   Excluded (N = 652)  Included (N = 422)  Test statistic
Continuous variables  Mean SD N Mean SD N T-test
Age  15.65 1.43 652 15.67 1.35 422 -0.22
CBCL Internalizing problems 61.42 9.71 485 61.04 9.68 409 0.58
Primary outcome Externalizing problems 68.09 10.13 485 68.29 10.06 409 -0.31
 Total behavioral problems 65.45 9.29 485 65.32 9.76 409 0.19
YSR Internalizing problems 51.58 11.19 431 50.78 11.5 356 0.99
 Externalizing problems 57.2 10.59 431 57.54 10.87 356 -0.45
 Total behavioral problems 53.4 10.91 431 53.59 11.02 356 -0.24
Parenting stress  2.09 2.01 425 2.06 2.07 397 0.21
         
Categorical variables  %  N %  N
Chi-Square 
statistic
Gender Male 68.9  447 67.2  275 0.31
 Female 31.1  202 32.8  134  
Country of birth Netherlands 73.7  468 83.4  341 20.32***
 Western country 3.3  21 4.6  19  
 Non-Western country 23.0  146 12.0  49  
Living situation adolescent Together with one parent 53.5  345 42.9  179 13.09***
 Together with multiple parents 43.1  278 51.1  213  
 Other 3.4  22 6.0  25  
Living situation adolescent Lived not at home 0.9  6 2.9  12 5.76*
Secondary outcome Lived at home 99.1  631 97.1  400  
Level of education None 14.8  93 13.7  56 2.07
 Primary education 3.8  24 2.7  11  
 Lower secondary education 64.3  404 66.8  274  
 Higher secondary education 16.9  106 16.8  69  
Previous treatment Absent 7.6  49 5.5  23 1.75
 Present 92.4  597 94.5  395  
Engagement in school or work Absent 31.2  193 22.6  91 8.99**
Secondary outcome Present 68.8  426 77.4  312  
Court order No 30.6  197 40.6  168 13.10**
 Civil 40.1  258 30.9  128  
 Criminal 29.2  188 28.5  118  
Police contacts during treatment Absent 46.3  285 50.8  198 1.87
Secondary outcome Present 53.7  330 49.2  192  
Relation father Absent 13.1  81 9.2  37 3.51
 Present 86.9  539 90.8  364  
Relation mother Absent 1.0  6 0.7  3 0.13
 Present 99.0  623 99.3  402  
Relation siblings Absent 7.4  45 6.0  23 0.74
 Present 92.6  563 94.0  361  
Relation peers Absent 1.1  7 1.3  5 0.04
 Present 98.9  615 98.7  393  
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Variable   Excluded (N = 652)  Included (N = 422)  Test statistic
Categorical variables  %  N %  N
Chi-Square 
statistic
Country of birth primary caregiver the Netherlands 59.3  369 79.3  325 52.10***
 Western country 4.2  26 4.9  20  
 Non-Western country 36.5  227 15.9  65  
Level of education primarycaregiver None 8.7  53 3.0  12 40.86***
 Primary education 18.1  110 8.0  32  
 Lower secondary education 29.7  181 31.3  126  
 Higher secondary education 31.0  189 39.1  157  
 Higher education 12.5  76 18.7  75  
Employment primary caregiver Employed 47.8  301 61.9  253 19.75***
 Unemployed 52.2  329 38.1  156  
Partner primary caregiver Absent 32.7  196 23.9  94 8.89**
 Present 67.3  403 76.1  299  
* p < .05, ** p < .01, *** p < .001
NOTE:
Values depict the mean values and standard deviations. Except for age and parenting stress all other 
scores are standardized T-scores, having a mean of 50 and a standard deviation of 10. For NOSI-R and 
parenting stress, normed z-scores are displayed.
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Table III. Standardized bias of missing indicators in full sample (N = 697)
Missing indicators§    
Before PS 
application
After PS 
application
CBCL Internalizing problems Missing 0.07 0.07
  Not missing 0.07 0.07
 Externalizing problems Missing 0.07 0.07
  Not missing 0.07 0.07
 Total behavioral problems Missing 0.07 0.07
  Not missing 0.07 0.07
YSR Internalizing problems Missing 0.14 0.11
  Not missing 0.14 0.11
 Externalizing problems Missing 0.14 0.11
  Not missing 0.14 0.11
 Total behavioral problems Missing 0.14 0.11
  Not missing 0.14 0.11
Parenting stress  Missing 0.01 0.06
  Not missing 0.01 0.06
Gender  Missing 0.07 0.07
  Not missing 0.07 0.07
Country of birth  Missing 0.05 0.04
  Not missing 0.05 0.04
Living situation adolescent  Missing 0.09 0.02
  Not missing 0.09 0.02
Living situation adolescent  Missing 0.16 0.04
Secondary outcome  Not missing 0.16 0.04
Level of education  Missing 0.02 0.07
  Not missing 0.02 0.07
Previous treatment  Missing 0.24 0.05
  Not missing 0.24 0.05
Engagement in school or work  Missing 0.12 0.09
Secondary outcome  Not missing 0.12 0.09
Court order  Missing 0.09 0.01
  Not missing 0.09 0.01
Police contacts during treatment  Missing 0.12 0.03
Secondary outcome  Not missing 0.12 0.03
Relation father  Missing 0.17 0.03
  Not missing 0.17 0.03
Relation mother  Missing 0.26 0.03
  Not missing 0.26 0.03
Relation siblings  Missing 0.18 0.09
  Not missing 0.18 0.09
Relation peers  Missing 0.16 0.05
  Not missing 0.16 0.05
Country of birth primary caregiver  Missing 0.11 0.20
  Not missing 0.11 0.20
Level of education primary caregiver Missing 0.31 0.01
  Not missing 0.31 0.01
Employment primary caregiver  Missing 0.16 0.05
  Not missing 0.16 0.05
Partner primary caregiver  Missing 0.05 0.11
  Not missing 0.05 0.11
§ No missing values were present for the variable ‘Age’, thus the missing indicator was not needed.
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Table IV. Baseline differences between adolescents assigned to FFT and MST and standardized bias for 
youth without a court order (N=370)
Variable   FFT (N = 202)  MST (N = 168)  Test statistic Standardized bias
Continuous variables Mean SD N Mean SD N T-test
Before PS 
application
After PS 
application
Age  15.72 1.61 202 15.28 1.39 168 2.76** 0.32 0.05
CBCL Internalizing problems 62.99 8.72 195 62.99 8.58 161 0.00 0.00 0.01
Primary outcome Externalizing problems 68.54 8.48 195 72.2 7.87 161  -4.18*** 0.47 0.04
 Total behavioral problems † 67.31 7.39 195 68.84 6.8 161  -2.02* 0.23 0.10
YSR Internalizing problems 55.21 11.15 182 52.76 11.42 139 1.93 0.22 0.04
 Externalizing problems 59.96 8.84 182 60.73 9.91 139 -0.73 0.08 0.02
 Total behavioral problems 58.34 8.96 182 56.76 9.8 139 1.50 0.16 0.02
Parenting stress  2.23 1.71 188 2.67 2.11 161  -2.12* 0.21 0.09
Categorical variables %  N  %  N
Chi-Square 
statistic
Before PS 
application
After PS 
application
Gender Male 52.3  102 61.5  99 3.03 0.19 0.10
 Female 47.7  93 38.5  62  0.19 0.10
Country of birth Netherlands 97.4  190 90.3  149 8.97* 0.13 0.06
 Western country 1.0  2 1.8  3  0.01 0.00
 Non-Western country 1.5  3 7.9  13  0.12 0.06
Living situation adolescent Together with one parent 31.3  62 35.5  59 1.23 0.08 0.22
 Together with multiple parents 66.7  132 61.4  102  0.10 0.25
 Other 2.0  4 3.0  5  0.02 0.03
Living situation adolescent Lived not at home 0.0  0 0.0  0 NA 0.00 0.00
Secondary outcome Lived at home 100.0  194 100.0  165  0.00 0.00
Level of education None 5.1  10 8.4  14 23.81*** 0.05 0.12
 Primary education 3.6  7 3.6  6  0.00 0.06
 Lower secondary education 53.8  106 73.1  122  0.27 0.27
 Higher secondary education 37.6  74 15.0  25  0.31 0.09
Previous treatment Absent 21.5  20 4.8  8 3.94* 0.26 0.06
 Present 78.5  73 95.2  160  0.26 0.06
Engagement in school or work Absent 12.1  23 20.0  33 4.14* 0.20 0.06
Secondary outcome Present 87.9  167 80.0  132  0.20 0.06
Court order No 100.0  202 100.0  168 NA 0.00 0.00
 Civil 0.0  0 0.0  0  0.00 0.00
 Criminal 0.0  0 0.0  0  0.00 0.00
Police contacts during treatment Absent 72.0  139 55.1  87 10.90*** 0.34 0.04
Secondary outcome Present 28.0  54 44.9  71  0.34 0.04
Relation father Absent 8.2  15 6.1  10 0.55 0.09 0.03
 Present 91.8  169 93.9  154  0.09 0.03
Relation mother Absent 0.6  1 0.6  1 0.00 0.01 0.00
 Present 99.4  180 99.4  165  0.01 0.00
Relation siblings Absent 38.5  10 5.6  9 0.00 0.00 0.03
 Present 61.5  16 94.4  151  0.00 0.03
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Table IV. Baseline differences between adolescents assigned to FFT and MST and standardized bias for 
youth without a court order (N=370)
Variable   FFT (N = 202)  MST (N = 168)  Test statistic Standardized bias
Continuous variables Mean SD N Mean SD N T-test
Before PS 
application
After PS 
application
Age  15.72 1.61 202 15.28 1.39 168 2.76** 0.32 0.05
CBCL Internalizing problems 62.99 8.72 195 62.99 8.58 161 0.00 0.00 0.01
Primary outcome Externalizing problems 68.54 8.48 195 72.2 7.87 161  -4.18*** 0.47 0.04
 Total behavioral problems † 67.31 7.39 195 68.84 6.8 161  -2.02* 0.23 0.10
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 Total behavioral problems 58.34 8.96 182 56.76 9.8 139 1.50 0.16 0.02
Parenting stress  2.23 1.71 188 2.67 2.11 161  -2.12* 0.21 0.09
Categorical variables %  N  %  N
Chi-Square 
statistic
Before PS 
application
After PS 
application
Gender Male 52.3  102 61.5  99 3.03 0.19 0.10
 Female 47.7  93 38.5  62  0.19 0.10
Country of birth Netherlands 97.4  190 90.3  149 8.97* 0.13 0.06
 Western country 1.0  2 1.8  3  0.01 0.00
 Non-Western country 1.5  3 7.9  13  0.12 0.06
Living situation adolescent Together with one parent 31.3  62 35.5  59 1.23 0.08 0.22
 Together with multiple parents 66.7  132 61.4  102  0.10 0.25
 Other 2.0  4 3.0  5  0.02 0.03
Living situation adolescent Lived not at home 0.0  0 0.0  0 NA 0.00 0.00
Secondary outcome Lived at home 100.0  194 100.0  165  0.00 0.00
Level of education None 5.1  10 8.4  14 23.81*** 0.05 0.12
 Primary education 3.6  7 3.6  6  0.00 0.06
 Lower secondary education 53.8  106 73.1  122  0.27 0.27
 Higher secondary education 37.6  74 15.0  25  0.31 0.09
Previous treatment Absent 21.5  20 4.8  8 3.94* 0.26 0.06
 Present 78.5  73 95.2  160  0.26 0.06
Engagement in school or work Absent 12.1  23 20.0  33 4.14* 0.20 0.06
Secondary outcome Present 87.9  167 80.0  132  0.20 0.06
Court order No 100.0  202 100.0  168 NA 0.00 0.00
 Civil 0.0  0 0.0  0  0.00 0.00
 Criminal 0.0  0 0.0  0  0.00 0.00
Police contacts during treatment Absent 72.0  139 55.1  87 10.90*** 0.34 0.04
Secondary outcome Present 28.0  54 44.9  71  0.34 0.04
Relation father Absent 8.2  15 6.1  10 0.55 0.09 0.03
 Present 91.8  169 93.9  154  0.09 0.03
Relation mother Absent 0.6  1 0.6  1 0.00 0.01 0.00
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Variable   FFT (N = 202)  MST (N = 168)  Test statistic Standardized bias
Categorical variables %  N  %  N
Chi-Square 
statistic
Before PS 
application
After PS 
application
Relation peers Absent 0.0  0 0.6  1 1.11 0.08 0.00
 Present 100.0  180 99.4  161  0.08 0.00
Country of birth primary caregiver the Netherlands 89.5  171 88.3  144 2.96 0.02 0.09
 Western country 4.2  8 1.8  3  0.04 0.00
 Non-Western country 6.3 12 9.8 16  0.06 0.09
Level of education primary caregiver None 1.1  2 0.6  1 1.14 0.01 0.00
 Primary education 2.2  4 3.1  5  0.01 0.03
 Lower secondary education 23.3  42 22.7  37  0.01 0.02
 Higher secondary education 50.6  91 47.2  77  0.04 0.04
 Higher education 22.8  41 26.4  43  0.04 0.02
Employment primary caregiver Employed 69.8  132 69.1  112 0.02 0.02 0.15
 Unemployed 30.2  57 30.9  50  0.02 0.15
Partner primary caregiver Absent 21.1  39 16.1  26 1.37 0.13 0.09
 Present 78.9  146 83.9  135  0.13 0.09
* p < .05, ** p < .01, *** p < .001
† Not selected for PS estimation.
NOTE:
Values depict the mean values and standard deviations. Except for age and parenting stress all other 
scores are standardized T-scores, having a mean of 50 and a standard deviation of 10. For NOSI-R and 
parenting stress, normed z-scores are displayed.
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Table V. Standardized bias of missing indicators in sample of youth without a court order (N = 370)
Missing indicators§    
Before PS 
application
After PS 
application
CBCL Internalizing problems Missing 0.04 0.06
  Not missing 0.04 0.06
 Externalizing problems Missing 0.04 0.06
  Not missing 0.04 0.06
 Total behavioral problems Missing 0.04 0.06
  Not missing 0.04 0.06
YSR Internalizing problems Missing 0.19 0.03
  Not missing 0.19 0.03
 Externalizing problems Missing 0.19 0.03
  Not missing 0.19 0.03
 Total behavioral problems Missing 0.19 0.03
  Not missing 0.19 0.03
Parenting stress  Missing 0.14 0.06
  Not missing 0.14 0.06
Gender  Missing 0.04 0.06
  Not missing 0.04 0.06
Country of birth  Missing 0.13 0.00
  Not missing 0.13 0.00
Living situation adolescent  Missing 0.07 0.06
  Not missing 0.07 0.06
Living situation adolescent  Missing 0.16 0.11
Secondary outcome  Not missing 0.16 0.11
Level of education  Missing 0.24 0.08
  Not missing 0.24 0.08
Previous treatment  Missing 0.00 0.00
  Not missing 0.00 0.00
Engagement in school or work  Missing 0.31 0.11
Secondary outcome  Not missing 0.31 0.11
Court order  Missing 0.00 0.00
  Not missing 0.00 0.00
Police contacts during treatment  Missing 0.06 0.06
Secondary outcome  Not missing 0.06 0.06
Relation father  Missing 0.43 0.00
  Not missing 0.43 0.00
Relation mother  Missing 0.85 0.06
  Not missing 0.85 0.06
Relation siblings  Missing 0.36 0.00
  Not missing 0.36 0.00
Relation peers  Missing 0.39 0.00
  Not missing 0.39 0.00
Country of birth primary caregiver  Missing 0.15 0.00
  Not missing 0.15 0.00
Level of education primary caregiver  Missing 0.46 0.00
  Not missing 0.46 0.00
Employment primary caregiver  Missing 0.15 0.10
  Not missing 0.15 0.10
Partner primary caregiver  Missing 0.21 0.03
  Not missing 0.21 0.03
§ No missing values were present for the variable ‘Age’, thus the missing indicator was not needed.
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Table VI: Variance ratio and 5-number summary of continuous covariates after PS application in sample 
of youth without court order (N = 370)
   
Variance 
ratio‡
Minimum
25th 
percentile
Median 75th 
percentile
Maximum
Age   FFT 0.83 12.10 14.25 15.18 16.08 20.39
    MST 11.07 14.54 15.29 16.39 17.88
CBCL
Internalizing 
problems
FFT 0.96 39.00 57.00 65.00 69.00 83.00
    MST 34.00 57.75 64.00 70.00 81.00
 
Externalizing 
problems
FFT 1.09 43.00 69.00 72.00 76.00 92.00
    MST 46.00 68.75 73.50 77.00 88.00
 
Total behavioral 
problems
FFT 1.03 44.00 65.00 70.00 74.00 84.00
    MST 50.00 65.00 70.00 74.00 82.00
YSR
Internalizing 
problems
FFT 1.17 30.00 45.00 54.00 60.54 83.00
    MST 30.00 46.00 53.00 62.00 81.00
 
Externalizing 
problems
FFT 1.25 37.00 55.00 60.96 68.01 80.00
    MST 29.00 54.00 61.00 68.00 88.00
 
Total behavioral 
problems
FFT 1.18 34.00 51.00 56.06 63.20 77.00
    MST 26.00 50.00 56.00 64.00 82.00
Parenting stress   FFT 1.40 -1.16 1.23 2.62 3.54 7.78
    MST -1.38 1.20 2.59 4.13 8.95
‡ In the weighted sample the 2.5th and 97.5th percentiles of the F-distribution are 0.63 and 1.37 
respectively. 
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Table VII: Baseline differences between adolescents assigned to FFT and MST and standardized bias for 
youth with court order (N=317)
Variable   FFT (N = 71)  MST (N = 246)  Test statistic Standardized bias 
Continuous variables Mean SD N Mean SD N T-test
Before PS 
application
After PS 
application
Age  16.4 1.42 71 15.94 1.26 246 2.58** 0.36 NA
CBCL Internalizing problems 60.77 10.25 66 59.84 10.14 240 0.66 0.09 NA
Primary outcome Externalizing problems 62.85 11.25 66 65.78 10.52 240  -1.97* 0.28 NA
 Total behavioral problems 62.18 10.73 66 63.09 10.7 240 -0.61 0.09 NA
YSR Internalizing problems 53.16 11.64 62 49.59 11.52 209 2.14* 0.31 NA
 Externalizing problems 57.21 11.85 62 55.55 11.01 209 1.02 0.15 NA
 Total behavioral problems 54.29 11.52 62 51.27 11.38 209 1.65 0.24 NA
Parentingl stress  1.24 1.82 68 1.68 1.93 228 -1.66 0.23 NA
Categorical variables %  N %  N
Chi-Square 
statistic
Before PS 
application
After PS 
application
Gender Male 56.1  37 70.4  169 4.85* 0.31 NA
 Female 43.9  29 29.6  71  0.31 NA
Country of birth Netherlands 91.0  61 78.2  186 5.92 0.18 NA
 Western country 1.5  1 6.7  16  0.07 NA
 Non-Western country 7.5  5 15.1  36  0.10 NA
Living situation adolescent Together with one parent 47.8  33 48.6  119 0.10 0.01 NA
 Together with multiple parents 44.9  31 43.3  106  0.03 NA
 Other 7.2  5 8.2  20  0.01 NA
Living situation adolescent Lived not at home 3.0  2 5.0  12 0.45 0.09 NA
Secondary outcome Lived at home 97.0  64 95.0  229  0.09 NA
Level of education None 13.0  9 17.6  42 2.90 0.05 NA
 Primary education 4.3  3 2.1  5  0.02 NA
 Lower secondary education 58.0  40 61.9  148  0.04 NA
 Higher secondary education 24.6  17 18.4  44  0.07 NA
Previous treatment Absent 8.5  6 5.7  14 0.70 0.12 NA
 Present 91.5  65 94.3  231  0.12 NA
Engagement in school or work Absent 21.9  14 24.8  58 0.23 0.07 NA
Secondary outcome Present 78.1  50 75.2  176  0.07 NA
Court order No 0.0  0 0.0  0 2.76 0.00 NA
 Civil 40.8  29 52.0  128  0.22 NA
 Criminal 59.2  42 48.0  118  0.22 NA
Police contacts during treatment Absent 51.5  35 47.6  108 0.32 0.08 NA
Secondary outcome Present 48.5  33 52.4  119  0.08 NA
Relation father Absent 3.0  2 11.6  27 4.30* 0.27 NA
 Present 97.0  64 88.4  206  0.27 NA
Relation mother Absent 0.0  0 0.9  2 0.58 0.09 NA
 Present 100.0  68 99.1  233  0.09 NA
Relation siblings Absent 12.1  7 6.4  14 2.14 0.23 NA
 Present 87.9  51 93.6  206  0.23 NA
Relation peers Absent 0.0  0 1.7  4 1.19 0.13 NA
 Present 100.0  68 98.3  228  0.13 NA
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Chi-Square 
statistic
Before PS 
application
After PS 
application
Gender Male 56.1  37 70.4  169 4.85* 0.31 NA
 Female 43.9  29 29.6  71  0.31 NA
Country of birth Netherlands 91.0  61 78.2  186 5.92 0.18 NA
 Western country 1.5  1 6.7  16  0.07 NA
 Non-Western country 7.5  5 15.1  36  0.10 NA
Living situation adolescent Together with one parent 47.8  33 48.6  119 0.10 0.01 NA
 Together with multiple parents 44.9  31 43.3  106  0.03 NA
 Other 7.2  5 8.2  20  0.01 NA
Living situation adolescent Lived not at home 3.0  2 5.0  12 0.45 0.09 NA
Secondary outcome Lived at home 97.0  64 95.0  229  0.09 NA
Level of education None 13.0  9 17.6  42 2.90 0.05 NA
 Primary education 4.3  3 2.1  5  0.02 NA
 Lower secondary education 58.0  40 61.9  148  0.04 NA
 Higher secondary education 24.6  17 18.4  44  0.07 NA
Previous treatment Absent 8.5  6 5.7  14 0.70 0.12 NA
 Present 91.5  65 94.3  231  0.12 NA
Engagement in school or work Absent 21.9  14 24.8  58 0.23 0.07 NA
Secondary outcome Present 78.1  50 75.2  176  0.07 NA
Court order No 0.0  0 0.0  0 2.76 0.00 NA
 Civil 40.8  29 52.0  128  0.22 NA
 Criminal 59.2  42 48.0  118  0.22 NA
Police contacts during treatment Absent 51.5  35 47.6  108 0.32 0.08 NA
Secondary outcome Present 48.5  33 52.4  119  0.08 NA
Relation father Absent 3.0  2 11.6  27 4.30* 0.27 NA
 Present 97.0  64 88.4  206  0.27 NA
Relation mother Absent 0.0  0 0.9  2 0.58 0.09 NA
 Present 100.0  68 99.1  233  0.09 NA
Relation siblings Absent 12.1  7 6.4  14 2.14 0.23 NA
 Present 87.9  51 93.6  206  0.23 NA
Relation peers Absent 0.0  0 1.7  4 1.19 0.13 NA
 Present 100.0  68 98.3  228  0.13 NA
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Variable   FFT (N = 71)  MST (N = 246)  Test statistic Standardized bias 
Categorical variables %  N %  N
Chi-Square 
statistic
Before PS 
application
After PS 
application
Country of birth primary caregiver the Netherlands 85.5  59 72.6  175 4.87 0.16 NA
 Western country 4.3  3 7.1  17  0.03 NA
 Non-Western country 10.1  7 20.3  49  0.13 NA
Level of education primary caregiver None 1.6  1 4.7  11 1.88 0.03 NA
 Primary education 9.7  6 11.5  27  0.02 NA
 Lower secondary education 41.9  26 37.2  87  0.05 NA
 Higher secondary education 30.6  19 32.9  77  0.02 NA
 Higher education 16.1  10 13.7  32  0.02 NA
Employment primary caregiver Employed 76.5  52 57.3  138 8.26** 0.39 NA
 Unemployed 23.5  16 42.7  103  0.39 NA
Partner primary caregiver Absent 24.2  16 30.1  68 0.85 0.13 NA
 Present 75.8  50 69.9  158  0.13 NA
* p < .05, ** p < .01, *** p < .001
NOTE:
Values depict the mean values and standard deviations. Except for age and parenting stress all other 
scores are standardized T-scores, having a mean of 50 and a standard deviation of 10. For NOSI-R and 
parenting stress, normed z-scores are displayed.
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Table VIII: Standardized bias of missing indicators in sample of youth with court order (N = 317)
Missing indicators§    
Before PS 
application
After PS 
application
CBCL Internalizing problems Missing 0.30 NA
  Not missing 0.30 NA
 Externalizing problems Missing 0.30 NA
  Not missing 0.30 NA
 Total behavioral problems Missing 0.30 NA
  Not missing 0.30 NA
YSR Internalizing problems Missing 0.07 NA
  Not missing 0.07 NA
 Externalizing problems Missing 0.07 NA
  Not missing 0.07 NA
 Total behavioral problems Missing 0.07 NA
  Not missing 0.07 NA
Parenting stress  Missing 0.12 NA
  Not missing 0.12 NA
Gender  Missing 0.30 NA
  Not missing 0.30 NA
Country of birth  Missing 0.13 NA
  Not missing 0.13 NA
Living situation adolescent  Missing 0.38 NA
  Not missing 0.38 NA
Living situation adolescent  Missing 0.35 NA
Secondary outcome  Not missing 0.35 NA
Level of education  Missing 0.00 NA
  Not missing 0.00 NA
Previous treatment  Missing 0.06 NA
  Not missing 0.06 NA
Engagement in school or work  Missing 0.23 NA
Secondary outcome  Not missing 0.23 NA
Court order  Missing 0.00 NA
  Not missing 0.00 NA
Police contacts during treatment  Missing 0.13 NA
Secondary outcome  Not missing 0.13 NA
Relation father  Missing 0.08 NA
  Not missing 0.08 NA
Relation mother  Missing 0.01 NA
  Not missing 0.01 NA
Relation siblings  Missing 0.25 NA
  Not missing 0.25 NA
Relation peers  Missing 0.06 NA
  Not missing 0.06 NA
Country of birth primary caregiver  Missing 0.06 NA
  Not missing 0.06 NA
Level of education primary caregiver Missing 0.36 NA
  Not missing 0.36 NA
Employment primary caregiver  Missing 0.16 NA
  Not missing 0.16 NA
Partner primary caregiver  Missing 0.04 NA
  Not missing 0.04 NA
§ No missing values were present for the variable ‘Age’, thus the missing indicator was not needed.
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This dissertation addresses two issues of contemporary interest in the field of youth care: 
1) the feasibility of cost-effectiveness research in this field and 2) the use of available, 
non-randomized, data in investigating the effectiveness of interventions in youth care 
practice. These issues will be discussed in light of the results in this dissertation and, 
subsequently, several recommendations will be provided for clinical practice and further 
research.
Cost-effectiveness research in youth care 
We investigated whether state of the art methods commonly applied in health care 
evaluation studies can be applied to systemic interventions in youth care. In Chapter 
2, Functional Family Therapy (FFT) was compared with Treatment as usual (TAU) in an 
illustrative probabilistic Markov model, in which parameter uncertainty and long-term 
cost-effectiveness were taken into account. Estimating long-term cost-effectiveness is 
essential when interventions are applied to youth aged 12 to 18 years and when treatment 
effects are expected to last into adulthood. By expressing the cost-effectiveness ratio 
in costs per Criminal Activity Free Year (CAFY), we used an outcome measure that 
addressed not only the clinical, but also the societal effect of the interventions. By doing 
so, clinically relevant issues and health economic questions were brought together. 
Chapter 2 thus showed that commonly applied economic evaluation methods are 
applicable in evaluating youth care.    
However, when modelling the cost-effectiveness of interventions, the results in 
both cost and effect estimates can be subject to uncertainty. This parameter uncertainty 
can be reduced by information obtained from further research. A value of information 
analysis can reveal the value and justify the direction of further research. In Chapter 
3, an illustrative value of information analysis was applied using the cost-effectiveness 
model developed in Chapter 2. Thereby, it was needed to assume a ‘willingness-to-
pay (WTP) value’ for one CAFY (i.e., what is society willing to pay for one year without 
criminal activity of one adolescent?) since the expected value of further information 
depends on this WTP value. Findings from a value of information analysis may lead to 
reimbursing the intervention studied or not under certain conditions. Chapter 3 showed 
that a value of information analysis in the field of youth care can also be interpreted as 
similar to cost/ Quality Adjusted Life Year (QALY) studies in health care evaluations and 
is particularly meaningful in this field, because the interest in cost-effectiveness research 
is increasing, and its analyses could use a wider range of input parameters than cost-
effectiveness research in health care, for instance.  
Both the cost-effectiveness analysis in Chapter 2 and the value of information 
analysis in Chapter 3 revealed important issues that should be considered in future cost-
effectiveness research in youth care. First, in contrast to health care evaluation studies, 
in youth care not only the referred client (i.e., the adolescent) should be the focus of 
research, but also the systems surrounding him. For example, the societal perspective 
chosen in the analysis should include the effect of the intervention in terms of reduced 
costs and increased well-being of family members, reduced victim costs, and reduced 
costs  because of avoided crimes, all taken into account over the defined time-horizon of 
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the analysis. Second, when measuring CAFYs, the type of criminal activity that is avoided, 
the seriousness of the crime, and the number of times it is committed should be defined. 
Even more, the outcome measure should be clinically relevant and should allow making 
comparisons with other interventions. A preference weighted measure, like the QALY 
may be preferred as it adds weights to different outcomes of the interventions. Third, 
we should be able to assign a value to the defined outcome, the so-called WTP value, 
in order to judge the cost-effectiveness results against a threshold value. This WTP value 
depends on the outcome defined and the cost categories included in the analysis, which 
should be reflected in this WTP value and vice versa. 
In conclusion, when evaluating the cost-effectiveness of youth care interventions, 
commonly applied economic evaluation methods are feasible and their results can be 
interpreted in the same manner as in health care evaluation studies. 
Use of observational data in treatment evaluation 
Evaluating the effectiveness of interventions in youth care becomes increasingly 
important, but due to practical and ethical constraints it is not always possible to 
randomly allocate adolescents and their families to treatment. As an alternative, research 
could follow clinical practice in gathering data. In that case, the propensity score (PS) 
method can be used to control for initial differences between treatment groups. It is 
thereby of interest to study subgroup effects when using the PS to tailor youth care to 
adolescents’ situations and needs. One can adjust for subgroup effects in several ways, 
for example by additionally adjusting for the subgroup or by splitting the dataset into 
the relevant subgroups. The first manner was studied in a Monte Carlo simulation study 
in Chapter 4. The research question was whether the subgroups should be added to the 
outcome model, together with an interaction term between treatment and subgroups, 
or whether the PS should be made multiple to estimate the specific treatment effects 
within subgroups. Both methods were found to be feasible, while the latter option (i.e., 
making the PS multiple on the subgroup and treatment options) gave less biased results 
compared to the first option (i.e., adding the subgroups to the outcome model). 
In Chapter 5, two youth care interventions, FFT and Multisystemic Therapy (MST) 
were compared on their effectiveness using Routine Outcome Monitoring (ROM) 
data and subgroups were investigated by splitting the dataset. The outcomes were 
externalizing problems of the adolescent, whether the adolescent was living at home 
after treatment, was engaged in school or work after treatment, and had had police 
contacts during treatment. Minor differences were found between the interventions. 
However, when splitting the dataset into subgroups of adolescents who had a court 
order before treatment and those who had not, different results were obtained: MST 
was more effective than FFT in reducing externalizing problems when adolescents had 
no court order. Because many more adolescents with a court order were assigned to 
MST than to FFT, the PS could not balance the intervention groups in this subsample. 
Therefore, no comparative treatment effect could be estimated in this subsample. 
In general, both Chapter 4 and Chapter 5 showed the applicability of the PS 
when evaluating youth care, and more importantly, the use of clinical practice data 
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to answer questions about the effectiveness of interventions. When using available, 
non-randomized clinical practice data, however, the following considerations should 
be kept in mind. The treatments evaluated and the results of the analyses should be 
considered in light of the selected dataset. For example, using data from one institution 
can complicate the applicability and generalizability of the findings to other institutions, 
as referral practices and outcome measures may differ between institutions. In addition, 
characteristics of the selected dataset influence the choice for the analyses, which may 
influence the results and the conclusions drawn. For instance, when one is interested in 
a subgroup effect, the definition of this subgroup determines whether it could moderate 
or mediate the relations between treatment and outcome. Even more, the findings 
should be interpreted in light of daily clinical practice because clinicians and patients 
should be able to use these findings in clinical practice. 
The two issues addressed in this thesis, cost-effectiveness analyses in youth care 
and treatment evaluation using observational data are related, since effectiveness 
studies are needed to decide on the necessity and relevance of a cost-effectiveness 
study. On the other hand, when a cost-effectiveness study is needed, data on the costs 
and effects of the interventions studied are needed. When data of a randomized trial 
are not available, alternatives such as clinical practice data gathered within ROM could 
be useful. 
Implications for youth care 
Interventions seem to be most efficiently studied and compared on effectiveness 
using clinical practice data. Setting up randomized controlled trials (RCT’s) and asking 
clinicians and adolescents and their parents to fill in questionnaires in addition to the 
questionnaires that are used to routinely monitor the treatment process can be too 
expensive and too burdensome for patients and clinicians (Borah, Moriarty, Crown, & 
Doshi, 2014). Within mental health care, and within youth care, various ROM systems 
already systematically and repeatedly collect data on patients’ mental health and function 
as an indicator of the treatment outcome. Not only can these data be used to monitor 
individual treatment progress, but they can also be used to evaluate interventions on 
their outcomes. Using such research findings in clinical practice can help youth and 
their families receive an intervention that is proven to be effective and evidence-based 
(APA, 2006). To accomplish this, research findings should effectively be communicated 
to clinical practice and should be translated into clinically relevant actions and policy 
considerations. Only then, practice-based evidence can lead to evidence-based practice 
(Veerman, van Yperen, Bijl, Ooms, & Roosma, 2008). 
Because Dutch budgets available for youth care were reduced and were transferred 
to local authorities in 2015, these authorities should have insight in which interventions 
are available and which of them are evidence-based: research findings from clinical 
practice are needed to gain these insights. When, for example, two interventions have 
the same target population and the intervention that is more effective is also more 
costly, it is relevant to evaluate these youth care interventions on their cost-effectiveness 
as an addition to the effectiveness study. This cost-effectiveness analysis is mostly seen 
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as an ‘additional’ part of the evaluation of interventions, but should become part of the 
evaluation process itself. Collecting relevant cost data on health care expenditures of 
patients in for example the ROM system, is a first step towards an economic evaluation. 
A second step is creating more awareness about the relevance of these types of analyses 
among clinicians and youth care institutions. For them, evidence based practice should 
also mean that one knows about the effectiveness of the intervention, its costs, and its 
cost-effectiveness and that they should be able to explain these results when needed. 
Moreover, policymakers who decide on the expenditure of youth care budgets (i.e., the 
municipalities in the Netherlands) should be informed about these types of analyses 
and the interpretation of the results too, since they should distribute youth care budgets 
wisely. Additionally, municipalities can play an important role in supporting institutions, 
scientists, and clinicians translating the data and findings to practically relevant outcomes. 
When the policymakers, youth care institutions, and clinicians understand each other’s 
language, results can more easily be applied and translated into reimbursement decisions 
in order to avoid wasting money on less effective and costly youth care interventions.
Recommendations for future research and policy 
The importance of evaluating youth care interventions on effectiveness and cost-
effectiveness should not only be emphasized within clinical practice, but also within 
research and policymaking. The following recommendations are important for future 
research and policy in the field of youth care. 
First, evaluating interventions using ‘real world data’ is becoming more widely 
accepted (Berger, Dreyer, Anderson, Towse, Sedrakyan, & Normand, 2012). Findings 
and conclusions from such datasets should be interpreted in light of the selected data 
and differences with the broader population should be emphasized. Furthermore, the 
statistical method that is chosen to analyse the data is likely to depend on the content of 
the data available and should take into account uncertainties within the dataset, such as 
missing values or having data only for a subgroup of adolescents. Using clinical practice 
data, or ‘real world data’, is not a substitution of conducting RCTs, since these study 
designs can address the comparative efficacy of two interventions without allocation bias 
(Borah et al., 2014). It is, however, a valid alternative to be able to use clinical practice 
data and apply correction methods such as the PS. When using methods like the PS, one 
should consider existing guidelines for observational research (i.e., Berger et al., 2012) 
so that using non randomized clinical practice data does not become an excuse for not 
gathering crucial data on patient characteristics and assignment to treatment (Borah et 
al., 2014). Even more, it could be necessary to develop standards in reporting results 
of PS methods to be transparent about the assessed balance and treatment outcome 
(Borah et al., 2014) and to register these observational studies (Berger et al., 2012; 
Williams, Tse, Harlan, & Zarin, 2010). In addition, the context of the field of youth care 
at the moment the data was gathered is also relevant, since for example reimbursement 
decisions or referral policies can change yearly within each municipality. If intervention 
A, for example, is reimbursed within year ‘X’, while it is not in year ‘Y’, the number 
and ‘type’ of adolescents assigned to intervention A can differ between these years, 
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which complicates the comparison of intervention A and intervention B over year X 
and Y. Thus, the context of the selected dataset and of the evaluation study should be 
considered and discussed when interpreting its findings. 
Second, not only research into the effectiveness and cost-effectiveness of youth 
care should be brought together, but also the criteria used to evaluate this research. 
The criteria used to rank the level of effectiveness of interventions could for instance 
be combined with the criteria used to decide on the reimbursement of interventions 
in youth care. The level of effectiveness of youth interventions can be found in the 
Database Effective Interventions (Netherlands Youth Institute, 2016). As described in 
the introduction of this thesis, the DEI is based on the so-called ‘effectladder’ in which 
an intervention is marked according to four ranked categories (Veerman & van Yperen, 
2008). The criteria to decide upon reimbursement, on the other hand, are formulated 
from a health economic perspective that is originally based on the ‘Trechter van 
Dunning’ (Busschbach & Delwel, 2010; Roscam Abbin, 1991). The decision to reimburse 
health care interventions is based on four criteria, of which proven effectiveness is 
the second criterion, after having evaluated the need for intervening, the necessity, 
in the first place (Busschbach & Delwel, 2010; Roscam Abbin, 1991; Zwaap, Knies, 
van der Meijden, Staal, & van der Heijden, 2015). The third criterion considers the 
cost-effectiveness, or efficiency, of the intervention. Combining the criteria could be 
accomplished by incorporating the youth care perspective, for example given in the 
criteria of the ‘effectladder’, in the second criterion of the ‘Trechter van Dunning’, which 
is also described in a report on how to decide upon the level of evidence in research 
and practice concerning health care (Zwaap et al., 2015). Another way to combine 
the effectiveness and the cost-effectiveness criteria could be to add the criteria for 
reimbursement of interventions to the level of evidence included in the DEI. This could 
be a first step in bringing evidence and decisions about reimbursements together in 
youth care, or at least to make the criteria to decide upon the level of evidence more 
explicit. A future step might even be to introduce and apply more detailed and explicit 
decision criteria, which could be brought together in a multi-criteria decision analysis 
(Baltussen & Niessen, 2006; Thokala & Duenas, 2012). A multi-criteria decision analysis 
is an approach to explicitly incorporate and weigh several criteria in a systematic and 
transparent way (Baltussen & Niessen, 2006; Thokala & Duenas, 2012). These criteria 
are scored and weighted to a sum score per treatment alternative. Policy makers can 
use this score as a tool to inform their reimbursement decision. As this approach is more 
widely applied in health technology assessment nowadays, it could be a tool to indeed 
bringing criteria to decide upon the reimbursement of youth care together and make 
them explicit and transparent.
Third, cost-effectiveness research in youth care needs guidelines that can improve 
the implementation of health economic evaluations in this field, because this type of 
research is not yet widely applied. For example, youth care could incorporate the already 
existing guidelines and best practices in health economics (Zorginstituut Nederland, 
2015), by which it would also follow international health technology assessment 
standards because these are included in these guidelines. In addition, these guidelines 
could be adjusted on advises and best practices that specifically fit this type of research 
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in youth care, to support this field in evaluating interventions on cost-effectiveness. 
The Netherlands organization for health research and development (ZonMw) recently 
funded research into the cost-effectiveness of youth care interventions (ZonMw, 2016). 
Part of this project was finding out whether economic evaluations in the youth sector 
could be standardized and which methodological issues and practical challenges 
would appear when applying economic evaluations in youth care (Dirksen & Evers, 
2016). Some of the issues found were concerned with the perspective of the economic 
evaluation: If a societal perspective is taken, how are costs and effects distributed over 
different stakeholders? What time horizon should be used? This would preferably be a 
long-term estimation to model cost-effectiveness into adulthood, especially because 
childhood risks can predict economic burden into adulthood (Caspi, Houts, Belsky, 
Harrington, Hogan, Ramrakha, et al., 2016). However, long-term follow-up data is often 
lacking and if modelling over long-term, what effects should be taken into account? 
Another issue of concern is the identification, measurement, and valuation of costs and 
outcomes: Should we measure costs of the child or adolescent alone, or also costs 
of the parents, and how are all service types valued if these are not mentioned in the 
Dutch costing manual (Hakkaart van Roijen, van der Linden, Bouwmans, Kanters, & Tan, 
2015)? Another question is whether we should use a generic outcome measure such as 
Quality Adjusted Life Years (QALY) in health economics, or not? Some of these issues 
also became apparent while conducting the research in this thesis, since we applied 
economic evaluation methods in youth care. For example, we modelled long-term cost-
effectiveness estimates because we made assumptions on how these effects would last 
over time. Measuring these effects over time would be preferred, but highly depends 
on the study design and needs including adolescents and parents for a longer period. 
Although we measured the effect of the interventions with criminal activity free years, 
this measure cannot broadly be applied to compare interventions not aimed at reducing 
criminal activity in youth care. Therefore, a generic outcome which is clinically relevant 
as well is highly recommended. Though this thesis showed that it is possible to conduct 
economic evaluation studies in youth care, in light of the issues raised by Dirksen and 
Evers (2016) it is important to develop standards to conduct or at least report on these 
issues in an economic evaluation study to be able to compare studies and the results 
of the interventions evaluated. The methodological and practical challenges raised by 
Dirksen and Evers (2016) thus provide a starting point to conduct further research and 
develop future guidelines. Moreover, there are prominent and important steps made 
in conducting economic evaluation studies in youth care in the Netherlands, of which 
Kremer and colleagues (2016) gave a first overview. They recommend to validate the 
model used, to use a generic outcome measure such as the QALY, to include all relevant 
costs and to report carefully and in detail about the analyses to be able to compare the 
results with other studies in youth care. 
Fourth, an additional recommendation for future studies pertains to the judicial 
context of some interventions. Adolescents referred to FFT and MST, for instance, often 
have a court order (Baglivio, Jackowski, Greenwald, & Wolff, 2014). When interventions 
are used in a judicial context, criminological theories and studies should be considered 
in evaluating their effectiveness and cost-effectiveness (i.e., Velthoven, 2008). For 
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example, in estimating willingness-to-pay values, one should wonder ‘Do we want to 
pay only for avoiding crimes, or do we want to pay for avoiding crimes in which the 
costs of investigations, prosecution, witnesses, legal aid, prevention programs, and the 
valuation of fear are also incorporated?’ (Cohen & Piquero, 2009; Cohen, Rust, Steen, 
& Tidd, 2004). Though the most recent Dutch guidelines on health economic studies 
mentioned this shortly, if youth care overlaps with the field of criminology there could 
be an additional set of issues that should be given attention in research and guidelines. 
In sum, evaluation studies and economic evaluations studies are an important tool in 
further developing the content, accessibility, and affordability of youth care interventions 
in the Netherlands. The developments mentioned above can further direct these types 
of studies and can bring together clinical practice and research in youth care. 
Limitations
Despite the strengths of the studies that are described in this thesis, such as the use 
of clinical practice data to evaluate the effectiveness of interventions, meaning that 
interventions and questionnaires were not adjusted for research purposes, and the use 
of an economic model to illustrate the applicability of these analyses in youth care, a 
number of limitations merit reflection.  
Firstly, the cost-effectiveness model that was introduced in Chapter 2 and further 
used in the value of information analysis in Chapter 3 was illustrative in the absence of 
underlying trial data. The analyses and interpretations illustrated how such a method 
could be applied when evaluating youth care interventions, specifically aimed at 
reducing juvenile delinquency. In applying these methods, health economic guidelines, 
nationally and internationally, prescribe the steps that should be taken in conducting 
a valid and reliable health economic evaluation study (Husereau, Drummond, Petrou, 
Carswell, Moher, Greenberg, et al., 2013; Zorginstituut Nederland, 2015. We were not 
able to follow these steps in much detail, because we only had limited data. However, 
future economic evaluations in youth care should take into account these guidelines 
and use them as a starting point to apply these methods in youth care, while different 
recommendations should be made for youth care specifically. Furthermore, the cost-
effectiveness study in this thesis was based on methods in health technology assessment 
and specifically focused on cost-effectiveness analyses. However, there are alternative 
methods such as a cost-utility analysis, in which the effect is measured and expressed in 
a generic, preference weighted outcome measure like the QALY. Another alternative is 
a cost-benefit analysis in which the benefit is expressed in costs as well. In the US, these 
cost-benefit analyses are widely adopted in the evaluation of youth interventions (Aos, 
Lieb, Mayfield, Miller, & Pennucci, 2004). In the Netherlands, guidelines for societal cost-
benefit analysis have been developed as well (Pomp, Schoemaker, & Polder, 2014). This 
approach, however, differs notably from the cost-effectiveness analysis presented in this 
thesis. If economic evaluation methods will be further applied in youth care, a uniform 
approach that is well documented and described is highly recommended (Dirksen & 
Evers, 2016). 
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Secondly, non-randomized data need sophisticated modelling or statistical 
techniques to control for limitations like uncertainty in the parameter estimates and 
differences in observed baseline variables. Although our statistical methods were 
carefully chosen, they are not the only methods available to adjust for data limitations. 
For example, using information about the parameters available only in the dataset when 
modelling the cost-effectiveness and estimating the value of conducting further research 
using a Markov model is one way to fill in the model. An alternative would have been 
to first systematically search the literature and fill in the model parameters based on 
this information, then modelling the uncertainty, and then updating the model with the 
information from the dataset available. An advantage would have been that all available 
evidence would have been submitted in the model. A disadvantage would have been 
that the evidence used came from different datasets with different contexts. Then, the 
question would arise how the conclusions would relate to the specific situation in which 
the data were gathered. In addition, there are available alternatives to the PS method 
to adjust for observed baseline differences between intervention groups. This method 
only controls for measured baseline differences and it is not the only method that can 
control for such differences. Alternatives such as instrumental variables and multivariate 
matching methods are also plausible options (Borah et al, 2014; Kreif, Grieve, Radice, 
Sadique, Ramsahai, & Sekhon, 2012). In addition, among other methods to test the 
robustness of the findings, like using sensitivity analyses or repeating the analyses in 
different subsets, one could think of using two or three different statistical techniques 
to find out whether the results found were robust (Borah et al., 2014; Duncan, Engel, 
Claessens, & Dowsett, 2014). It could overcome misinterpretations and false conclusions 
from analyses, especially when only the p-value is used to draw inferences from the 
analyses (Greenland, Senn, Rothman, Carlin, Poole, Goodman et al., 2016). Results could 
be presented as a probability that the findings are likely given the selected dataset, and 
the robustness of the findings can be represented in the method, in the interpretations, 
and in the selected datasets (Nuzzo, 2014). 
Conclusion
Although the methods used were not new in all aspects (e.g., in applying a cost-
effectiveness framework or using statistical methods to control for allocation bias), the 
studies in this thesis showed the practical applicability of these methods and of the use 
of clinical practice data to answer relevant research questions. More importantly, this 
thesis showed that different research fields can learn from each other. Health economic 
evaluations are not yet widely applied in youth care. Therefore, youth care can learn 
from and adopt these modelling techniques. The other way around, health economics 
can learn from youth care practice and adopt strategies from that field when deciding 
on guidelines. Issues that are initially thought to be specific for a certain research area 
are probably not that specific and can be used in related fields as well. 
Thus, this thesis showed that cost-effectiveness analyses provide valuable information 
that can be used to allocate public budgets on available youth care interventions wisely. 
Furthermore, using clinical practice data in youth care that are routinely gathered is 
| Chapter 6 General discussion |
6
| 148 149 |
needed to evaluate interventions on their effectiveness, and is needed to ultimately 
evaluate these intervention on their costs and effectiveness in every day practice 
setting. When this information is available, money saved by not reimbursing a costly 
and ineffective treatment can be spend wisely by helping adolescents and their families 
with an intervention that is cost-effective.
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In health care, economic evaluation studies using state of the art decision analytic 
methods are common practice. The data used in such studies are often gathered within 
randomized clinical trials, but observational data are considered a valid alternative. In 
contrast, in Dutch youth care   cost-effectiveness research and the use of available, non-
randomized data are not common practice. Therefore, this thesis addressed the use and 
feasibility of state of the art decision analytical methods in youth care and showed how 
available, non-randomized data can be used when evaluating youth care. 
In Chapter 2, we constructed a probabilistic Markov model to assess the cost-
effectiveness of systemic interventions in youth care. To illustrate model functioning 
and the interpretation of the results, Functional Family Therapy (FFT) was compared to 
Treatment as Usual (TAU). The assumptions and parameters normally used to evaluate 
health care interventions were adjusted to better fit the characteristics of the systemic 
interventions. The treatment outcome, for example, was defined as Criminal Activity 
Free Years (CAFY) to address the clinical and the societal effect of the interventions. 
In addition, costs of resource use of the adolescents and of one of their parents were 
taken into account in the model, because systemic interventions are not only aimed at 
the referred client (i.e., the adolescent), but also at the system surrounding him or her. 
Resource use was defined broader than health care costs alone; The assignment to a 
foster home, a residential institution, or several contacts within the criminal justice system, 
for example, were also measured and expressed in costs per adolescent. Because the 
interventions were provided to youth aged 12 to 18 years and treatment effects can be 
expected to last into adulthood, long-term cost-effectiveness was estimated. The results 
of this model showed that (slightly adjusted) common economic evaluation methods are 
applicable in evaluating youth care. Moreover, the results can be interpreted in the same 
way as other economic evaluation results. These findings are an important first step 
towards a more systematic application of this method in youth care. The findings also led 
to important recommendations, such as defining an outcome that allows comparisons 
with other youth care interventions and taking into account costs outside the health care 
system (e.g., victim costs and reduced costs of avoided crimes). 
Because the input in a cost-effectiveness analysis can be uncertain due to imperfect 
or incomplete estimates of costs and effects, the decision whether or not to reimburse an 
intervention, based on this cost-effectiveness analysis, is marked by uncertainty. Further 
research may reduce this uncertainty, but is probably not without costs. The added value 
of future cost-effectiveness research is estimated in a value of information analysis. The 
aim of Chapter 3 was to investigate whether a value of information analysis, which 
is commonly applied in health care evaluation studies, is feasible and meaningful in 
youth care as well, and especially applicable to systemic interventions aimed at reducing 
criminal activity of adolescents. The cost-effectiveness model of Chapter 2 was used 
to illustrate such a value of information analysis, in which FFT was compared to the 
Course House (i.e., a comparative intervention on which we had literature data). Model 
parameters were grouped to identify those parameters that contributed most to the 
uncertainty and, therefore, would be most worthwhile for future research. Thereby, it 
was needed to assume a ‘willingness-to-pay (WTP) value’ for one CAFY (i.e., what is 
society willing to pay for one year without criminal activity of one adolescent?), because 
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the expected value of further information depends on this WTP value. The illustrative 
WTP value was based on and averaged over different values society wants to pay to 
prevent crimes like robbery and vandalism. The illustrative value of information analysis 
revealed that at a societal willingness-to-pay of €71,700 per criminal activity free year, 
further research to eliminate parameter uncertainty was valued at €176 million. This 
means that society should be willing to spend a maximum of €176 million in reducing 
decision uncertainty in the cost-effectiveness of the two interventions. In particular, most 
of the uncertainty was found in the effects of the interventions, which was translated to 
transition probabilities of adolescents moving from one state to another in the Markov 
model, and, to a lesser extent, in the intervention costs of the Course House and the 
direct non health-care costs in both model states. This illustrative analysis showed that 
the results were meaningful and can be interpreted according to health care evaluation 
studies. Moreover, it showed that this analysis can be helpful in justifying additional 
research funds to further inform the reimbursement decision with regard to youth care 
interventions. Finally, this study made important recommendations for applying this 
method more systematically in youth care, like defining a WTP value to the defined 
outcome and, as in the cost-effectiveness analysis itself, determining the range of effects 
and costs that should be taken into account. 
In Chapters 4 and 5, the aim was to investigate and illustrate the use of available, 
non-randomized data when evaluating treatments in clinical practice. The propensity 
score (PS) method was used to control for initial differences due to the non-random 
assignment of adolescents to the treatments evaluated. In Chapter 4, the feasibility of 
the univariate and multivariate PS method was demonstrated in subgroup analyses of 
outcomes research. The performance of using the univariate PS was tested using Monte 
Carlo simulations with additional adjustment on the subgroups. . The multivariate PS was 
estimated by combining the treatment groups and subgroup categories. The treatment 
effect and subgroup effects were estimated in a linear regression model adjusting 
for either of the two PS estimations. The bias and mean squared error showed minor 
differences between both PS methods, with marginally lower values of the bias and 
mean squared error when using the multivariate PS. Clinical practice data from a large 
effectiveness study on psychotherapy in personality disorders were used to compare 
the two methods. Using these data, the differences between short-term and long-term 
treatment were compared using the severity of patients’ problems as the subgroup 
of interest. Both the univariate and multivariate PS estimations yielded similar results. 
The results of this study support the use of the multivariate PS with slightly less biased 
estimated treatment effects. The choice of the subgroup of interest, however, should 
be clinically relevant and influences the choice for analyses and interpretations as well.  
In Chapter 5, two youth care interventions, FFT and Multisystemic Therapy 
(MST) were compared on their effectiveness using non-randomized, clinical practice 
data from adolescents assigned to either one of these interventions (422 MST; 275 
FFT) at the Viersprong, institute for personality disorders and behavioral problems in 
the Netherlands. Data were gathered within Routine Outcome Monitoring and the 
effectiveness of the two interventions was estimated using the PS method to control 
for initial measured differences between the treatment groups. The primary outcome 
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was externalizing problem behavior. The secondary outcomes were the proportion 
of adolescents who were living at home, who were engaged in school or work after 
treatment, and who lacked police contact during treatment. No difference was found 
between MST and FFT regarding externalizing problem behavior, but the adolescents 
who received MST were more likely to be engaged in school or work after treatment 
compared with FFT. Because the risk-need-responsivity (RNR) model guided treatment 
assignment, effectiveness was also estimated in youth with and without a court order, 
as an indicator of their risk level. For adolescents without a court order, MST yielded 
a larger effect on externalizing problems. The propensity score could not balance the 
treatment groups in the subsample of adolescents with a court order, and, therefore, 
MST and FFT could not be compared on their effectiveness in this subsample. Though 
treatment assignment was based on the RNR model, results in the group without a 
court order were not in accordance with this model, while higher-risk adolescents with a 
court order were indeed more often assigned to the more intensive treatment, namely 
MST. Although MST is expected to be the more expensive treatment because it is more 
intensive, estimating the cost-effectiveness of these interventions seems only relevant in 
the subgroup of adolescents without a court order. 
In the general discussion in Chapter 6 we summarized the findings of this thesis 
and we conclude that cost-effectiveness analyses provide valuable information to 
allocate public budgets to available youth care interventions wisely. In addition, we 
conclude that clinical practice data in youth care, that is routinely gathered, is needed to 
evaluate interventions on their effectiveness, and ultimately on their cost-effectiveness. 
Furthermore, the implications for youth care and for future research and policy are 
discussed. From a youth care perspective, this thesis implicates that research findings 
from evaluation studies in every day practice should be brought to clinical practice by 
effectively communicating these findings to clinicians, patients, and policymakers to 
enable them to assign youth to evidence-based interventions. Data on health care costs 
besides the intervention itself should be routinely gathered to evaluate interventions 
on their cost-effectiveness. Cost-effectiveness research is especially important since a 
large number of municipalities have to decide on reimbursing interventions and current 
standards may differ between municipalities. From a research and policy perspective, 
it is recommended, whenever possible, to follow guidelines in reporting findings from 
studies using clinical practice data, since in such studies the context of the interventions 
is even more important than in randomized controlled trials. Furthermore, the criteria to 
decide upon the level of effectiveness and cost-effectiveness evidence should be made 
more explicit and transparent, especially if this evidence is used to decide upon the 
reimbursement of youth care interventions. To improve the implementation of health 
economic evaluation studies in youth care, guidelines on cost-effectiveness research 
in youth care should be developed. When developing these guidelines, one should be 
prone to learning from other related research fields and combine relevant perspectives 
and methods. 
Samenvatting
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Economische evaluaties op basis van besliskundige modellen worden binnen 
de gezondheidszorg veelvuldig toegepast om interventies te onderzoeken op 
kosteneffectiviteit. De gegevens die gebruikt worden in deze evaluaties, worden veelal 
verzameld binnen gerandomiseerd onderzoek. Observationeel of quasi experimenteel 
onderzoek, waarin deelnemers niet op basis van toeval zijn toegewezen aan interventies, 
kunnen als een valide alternatief worden beschouwd, onder de voorwaarden dat met 
statistische technieken op een valide manier gecorrigeerd wordt voor verschillen in 
baseline kenmerken tussen de groepen. In tegenstelling tot de gezondheidszorg, staat 
binnen de jeugdzorg het onderzoek naar kosteneffectiviteit van interventies en het 
gebruik maken van observationele data nog in de kinderschoenen. In dit proefschrift 
staan deze onderwerpen dan ook centraal: 1) het gebruik en de interpreteerbaarheid 
van economische evaluatiemethoden om de kosteneffectiviteit van interventies binnen 
de jeugdzorg te kunnen bepalen en 2) het gebruik van observationele en reeds 
beschikbare, niet gerandomiseerde gegevens in onderzoek naar de effectiviteit van 
jeugdinterventies. 
Om de toepassing van een kosteneffectiviteitsanalyse in de jeugdzorg te 
illustreren, wordt in Hoofdstuk 2 een Markovmodel gepresenteerd. Als voorbeeld 
wordt Functionele Gezinstherapie (Functional Family Therapy, FFT) vergeleken met 
andere beschikbare  behandelingen. De parameters en aannames in het model werden 
specifiek toegespitst op de vergelijking van deze jeugdinterventies. Onder andere 
werd de uitkomstmaat gedefinieerd als crimineel-vrije-jaren (CAFY) om daarmee 
het klinische en maatschappelijke effect van de interventies weer te kunnen geven. 
Daarnaast werd niet alleen het zorggebruik van de jongere, maar ook dat van een 
van de ouders meegenomen, omdat systemische interventies zich ook richten op de 
verbetering van het gezinsfunctioneren en de relaties in het systeem rond een jongere. 
Omdat deze interventies zich richten op meer dan alleen gezondheidswinst, zijn ook 
kosten buiten de gezondheidszorg nadrukkelijk betrokken in het model, zoals de kosten 
van een uithuisplaatsing of tijdelijke plaatsing in een pleeggezin en de kosten binnen 
het justitieel kader. Vanwege het verwachte lange termijn effect van de interventies 
werden in het Markovmodel effecten tot 30 jaar later gemodelleerd. De resultaten 
tonen aan dat kosteneffectiviteitsanalyses op basis van besliskundige modellen 
bruikbaar en toepasbaar zijn binnen de jeugdzorg en dat de resultaten op eenzelfde 
manier kunnen worden geïnterpreteerd als binnen de gezondheidszorg. De resultaten 
vormen een belangrijke stap in het toepassen van economische evaluaties, en meer 
specifiek kosteneffectiviteitsanalyses, binnen de jeugdzorg. Het verdient aanbeveling 
in toekomstige economische evaluaties in de jeugdzorg rekening te houden met 
bijvoorbeeld het definiëren van een meer generieke uitkomstmaat die vergelijkingen 
met andere jeugdinterventies mogelijk maakt. Ook kosten van zorggebruik buiten de 
gezondheidszorg die in ons onderzoek niet gemeten zijn, zoals mogelijke kosten van 
slachtoffers van criminaliteit gepleegd door de jongere en kosten van criminaliteit die 
voorkomen zijn door de interventies, zouden in toekomstige analyses meegenomen 
kunnen worden. 
De parameters in een Markovmodel zijn schattingen op basis van data uit de 
klinische praktijk of op basis van literatuur. Deze schattingen hebben een mate van 
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onzekerheid die is weergegeven in termen van de verdelingen van de parameters. Als 
op basis van die onzekerheid een beslissing rond het vergoeden van jeugdinterventies 
wordt genomen, wordt die beslissing eveneens gekenmerkt door onzekerheid. Verder 
onderzoek kan de onzekerheid rond de schatter van de parameter reduceren, en 
daarmee de onzekerheid in het model. Met dergelijk aanvullend onderzoek zijn echter 
ook kosten gemoeid. Om een goede afweging te kunnen maken met betrekking tot 
investeringen in verder onderzoek, kan een zogenaamde ‘value-of-information’ analyse 
uitgevoerd worden. In deze analyse worden de kosten berekend van het nemen van 
een verkeerde beslissing als gevolg van onzekerheid in de gebruikte parameters. Op 
die manier kan de waarde van het verzamelen van aanvullende informatie worden 
bepaald, de zogenaamde ‘verwachte waarde van perfecte informatie’. Als deze perfecte 
informatie voorhanden zou zijn, dan zou dit de onzekerheid in een model kunnen 
beperken. Het doel van Hoofdstuk 3 was te bepalen of een value-of-information 
analyse zinvol en interpretabel is in aanvulling op de kosteneffectiviteitsanalyse uit 
Hoofdstuk 2. Dergelijke analyses worden in de gezondheidszorg namelijk al gebruikt, 
maar in de jeugdzorg nog niet. In de value-of-information analyse werd FFT vergeleken 
met het Kursushuis (een vergelijkbare interventie). In kosteneffectiviteitsanalyses in het 
algemeen, en in een value-of-information analyse in het bijzonder, is het van belang om 
een zogenaamde kosteneffectiviteitsgrenswaarde te bepalen. Dat is de waarde die de 
budgethouder of de maatschappij bereid is te betalen voor in dit geval één crimineel-vrij 
jaar. De waarde van het nog uit et voeren onderzoek is afhankelijk van deze grenswaarde. 
Ter illustratie is deze kosteneffectiviteitsgrenswaarde berekend als gemiddelde van 
verschillende grenswaarden ter voorkoming van verschillende soorten criminaliteit, 
zoals vandalisme en diefstal. De value-of-information analyse liet zien dat bij een 
kosteneffectiviteitsgrenswaarde van €71,700 per crimineel-vrij-jaar, verder onderzoek 
om onzekerheid rond de modelparameters te reduceren gewaardeerd werd op €176 
miljoen. Dit betekent dat de maatschappij maximaal €176 miljoen zou moeten willen 
uitgeven om de onzekerheid rond de vergoedingsbeslissing van de jeugdinterventies 
FFT en Kursushuis te willen reduceren en perfecte informatie te hebben. De onzekerheid 
in het model zat met name in de geschatte effectiviteit van de interventies. In mindere 
mate zat de onzekerheid in de geschatte kosten van het Kursushuis en de directe 
kosten buiten de gezondheidszorg. Concluderend werd in Hoofdstuk 3 aangetoond 
dat de resultaten van een value-of-information analyse zinvol en bruikbaar zijn in de 
jeugdzorg. Het verdient aanbeveling een kosteneffectiviteitsgrenswaarde te definiëren 
voor een uitkomstmaat die breed toepasbaar is in het jeugdveld en om de relevante 
kosten en effecten van jeugdinterventies breed te definiëren en mee te wegen in een 
kosteneffectiviteitsanalyse en in een value-of-information analyse. 
In Hoofdstuk 4 en 5 stond het gebruiken van beschikbare, observationele en 
niet gerandomiseerde gegevens centraal bij de evaluatie van jeugdinterventies. De 
‘propensity score’ werd gebruikt om te corrigeren voor verschillen tussen jongeren 
in de verschillende behandelingen. Zulke verschillen kunnen ontstaan door het 
onwillekeurig toewijzen van jongeren aan een behandeling, of anders gezegd, doordat 
alleen jongeren met specifieke kenmerken in aanmerking komen voor een bepaalde 
interventie. Met de propensity score wordt gecorrigeerd voor de kans op toewijzing 
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aan een behandelgroep, gegeven een set van gemeten baseline kenmerken. In 
Hoofdstuk 4 is de bruikbaarheid van de univariate propensity score (toepasbaar om 
twee behandelgroepen te vergelijken) en de multivariate propensity score (toepasbaar 
om meerdere behandelgroepen te vergelijken) aangetoond in subgroep analyses. 
Met Monte Carlo simulaties zijn fictieve datasets gegenereerd. Hierin is met de 
univariate propensity score gecorrigeerd voor baseline kenmerken terwijl daarnaast 
een subgroep effect berekend is. De multivariate propensity score corrigeerde voor 
de baseline verschillen tussen de behandelgroepen gecombineerd met de subgroepen 
om het behandeleffect in subgroepen te kunnen berekenen. Beide methoden lieten 
minimale verschillen zien in de berekende behandeluitkomst, met iets lagere berekende 
afwijkingen van de juist voorspelde waarde voor de multivariate propensity score. 
Wanneer beide propensity scores toegepast werden op data van een omvangrijke studie 
naar de effectiviteit van psychotherapie bij persoonlijkheidsstoornissen (SCEPTRE), 
lieten beide propensity scores vergelijkbare resultaten zien. Concluderend lijkt de 
behandeluitkomst iets zuiverder geschat te kunnen worden door te corrigeren met de 
multivariate propensity score. De keuze voor de analyse, en dus voor het toepassen 
van de univariate of multivariate propensity score, is echter ook afhankelijk van de het 
subgroep effect waarin men geïnteresseerd is. 
In Hoofdstuk 5 is de effectiviteit van twee jeugdinterventies, FFT en Multisysteem 
Therapie (MST) vergeleken. Hierbij is gebruik gemaakt van data uit de klinische praktijk 
van de Viersprong, een hoogspecialistische GGZ instelling. De jongeren werden volgens 
de reguliere klinische praktijk toegewezen aan een van beide interventies (422 jongeren 
aan MST; 275 aan FFT). De gegevens werden verzameld met ‘Routine Outcome 
Monitoring’. De effectiviteit is onderzocht door de univariate propensity score toe te 
passen om te corrigeren voor gemeten baseline verschillen tussen de behandelgroepen. 
De primaire uitkomstmaat was externaliserend probleemgedrag, gemeten na afloop 
van de behandeling. De secundaire uitkomstmaten was het percentage jongeren dat 
thuis woonde na afloop van de behandeling, het percentage jongeren dat een zinvolle 
dagbesteding had na de behandeling, zoals werk of school, en het percentage jongeren 
dat geen politiecontact heeft gehad tijdens de behandeling. Kijkend naar de gehele 
behandelde groep verschilden MST en FFT niet wat betreft hun effect op externaliserend 
probleemgedrag. Wel had na afloop van MST een groter percentage van de jongeren 
een zinvolle dagbesteding dan na FFT. Omdat het ‘risk-need-responsivity’ (RNR) model 
de basis vormde om jongeren aan MST of FFT toe te wijzen, leek het zinvol ook naar 
subgroepen te kijken. Volgens het RNR-model zouden jongeren met meer risicofactoren 
namelijk meer moeten profiteren van een intensievere behandeling. Daarom werd de 
effectiviteit van MST en FFT ook onderzocht in subgroepen van jongeren met een 
hoog of laag risico. Als indicatie voor een hoog risico werd de aanwezigheid van een 
civielrechtelijke of strafrechtelijke maatregel gebruikt. Wanneer geen sprake was van een 
maatregel, werd het risico laag geacht. Uit de subgroep analyses bleek dat als jongeren 
voorafgaand aan de behandeling geen strafrechtelijke of civielrechtelijke maatregel 
hadden, MST een beter effect behaalde op externaliserend probleemgedrag dan FFT. 
Dit is niet in overeenstemming met het RNR-model waarin verwacht zou worden dat 
een minder intensieve behandeling, FFT, voldoende effectief zou zijn om deze jongeren 
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met een laag risico te behandelen. In de groep jongeren die voorafgaand aan de 
behandeling wel een maatregel had, was het niet mogelijk om met de propensity score 
te corrigeren voor baseline verschillen tussen de behandelgroepen; MST en FFT konden 
niet worden vergeleken in deze subgroep. In lijn met het RNR-model bleek dat jongeren 
met een maatregel voorafgaand aan de behandeling inderdaad vaker toegewezen 
waren aan MST dan aan FFT. Omdat verwacht wordt dat MST een meer intensieve en 
duurdere behandeling is dan FFT, lijkt aanvullend onderzoek naar de kosteneffectiviteit 
van MST en FFT op basis van deze resultaten alleen relevant in de groep jongeren 
zonder maatregel voorafgaand aan de behandeling. 
In Hoofdstuk 6 zijn de bevindingen uit de voorgaande hoofdstukken 
samengevat en als geheel nader beschouwd. Hieruit kan geconcludeerd worden dat 
kosteneffectiviteitsanalyses bruikbaar en waardevol zijn binnen het jeugdveld en dat de 
resultaten uit deze analyses gebruikt zouden kunnen worden om beschikbare budgetten 
in het jeugdveld te verdelen. Daarnaast hebben de onderzoeken naar de effectiviteit 
en kosteneffectiviteit van jeugdinterventies aangetoond dat het gebruik van data 
verzameld in de klinische praktijk, zoals via Routine Outcome Monitoring, valide en zinvol 
is. In Hoofdstuk 6 zijn ook de implicaties van dit proefschrift voor praktijk, onderzoek 
en beleid beschreven. De bevindingen uit wetenschappelijk onderzoek dienen actief 
bij hulpverleners, cliënten en beleidsmakers onder de aandacht gebracht te worden, 
zodat alle partijen over dezelfde informatie beschikken om te kiezen voor effectieve 
en kosteneffectieve interventies. Om de kosteneffectiviteit van interventies in kaart te 
brengen, zou het zorggebruik van jongeren routinematig gemeten moeten worden, 
bijvoorbeeld in Routine Outcome Monitoring. Onderzoek naar de kosteneffectiviteit van 
interventies lijkt immers een grotere rol te gaan spelen nu gemeenten verantwoordelijk zijn 
voor de jeugdzorg budgetten. Onderzoekers die gebruik maken van data uit de klinische 
praktijk, zouden richtlijnen moeten volgen die aangeven op welke manier transparant 
gerapporteerd kan worden over het gebruik van observationele data in evaluatiestudies. 
Ten slotte, als onderzoeksresultaten gebruikt worden om een jeugdinterventie al dan 
niet te vergoeden, zouden de vergoedingscriteria inzichtelijk en transparant moeten 
zijn. Er is grote behoefte aan richtlijnen voor kosteneffectiviteitsonderzoek in het 
jeugdveld om dergelijk onderzoek in het jeugdveld te bevorderen en te verbeteren. Bij 
het ontwikkelen van deze richtlijnen kan het noodzakelijk zijn over de grenzen van het 
eigen (jeugd)werkveld te kijken en gebruik te maken van andere relevante perspectieven 
en methoden. 
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